[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"_public_publisher_all{\"sortAscending\":false,\"sortField\":\"updateTime\",\"page\":0,\"size\":10,\"facet\":true,\"searchKey\":\"\"}":3,"_public_publisher_byId_83289c5a-0e1a-4089-90d0-8447ef02c8ba":656,"_public_publication_all{\"sortAscending\":false,\"sortField\":\"totalCitation\",\"page\":0,\"size\":10,\"facet\":true,\"searchKey\":\"publisherId:83289c5a-0e1a-4089-90d0-8447ef02c8ba,\"}":671},{"meta":4,"data":6},{"total":5},"117",[7,60,176,207,299,413,445,480,543,572],{"id":8,"createTime":9,"updateTime":10,"relativeEntities":11,"slug":12,"properties":13,"entityType":24,"verifyStatus":25,"verifyTime":26,"verifyNote":27,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":29,"subjectFields":30,"manageAffiliations":31,"indexDatabases":32,"url":33,"thumbnailPath":34,"statistic":35,"gsStatistic":26,"type":26,"analyzePriority":26},"5a09599f-54d1-44c3-8f16-3847ac552024","2023-08-17T04:28:50.832+00:00","2025-10-13T23:58:52.517+00:00",[],"T%E1%BA%A1p-ch%C3%AD-Truy%E1%BB%81n-nhi%E1%BB%85m-Vi%E1%BB%87t-Nam",{"country":14,"issn":16,"introduce":18,"title":21},{"VOID":15},"VN",{"VOID":17},"08667829",{"EN":19,"VI":20},"{\"ops\":[{\"insert\":\"Vietnam Journal of Infectious Diseases is a social - professional forum of the Vietnam Society for Infectious Diseases, whose responsibility is to introduce the researches, the scientific advances in Vietnam and from the world; to contribute to the improvement of knowledges for health care staffs about clinic, treatment, guideline, prevention, epidemiology for infectious diseases, HIV\u002FAIDS and community health care; to provide, exchange and publish scientific information to the public accurately and promptly.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Vietnam Journal of Infectious Diseases publishes in the whole country; serves the professional work for researchers, clinical staffs, administrators, undergraduate and postgraduate students who are working and studying in the infections, tropical diseases and HIV\u002FAIDS from central to local levels, also organizations and individuals in the world who are interested in infectious and tropical diseases and prevention for HIV\u002FAIDS.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Editor in Chief:\"},{\"attributes\":{\"header\":4},\"insert\":\"\\n\"},{\"insert\":\"Prof. Dr. Nguyen Van Kinh. - Chairman of Editorial Board\"},{\"attributes\":{\"align\":\"justify\",\"blockquote\":true},\"insert\":\"\\n\"},{\"insert\":\"Prof. Dr. Nguyen Van Mui.\"},{\"attributes\":{\"align\":\"justify\",\"blockquote\":true},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Headquarter:\"},{\"attributes\":{\"header\":4},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Address:\"},{\"insert\":\" Level 6, National Hospital for Tropical Diseases, No. 78 Giai Phong Street, Dong Da District, Hanoi city, Vietnam.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Tel:\"},{\"insert\":\" \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Fvjid\u002Fmanagement\u002Fsettings\u002Fcontext\u002Ftel:02435765464\"},\"insert\":\"02435765464\"},{\"insert\":\"; \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Fvjid\u002Fmanagement\u002Fsettings\u002Fcontext\u002Ftel:0913552672\"},\"insert\":\"0913552672\"},{\"insert\":\"; \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Fvjid\u002Fmanagement\u002Fsettings\u002Fcontext\u002Ftel:0913228072\"},\"insert\":\"0913228072\"},{\"insert\":\".\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Email\"},{\"insert\":\": \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Findex\u002Fadmin\u002Fcontexts\u002Fmailto:tungphamvan52@gmail.com\"},\"insert\":\"tungphamvan52@gmail.com\"},{\"insert\":\"; \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Fvjid\u002Fmanagement\u002Fsettings\u002Fcontext\u002Fmailto:tapchitruyennhiem@gmail.com\"},\"insert\":\"tapchitruyennhiem@gmail.com\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Bank account:\"},{\"insert\":\" 0021000275119, Vietcombank Hanoi Branch. Transaction office No. 7, 402 Tran Khat Chan, Hai Ba Trung District, Hanoi city, Vietnam.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"\\n\"}]}","{\"ops\":[{\"insert\":\"Tạp chí Truyền nhiễm Việt Nam là cơ quan ngôn luận của Hội Truyền nhiễm Việt Nam, chịu sự lãnh đạo, chỉ đạo trực tiếp của Thường vụ Ban Chấp hành Hội Truyền nhiễm Việt Nam; sự kiểm tra, giám sát về nghiệp vụ báo chí của các cơ quan chức năng quản lý báo chí thuộc Bộ Thông tin và Truyền thông và Ban Tuyên giáo Trung ương Đảng.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Tạp chí có trách nhiệm giới thiệu các công trình nghiên cứu khoa học, những tiến bộ khoa học trên thế giới và trong nước, góp phần nâng cao kiến thức khoa học cho cán bộ y tế về lâm sàng, điều trị, hướng dẫn, dự phòng, dịch tễ học các bệnh truyền nhiễm, HIV\u002FAIDS và chăm sóc sức khỏe cộng đồng; cung cấp, trao đổi, phổ biến các thông tin khoa học tới công chúng chính xác và kịp thời.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Tạp chí xuất bản 03 tháng\u002F01 kỳ và được phát hành qua Bưu điện và tự phát hành trong phạm vi toàn quốc.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Lãnh đạo Tạp chí: \"},{\"attributes\":{\"header\":4},\"insert\":\"\\n\"},{\"insert\":\"Tổng Biên tập: ThS.BSCKII Nguyễn Trung Cấp\"},{\"attributes\":{\"align\":\"justify\",\"blockquote\":true},\"insert\":\"\\n\"},{\"insert\":\"Phó Tổng Biên tập:\"},{\"attributes\":{\"align\":\"justify\",\"blockquote\":true},\"insert\":\"\\n\"},{\"insert\":\"            TS.BSCKII Phạm Ngọc Thạch\"},{\"attributes\":{\"align\":\"justify\",\"blockquote\":true},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Trụ sở tòa soạn:\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Địa chỉ: Tầng 6, Bệnh viện Bệnh Nhiệt đới Trung ương, 78 đường Giải Phóng, phường Phương Mai, quận Đống Đa, thành phố Hà Nội.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Điện thoại:\"},{\"insert\":\" \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Fvjid\u002Fmanagement\u002Fsettings\u002Fcontext\u002Ftel:02435765464\"},\"insert\":\"02435765464\"},{\"insert\":\" - \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Fvjid\u002Fmanagement\u002Fsettings\u002Fcontext\u002Ftel:0913228072\"},\"insert\":\"0913228072\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Email\"},{\"insert\":\": \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Findex\u002Fadmin\u002Fcontexts\u002Fmailto:tungphamvan52@gmail.com\"},\"insert\":\"tungphamvan52@gmail.com\"},{\"insert\":\"; \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Fvjid\u002Fmanagement\u002Fsettings\u002Fcontext\u002Fmailto:tapchitruyennhiem@gmail.com\"},\"insert\":\"tapchitruyennhiem@gmail.com\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Tài khoản:\"},{\"insert\":\" Số 0021000275119 Ngân hàng Ngoại thương Việt Nam, chi nhánh Hà Nội (Vietcombank Hà Nội). Phòng giao dịch số 7, 402 Trần Khát Chân, quận Hai Bà Trưng, Thành phố Hà Nội.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"\\n\"}]}",{"EN":22,"VI":23},"Vietnam Journal of Infectious Diseases","Tạp chí Truyền nhiễm Việt Nam","PUBLISHER","VERIFIED",null,"Admin update database","PENDING",51,[],[],[],"https:\u002F\u002Ftruyennhiemvietnam.vn\u002Findex.php\u002Fvjid","\u002Fapi\u002Fpublic\u002Ffile\u002Fpublisher\u002F5a09599f-54d1-44c3-8f16-3847ac552024\u002Fadb0e52bf25e0de580fd4289519cb8bf.jpg",{"impactFactor":36,"impactFactorByYear":37,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":41,"totalPublicationByYear":42,"totalCitation":48,"totalCitationByYear":49,"totalCitationPerPublication":54,"totalCitationPerPublicationByYear":55,"hindexLast5Year":59,"hindex":59},0,{"2022":38,"2023":39,"2024":40},0.01,0.03,0.13,315,{"2020":43,"2021":44,"2022":45,"2023":46,"2024":47},63,58,57,65,72,43,{"2020":50,"2021":51,"2022":52,"2023":53},8,15,9,11,0.14,{"2020":40,"2021":56,"2022":57,"2023":58},0.26,0.16,0.17,3,{"id":61,"createTime":62,"updateTime":63,"relativeEntities":64,"slug":65,"properties":66,"entityType":24,"verifyStatus":25,"verifyTime":78,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":79,"subjectFields":80,"manageAffiliations":81,"indexDatabases":136,"url":137,"thumbnailPath":26,"statistic":138,"gsStatistic":155,"type":175,"analyzePriority":26},"25b6bd10-676c-40c0-8dc3-356d1679a284","2023-05-19T02:22:33.430+00:00","2026-06-18T23:33:57.141+00:00",[],"T%E1%BA%A1p-ch%C3%AD-Y-D%C6%B0%E1%BB%A3c-h%E1%BB%8Dc-C%E1%BA%A7n-Th%C6%A1",{"country":67,"issn":68,"introduce":70,"title":73,"gsId":76},{"VOID":15},{"VOID":69},"23541210",{"EN":71,"VI":72},"\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">04\u002F10\u002F2015 Ministry of Information and Communications allowed Can Tho journal of medicine and pharmacy to operate (102 \u002FGP-BTTTT)\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">07\u002F16\u002F2015 Can Tho journal of medicine and pharmacy is internationally recognized: ISSN 2354-1210\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">In 2016, The journal has been included in the list of medical science journals by The State Council for professorship which is awarded a work score of 0-0.5 points for a published article.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Can Tho Journal of Medicine and Pharmacy welcome original works that haven’t been submitted or published in other medical journals. Posts must contain content related to one of the journal’s categories.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">The content published\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">The journal is divided into 3 categories:\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">- Scientific research article: are valuable scientific works, which have been researched and accepted.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">- Overview of medicine, biology and pharmacy: serving the objective of continuing training in the fields of medicine, biology and pharmacy; to systematize classical and modern knowledge.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">- Update information on new knowledge about medicine, biology, pharmacy in the country and in the world.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Scope\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">- Publication and introduction of scientific research in the fields:\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">+ Medicine (internal medicine, surgery, pediatrics, obstetrics and gynecology, odonto-stomatology, laboratory, oncology, traditional medicine, nursing).\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">+ Biology (genetics, biotechnology).\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">+ Pharmacology (pharmaceutics, drug quality analysis-control, synthetic pharmaceutical chemistry, biochemistry, pharmacognosy, botany, clinical pharmacy).\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">- To enhance the quality of undergraduate, postgraduate education, scientifically researching and meet the necessary treatment in hospital.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">- Introducing the updated domestic and oversea information about science technology to promote scientific research and exchanging technology in local, other universities.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">- Exchanging pharmaceutical and medical information for social health developing in the Mekong Delta and Vietnam.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">The object\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Postgraduate students, student of Can Tho University of Medicine and Pharmacy, scientists from schools, research institutes, hospitals, health centers, pharmaceutical companies of the Mekong Delta; other provinces and regions in Vietnam and other country.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Address\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Headquarters of Can Tho Journal of Medicine and Pharmacy, located Scientific Research and International Cooperation Office: 179 Nguyen Van Cu Street, An Khanh Ward, Ninh Kieu District, Can Tho City, Vietnam.\u003C\u002Fspan>\u003C\u002Fp>","\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Ngày 16\u002F7\u002F2015, Tạp chí Y Dược học Cần Thơ được cấp chỉ số quốc tế: ISSN 2354-1210.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Từ tháng 4\u002F2016, Tạp chí đã được Hội đồng Giáo sư ngành Y đưa vào danh sách các tạp chí khoa học Y học được tính điểm công trình 0-0,5 điểm cho một bài báo đăng.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Năm 2020 Tạp chí Y Dược học Cần Thơ đã được phê duyệt vào danh mục của các Hội đồng Giáo sư ngành Dược học được tính điểm công trình 0-0,5 điểm cho một bài báo đăng.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tạp chí Y Dược học Cần Thơ ra 12 số\u002Fnăm, 180-200 trang\u002Fsố.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Từ tháng 12\u002F2022 Tạp chí Y Dược học Cần Thơ là thành viên của hệ thống Crossref và từ tháng 01\u002F2023 tạp chí thực hiện bình duyệt online kín 2 chiều nhằm tăng tính minh bạch, tin cậy của các công trình nghiên cứu khoa học và đảm bảo tốt nhất chất lượng khoa học của bài viết.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tôn chỉ, mục đích và phạm vi của tạp chí\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tôn chỉ và mục đích hoạt động của tạp chí: xuất bản nhằm mục đích phổ biến kết quả từ các đề tài nghiên cứu khoa học; giao lưu trao đổi khoa học, chia sẻ kinh nghiệm, học tập, đồng thời cập nhật thông tin khoa học mới trong các lĩnh vực y, sinh, dược học trong và ngoài nước.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Phạm vi của tạp chí: Tạp chí xuất bản được chia thành 3 chuyên mục: (i) Bài báo nghiên cứu khoa học là kết quả công trình nghiên cứu khoa học có giá trị đã được triển khai nghiên cứu, (ii) Bài tổng quan y, sinh, dược học: phục vụ mục tiêu đào tạo liên tục trong lĩnh vực y, sinh, dược học; nhằm hệ thống hóa những kiến thức kinh điển và hiện đại; (iii) Thông tin cập nhật kiến thức mới về y, sinh, dược học trong nước và trên thế giới.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Chính sách truy cập mở\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tạp chí Y Dược học Cần Thơ áp dụng chính sách truy cập mở đối với các bài báo đã xuất bản đến với độc giả, nhằm mở rộng cơ hội tiếp cận các kết quả nghiên cứu chất lượng cao và tăng cường trao đổi kiến thức. Tạp chí đăng tải trực tuyến (miễn phí) toàn văn các bài báo được công bố trên website của Tạp chí (https:\u002F\u002Ftapchi.ctump.edu.vn).\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Đạo đức xuất bản\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tạp chí Y Dược học Cần Thơ cam kết tuân thủ đạo đức xuất bản phù hợp với các hướng dẫn và tiêu chuẩn của the Committee on Publication Ethics (COPE), tuân thủ các nguyên tắc của COPE’s Core Practices, Best Practices Guidelines for Journal Editors và Guidelines on Good Publication Practices.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Bản thảo bài báo chỉ được chấp nhận khi được tác giả chịu trách nhiệm chính cam kết các nội dung sau: Các nội dung của bản thảo chưa được đăng tải toàn bộ hoặc một phần ở các tạp chí khác; Tất cả các tác giả đều có đóng góp một cách đáng kể vào quá trình nghiên cứu hoặc chuẩn bị bản thảo và cùng chịu trách nhiệm về các nội dung của bản thảo; Tuân thủ các biện pháp đảm bảo đạo đức nghiên cứu (ví dụ thỏa thuận đồng ý tham gia nghiên cứu).\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Cam kết bảo mật\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tạp chí cam kết thực hiện và tuân thủ các quy định của luật và các văn bản hướng dẫn liên quan đến bảo mật thông tin cá nhân trên không gian mạng. Các thông tin mà người dùng (tác giả, độc giả, biên tập viên, người phản biện) nhập vào các biểu mẫu trên Hệ thống Quản lý xuất bản trực tuyến của tạp chí chỉ được sử dụng vào các mục đích đã được tuyên bố rõ ràng và sẽ không được cung cấp cho bất kỳ bên thứ ba nào khác, hay dùng vào bất kỳ mục đích nào khác.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Phí gửi bài\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Lệ phí gửi đăng bài: 1.000.000đ\u002Fbài báo\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Lệ phí gửi đăng nhanh: 1.500.000đ\u002Fbài báo\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Đối với tác giả là cán bộ viên chức thuộc Trường Đại học Y Dược Cần Thơ thì được hỗ trợ 50% lệ phí gửi đăng bài.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Đối với sinh viên thực hiện đề tài nghiên cứu khoa học cấp trường được hỗ trợ 100% lệ phí đăng bài ( Tác giả gửi đính kèm “ Quyết định về việc giao tổ chức thực hiện đề tài nghiên cứu khoa học cấp Trường của sinh viên”).\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Hình thức nộp lệ phí:\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">1. Tiền mặt:\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Nộp trực tiếp tại Phòng Tài chính - Kế toán, Trường Đại học Y Dược Cần Thơ, số 179 Nguyễn Văn Cừ, P. An Khánh, Q. Ninh Kiều, thành phố Cần Thơ.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">2. Chuyển khoản:\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tên Tài khoản: Trường ĐHYD Cần Thơ, Số TK: 0111000115668, tại ngân hàng Vietcombank chi nhánh Cần Thơ.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Thời gian: Áp dụng từ ngày 01\u002F02\u002F2023.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">* Phí gửi bài không được hoàn trả khi bài viết bị từ chối hoặc tác giả xin rút bài viết.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Quy trình phản biện bài báo\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tạp chí Y Dược học Cần Thơ thực hiện quy trình phản biện kín hai chiều nghiêm ngặt. Danh tính của những người phản biện không được tiết lộ cho các tác giả và ngược lại. Quy trình thẩm định bài báo đăng gồm các bước sau:\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tiếp nhận bản thảo\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tác giả liên hệ gửi bản thảo đến Tạp chí qua hệ thống trực tuyến tại website: https:\u002F\u002Ftapchi.ctump.edu.vn. Hướng dẫn về cách đăng ký, gửi bài và chuẩn bị bản thảo được cung cấp trên website của Tạp chí.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Sàng lọc sơ bộ\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Sau khi Tòa soạn nhận được bài báo của tác giả, Ban Thư ký sẽ tiến hành kiểm tra sơ bộ bài báo (các yêu cầu về nội dung và hình thức). Những bài báo không đúng quy cách hoặc có nội dung không phù hợp hoặc vi phạm bản quyền sẽ bị từ chối (Ban Thư ký thông báo phản hồi đến tác giả trong vòng 1 tuần). Những bài báo đủ điều kiện, được Ban Thư ký tòa soạn chuyển đến Ban Biên tập có cùng chuyên môn với nội dung bài báo để đề xuất người phản biện. Thời gian kể từ khi Ban Biên tập nhận bài báo đến khi đề xuất người phản biện bài báo chậm nhất là 5 ngày.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Vòng phản biện\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">1. Ban Thư ký gửi bài và yêu cầu phản biện đến 02 phản biện độc lập.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">2. Các phản biện gởi nhận xét cho Ban Thư ký. Thời gian từ khi gửi bài cho phản biện đến khi nhận ý kiến của phản biện tối đa là 20 ngày.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Xử ký kết quả phản biện\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">1. Nếu ý kiến đồng ý cho đăng và không cần chỉnh sửa, Ban Thư ký tiếp tục đăng bài theo qui trình.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">2. Nếu ý kiến đồng ý đăng và cần chỉnh sửa, Ban Thư ký sẽ thông tin đến tác giả chỉnh sửa theo yêu cầu của người phản biện. Thời gian chỉnh sửa và gửi lại kéo dài không quá 2 tuần, từ khi tác giả bài báo nhận được thông tin (Quá trình này có thể lặp lại tối đa 2 lần\u002F1 bài báo). Khi có sự thống nhất, đồng ý của người phản biện; bài báo được tiếp tục đăng theo qui trình.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">3. Những bài báo có chất lượng không đạt yêu cầu, cả 2 phản biện không đồng ý cho đăng sẽ bị Tòa soạn từ chối đăng.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Xuất bản\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">1. Ban Thư ký tổng hợp các bản thảo đã được tác giả hoàn thiện sau thẩm định trình Ban Biên tập xem xét, Tổng Biên tập phê duyệt, quyết định bài đăng theo các tiêu chí: sự phù hợp nội dung với tôn chỉ và mục đích, thể loại bài viết (ưu tiên các bài có bài có nghiên cứu chuyên sâu, hàm lượng khoa học cao), đóng góp mới bài báo, bài báo được ưu tiên đăng trong số gần nhất của Tạp chí theo thứ tự: tính thời sự, chất lượng bài báo và thời gian gửi bài.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">2. Ban Biên tập và Ban Thư ký biên tập bản thảo, chế bản, đọc rà soát lỗi. Thời gian hoàn thành từ 10-15 ngày.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">3. Ban Thư ký có trách nhiệm thông báo cho tác giả bài báo (bằng e-mail) về tình hình phê duyệt bài báo, thời gian, số kỳ, tập xuất bản bài báo theo qui định.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">4. Danh sách bài báo theo số Tạp chí được in ấn và phát hành trong năm định kỳ được công bố chính thức trên website: https:\u002F\u002Ftapchi.ctump.edu.vn\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>",{"EN":74,"VI":75},"Cantho Journal of Medicine and Pharmacy","Tạp chí Y Dược học Cần Thơ",{"VOID":77},"wcQ1uqwAAAAJ","2023-05-30T08:17:21.868+00:00",32,[],[82],{"id":83,"createTime":84,"updateTime":85,"relativeEntities":86,"slug":87,"properties":88,"entityType":98,"verifyStatus":25,"verifyTime":99,"verifyNote":26,"syncStatus":28,"languages":100,"translateLanguages":26,"viewCount":103,"url":104,"parentIds":105,"statistic":106},"6413896b-eca9-442b-a73f-182a58a0ce40","2023-06-12T14:59:13.446+00:00","2026-06-19T02:29:32.871+00:00",[],"Tr%C6%B0%E1%BB%9Dng-%C4%90%E1%BA%A1i-h%E1%BB%8Dc-Y-D%C6%B0%E1%BB%A3c-C%E1%BA%A7n-Th%C6%A1",{"country":89,"title":90,"address":93,"abbreviation":96},{"VOID":15},{"EN":91,"VI":92},"Can Tho University of Medicine and Pharmacy","Trường Đại học Y Dược Cần Thơ",{"VI":94,"EN":95},"Số 179, đường Nguyễn Văn Cừ, phường An Khánh, quận Ninh Kiều, thành phố Cần Thơ, Việt Nam","No 179, Nguyen Van Cu street, An Khanh ward, Ninh Kieu district, Can Tho city, Vietnam",{"VOID":97},"ctump","AFFILIATION","2023-08-01T14:07:27.977+00:00",[101,102],"VI","EN",12,"http:\u002F\u002Fwww.ctump.edu.vn\u002F",[],{"impactFactor":36,"impactFactorByYear":107,"i10Index":111,"i10IndexLast5Year":59,"totalPublication":112,"totalPublicationByYear":113,"totalCitation":122,"totalCitationByYear":123,"totalCitationPerPublication":128,"totalCitationPerPublicationByYear":129,"hindexLast5Year":135,"hindex":135},{"2022":108,"2023":109,"2024":110,"2025":38},0.1,0.05,0.07,4,1489,{"2013":114,"2014":115,"2015":115,"2016":111,"2017":115,"2018":59,"2019":114,"2020":116,"2021":117,"2022":118,"2023":119,"2024":120,"2025":121,"2026":111},2,1,10,84,281,680,260,156,313,{"2013":59,"2014":114,"2018":124,"2021":125,"2022":126,"2023":127},17,36,123,132,0.21,{"2013":130,"2014":114,"2018":131,"2021":132,"2022":133,"2023":134},1.5,5.67,0.43,0.44,0.19,6,[],"https:\u002F\u002Ftapchi.ctump.edu.vn\u002Findex.php\u002Fctump",{"impactFactor":36,"impactFactorByYear":139,"i10Index":114,"i10IndexLast5Year":114,"totalPublication":140,"totalPublicationByYear":141,"totalCitation":147,"totalCitationByYear":148,"totalCitationPerPublication":151,"totalCitationPerPublicationByYear":152,"hindexLast5Year":135,"hindex":135},{"2022":38,"2023":36,"2024":39,"2025":38},1956,{"0":114,"2019":114,"2020":50,"2021":142,"2022":143,"2023":144,"2024":145,"2025":146},76,403,789,305,371,524,{"0":114,"2019":135,"2021":124,"2022":149,"2023":150,"2024":111,"2025":114},287,206,0.27,{"0":115,"2019":59,"2021":153,"2022":154,"2023":56,"2024":38,"2025":38},0.22,0.71,{"impactFactor":26,"impactFactorByYear":26,"i10Index":114,"i10IndexLast5Year":114,"totalPublication":156,"totalPublicationByYear":157,"totalCitation":163,"totalCitationByYear":164,"totalCitationPerPublication":169,"totalCitationPerPublicationByYear":170,"hindexLast5Year":135,"hindex":135},461,{"0":158,"2019":114,"2021":159,"2022":160,"2023":161,"2024":158,"2025":162},7,37,296,107,5,419,{"2021":59,"2022":59,"2023":165,"2024":166,"2025":167,"2026":168},71,126,171,41,0.91,{"2021":171,"2022":38,"2023":172,"2024":173,"2025":174},0.08,0.66,18,34.2,"JOURNAL",{"id":177,"createTime":178,"updateTime":179,"relativeEntities":180,"slug":181,"properties":182,"entityType":24,"verifyStatus":25,"verifyTime":193,"verifyNote":26,"syncStatus":28,"languages":194,"translateLanguages":26,"viewCount":36,"subjectFields":195,"manageAffiliations":196,"indexDatabases":197,"url":198,"thumbnailPath":26,"statistic":26,"gsStatistic":199,"type":175,"analyzePriority":26},"f8d0bf97-8d89-482e-b58c-2fc481a0b79b","2025-10-27T06:27:08.591+00:00","2026-06-18T23:33:41.667+00:00",[],"T%E1%BA%A1p-ch%C3%AD-Khoa-h%E1%BB%8Dc-v%C3%A0-C%C3%B4ng-ngh%E1%BB%87-nhi%E1%BB%87t-%C4%91%E1%BB%9Bi",{"country":183,"introduce":184,"gsId":186,"title":188,"issn":191},{"VOID":15},{"EN":185},"\u003Cp style=\"text-align:justify;\">     Journal of Tropical Science and Engineering (JTSE) is a multidisciplinary scientific journal, licensed to operate as a print journal in 2012 and an electronic journal in 2024 (License No.1479\u002FGP-BTTTT dated August 20, 2012 and No.91\u002FGP-BTTTT dated April 9, 2024 issued by the Ministry of Information and Communications of Vietnam). The JTSE is headquartered in Hanoi.\u003C\u002Fp>\u003Cp style=\"text-align:justify;\">        The JTSE is published every 3 months (4 issues\u002Fyear), publishing research results and overview articles in 3 groups of fields: Tropical Ecology and Environment; Chemistry and Material Sciences; Biomedicine and Pharmacy. In 2022, the JTSE registered the international identifier Digital Object Identifier (DOI): 10.58334\u002Fvrtc.jtst and assigned DOI codes to all articles of the journal. The members of the Editorial Board of the JTSE are prestigious scientists and leading scientists from Vietnam and many countries in the world. The JTSE has been recognized by the Vietnam State Council for Professorship to score scientific articles in Chemistry, Medicine and Biology with scores ranging from 0-0.75 points.\u003C\u002Fp>\u003Cp style=\"text-align:justify;\">      Currently, the JTSE is building and perfecting a set of criteria and making efforts to join the List of prestigious  international journals with a roadmap to enter Scopus and SCIE in the coming time.\u003C\u002Fp>",{"VOID":187},"MS2_GJQAAAAJ",{"VI":189,"EN":190},"Tạp chí Khoa học và Công nghệ nhiệt đới","Journal of Tropical Science and Engineering",{"VOID":192},"08667535","2025-10-27T06:27:25.058+00:00",[101,102],[],[],[],"https:\u002F\u002Ftapchikhcnnd.com.vn",{"impactFactor":26,"impactFactorByYear":26,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":200,"totalPublicationByYear":201,"totalCitation":161,"totalCitationByYear":203,"totalCitationPerPublication":153,"totalCitationPerPublicationByYear":205,"hindexLast5Year":114,"hindex":114},481,{"0":115,"2020":115,"2021":115,"2022":114,"2024":115,"2025":202,"2026":115},474,{"2017":114,"2018":115,"2019":111,"2020":162,"2021":162,"2022":116,"2023":50,"2024":162,"2025":204,"2026":52},52,{"2020":162,"2021":162,"2022":162,"2024":162,"2025":206,"2026":52},0.11,{"id":208,"createTime":209,"updateTime":210,"relativeEntities":211,"slug":212,"properties":213,"entityType":24,"verifyStatus":25,"verifyTime":221,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":222,"subjectFields":223,"manageAffiliations":224,"indexDatabases":225,"url":226,"thumbnailPath":26,"statistic":227,"gsStatistic":276,"type":175,"analyzePriority":26},"a3d1e82a-57e2-40f9-940e-f5fa8b9ef64a","2023-06-01T07:11:26.039+00:00","2026-06-18T23:33:28.573+00:00",[],"VNU-Journal-of-Science-Earth-and-Environmental-Sciences",{"issn":214,"title":216,"country":218,"gsId":219},{"VOID":215},"26159279",{"EN":217},"VNU Journal of Science: Earth and Environmental Sciences",{"VOID":15},{"VOID":220},"UmXD8vEAAAAJ","2023-06-01T07:17:59.210+00:00",27,[],[],[],"https:\u002F\u002Fjs.vnu.edu.vn\u002FEES",{"impactFactor":36,"impactFactorByYear":228,"i10Index":234,"i10IndexLast5Year":36,"totalPublication":235,"totalPublicationByYear":236,"totalCitation":246,"totalCitationByYear":247,"totalCitationPerPublication":261,"totalCitationPerPublicationByYear":262,"hindexLast5Year":103,"hindex":103},{"2010":229,"2012":40,"2013":230,"2014":230,"2015":231,"2016":54,"2017":171,"2018":109,"2019":110,"2020":57,"2021":232,"2022":233,"2023":151,"2024":58},0.02,0.04,0.09,0.31,0.4,19,656,{"2008":237,"2009":238,"2010":239,"2011":238,"2012":240,"2013":241,"2014":239,"2015":242,"2016":243,"2017":244,"2018":245,"2019":165,"2020":125,"2021":168,"2022":125,"2023":222,"2024":111},23,24,22,28,25,20,146,29,78,1038,{"2008":248,"2009":249,"2010":250,"2011":251,"2012":252,"2013":253,"2014":254,"2015":255,"2016":256,"2017":257,"2018":161,"2019":258,"2020":259,"2021":29,"2022":260},119,64,66,86,38,73,59,31,129,39,97,53,26,1.58,{"2008":263,"2009":264,"2010":59,"2011":265,"2012":266,"2013":267,"2014":268,"2015":269,"2016":270,"2017":271,"2018":272,"2019":272,"2020":273,"2021":274,"2022":275},5.17,2.67,3.58,1.36,2.92,2.68,1.55,0.88,1.34,1.37,1.47,1.24,0.72,{"impactFactor":26,"impactFactorByYear":26,"i10Index":173,"i10IndexLast5Year":135,"totalPublication":277,"totalPublicationByYear":278,"totalCitation":279,"totalCitationByYear":280,"totalCitationPerPublication":288,"totalCitationPerPublicationByYear":289,"hindexLast5Year":158,"hindex":298},113,{"2007":114,"2008":103,"2009":173,"2010":116,"2011":51,"2012":239,"2013":103,"2014":162,"2015":53,"2016":135},616,{"2009":162,"2010":114,"2011":52,"2012":124,"2013":222,"2014":255,"2015":48,"2016":44,"2017":281,"2018":282,"2019":259,"2020":283,"2021":284,"2022":285,"2023":286,"2024":257,"2025":287,"2026":59},54,60,49,47,34,44,33,5.45,{"2009":290,"2010":291,"2011":292,"2012":293,"2013":294,"2014":295,"2015":296,"2016":297},0.28,0.2,0.6,0.77,2.25,6.2,3.91,9.67,14,{"id":300,"createTime":301,"updateTime":302,"relativeEntities":303,"slug":304,"properties":305,"entityType":24,"verifyStatus":25,"verifyTime":316,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":234,"subjectFields":317,"manageAffiliations":318,"indexDatabases":388,"url":389,"thumbnailPath":390,"statistic":391,"gsStatistic":409,"type":175,"analyzePriority":26},"a7166325-6c9e-4db3-8a59-7c879701a372","2023-07-31T04:28:49.231+00:00","2026-06-18T23:33:22.428+00:00",[],"VNU-Journal-of-Science-Policy-and-Management-Studies",{"country":306,"issn":307,"eissn":309,"title":311,"gsId":314},{"VOID":15},{"VOID":308},"26159295",{"VOID":310},"25881116",{"EN":312,"VI":313},"VNU Journal of Science: Policy and Management Studies","Tạp chí Nghiên cứu Chính sách và Quản lý",{"VOID":315},"xKW2E_cAAAAJ","2023-08-01T03:23:46.688+00:00",[],[319],{"id":320,"createTime":321,"updateTime":322,"relativeEntities":323,"slug":324,"properties":325,"entityType":98,"verifyStatus":25,"verifyTime":335,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":336,"url":337,"parentIds":338,"statistic":339},"12466116-8f60-4b01-8faf-2411483a0977","2023-05-30T09:37:38.472+00:00","2026-06-19T02:14:28.352+00:00",[],"Vietnam-National-University",{"country":326,"title":327,"abbreviation":330,"address":332},{"VOID":15},{"EN":328,"VI":329},"Vietnam National University, Hanoi","Đại học Quốc gia Hà Nội",{"VOID":331},"VNU",{"VI":333,"EN":334},"Số 144 Xuân Thủy, Phường Dịch Vọng Hậu, Quận Cầu Giấy, Hà Nội, Việt Nam","No. 144 Xuan Thuy Street, Dich Vong Hau Ward, Cau Giay District, Hanoi, Vietnam","2023-08-02T13:58:17.029+00:00",16,"http:\u002F\u002Fwww.vnu.edu.vn\u002F",[],{"impactFactor":36,"impactFactorByYear":340,"i10Index":285,"i10IndexLast5Year":162,"totalPublication":344,"totalPublicationByYear":345,"totalCitation":354,"totalCitationByYear":355,"totalCitationPerPublication":368,"totalCitationPerPublicationByYear":369,"hindexLast5Year":336,"hindex":336},{"2014":109,"2015":231,"2016":231,"2017":206,"2018":341,"2019":110,"2020":342,"2021":343,"2022":171,"2023":231,"2024":110,"2025":39},0.06,0.18,0.35,1247,{"2003":115,"2004":115,"2005":114,"2006":59,"2007":111,"2008":162,"2009":59,"2010":50,"2011":124,"2012":336,"2013":260,"2014":244,"2015":250,"2016":281,"2017":346,"2018":347,"2019":348,"2020":349,"2021":350,"2022":351,"2023":352,"2024":353,"2025":255,"2026":50},94,88,83,67,176,185,187,93,1644,{"2004":111,"2005":115,"2006":52,"2007":298,"2008":356,"2009":298,"2010":286,"2011":357,"2012":244,"2013":358,"2014":359,"2015":360,"2016":361,"2017":362,"2018":363,"2019":364,"2020":365,"2021":366,"2022":367,"2023":367,"2024":162},13,81,48,70,151,115,109,259,174,181,121,101,1.32,{"2004":111,"2005":370,"2006":59,"2007":371,"2008":372,"2009":373,"2010":374,"2011":375,"2012":376,"2013":377,"2014":378,"2015":379,"2016":380,"2017":381,"2018":382,"2019":383,"2020":384,"2021":385,"2022":386,"2023":387,"2024":109},0.5,3.5,2.6,4.67,5.5,4.76,1.81,1.85,2.41,2.29,2.13,1.16,2.94,2.1,2.7,0.69,0.55,0.54,[],"https:\u002F\u002Fjs.vnu.edu.vn\u002FPaM","\u002Fapi\u002Fpublic\u002Ffile\u002Fpublisher\u002Fa7166325-6c9e-4db3-8a59-7c879701a372\u002Fecfe83f4bcc60c7023ae04d8900fe0ac.jpg",{"impactFactor":36,"impactFactorByYear":392,"i10Index":111,"i10IndexLast5Year":36,"totalPublication":394,"totalPublicationByYear":395,"totalCitation":399,"totalCitationByYear":400,"totalCitationPerPublication":293,"totalCitationPerPublicationByYear":403,"hindexLast5Year":158,"hindex":158},{"2018":109,"2019":171,"2020":393,"2021":108,"2022":54,"2023":206,"2024":54},0.23,320,{"2015":50,"2016":239,"2017":286,"2018":396,"2019":397,"2020":159,"2021":398,"2022":168,"2023":79,"2024":255},30,35,40,247,{"2015":115,"2016":242,"2017":401,"2018":222,"2019":402,"2020":79,"2021":239,"2022":50,"2023":116},77,50,{"2015":404,"2016":169,"2017":405,"2018":406,"2019":407,"2020":408,"2021":386,"2022":291,"2023":232},0.12,1.75,0.9,1.43,0.86,{"impactFactor":26,"impactFactorByYear":26,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":103,"totalPublicationByYear":410,"totalCitation":234,"totalCitationByYear":411,"totalCitationPerPublication":261,"totalCitationPerPublicationByYear":412,"hindexLast5Year":114,"hindex":59},{"2015":114,"2016":116},{"2016":115,"2017":114,"2018":114,"2019":59,"2020":114,"2021":59,"2022":114,"2023":114,"2024":115,"2026":115},{"2016":108},{"id":414,"createTime":415,"updateTime":416,"relativeEntities":417,"slug":418,"properties":419,"entityType":24,"verifyStatus":25,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":238,"subjectFields":428,"manageAffiliations":429,"indexDatabases":430,"url":431,"thumbnailPath":26,"statistic":432,"gsStatistic":438,"type":175,"analyzePriority":26},"16e65a3f-d274-47dd-8691-56d76eb58c3d","2023-05-30T09:10:06.062+00:00","2026-06-18T23:33:17.679+00:00",[],"Vietnam-Journal-of-Otorhinolaryngology-Head-and-Neck-Surgery",{"country":420,"issn":421,"title":423,"gsId":426},{"VOID":15},{"VOID":422},"18593704",{"EN":424,"VI":425},"Vietnam Journal of Otorhinolaryngology - Head and Neck Surgery","Tạp chí Tai Mũi Họng Việt Nam",{"VOID":427},"L78B_eIAAAAJ",[],[],[],"https:\u002F\u002Ftapchitaimuihong.vn\u002Findex.php\u002Ftmh",{"impactFactor":36,"impactFactorByYear":433,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":434,"totalPublicationByYear":435,"totalCitation":111,"totalCitationByYear":436,"totalCitationPerPublication":230,"totalCitationPerPublicationByYear":437,"hindexLast5Year":115,"hindex":115},{"2024":229},95,{"2022":52,"2023":286,"2024":255,"2025":53},{"2023":111},{"2023":231},{"impactFactor":26,"impactFactorByYear":26,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":240,"totalPublicationByYear":439,"totalCitation":234,"totalCitationByYear":440,"totalCitationPerPublication":441,"totalCitationPerPublicationByYear":442,"hindexLast5Year":114,"hindex":114},{"2023":53,"2024":116,"2025":135,"2026":115},{"2024":59,"2025":298,"2026":114},0.68,{"2024":443,"2025":444,"2026":114},0.3,2.33,{"id":446,"createTime":447,"updateTime":448,"relativeEntities":449,"slug":450,"properties":451,"entityType":24,"verifyStatus":25,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":396,"subjectFields":460,"manageAffiliations":461,"indexDatabases":462,"url":463,"thumbnailPath":464,"statistic":465,"gsStatistic":472,"type":175,"analyzePriority":26},"25988add-c322-4eda-afda-63b1559bb824","2023-04-07T03:49:55.817+00:00","2026-06-18T23:32:23.776+00:00",[],"T%E1%BA%A1p%20ch%C3%AD%20Y%20-%20D%C6%B0%E1%BB%A3c%20h%E1%BB%8Dc%20qu%C3%A2n%20s%E1%BB%B1",{"country":452,"issn":453,"title":455,"gsId":458},{"VOID":15},{"VOID":454},"18590748",{"EN":456,"VI":457},"Journal of Military Pharmaco-medicine","Tạp chí Y - Dược học quân sự",{"VOID":459},"_pmQ8IEAAAAJ",[],[],[],"https:\u002F\u002Fjmpm.vn\u002Findex.php\u002Fjmpm","\u002Fapi\u002Fpublic\u002Ffile\u002Fpublisher\u002F25988add-c322-4eda-afda-63b1559bb824\u002F09c6bc42157cf5ece95edc971ccddb52.jpg",{"impactFactor":36,"impactFactorByYear":466,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":467,"totalPublicationByYear":468,"totalCitation":135,"totalCitationByYear":470,"totalCitationPerPublication":38,"totalCitationPerPublicationByYear":471,"hindexLast5Year":115,"hindex":115},{"2023":229,"2024":38},475,{"2022":168,"2023":365,"2024":469,"2025":124},236,{"2022":114,"2023":111},{"2022":109,"2023":229},{"impactFactor":26,"impactFactorByYear":26,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":277,"totalPublicationByYear":473,"totalCitation":401,"totalCitationByYear":474,"totalCitationPerPublication":441,"totalCitationPerPublicationByYear":475,"hindexLast5Year":59,"hindex":59},{"2015":115,"2018":114,"2019":115,"2020":115,"2021":59,"2022":103,"2023":159,"2024":287,"2025":237},{"2020":115,"2021":115,"2022":115,"2023":52,"2024":237,"2025":79,"2026":116},{"2020":115,"2021":476,"2022":171,"2023":477,"2024":478,"2025":479},0.33,0.24,0.7,1.39,{"id":481,"createTime":482,"updateTime":483,"relativeEntities":484,"slug":485,"properties":486,"entityType":24,"verifyStatus":25,"verifyTime":26,"verifyNote":27,"syncStatus":28,"languages":496,"translateLanguages":26,"viewCount":45,"subjectFields":497,"manageAffiliations":498,"indexDatabases":525,"url":526,"thumbnailPath":527,"statistic":528,"gsStatistic":26,"type":26,"analyzePriority":26},"2b8d7b12-2d20-4777-be98-077f44f03c69","2023-09-07T07:40:58.286+00:00","2025-07-13T21:21:00.542+00:00",[],"VNU-Journal-of-Social-Sciences-and-Humanities",{"country":487,"issn":488,"introduce":490,"title":493},{"VOID":15},{"VOID":489},"23541172",{"EN":491,"VI":492},"{\"ops\":[{\"insert\":\"VNU Journal of Social Sciences and Humanities (ISSN 2354-1172) is a double-blind peer-reviewed journal published by University of Social Sciences and Humanities, Vietnam National University, Hanoi, Vietnam, under the publication permit no. 155\u002FGP-BTTTT, issued on 11\"},{\"attributes\":{\"script\":\"super\"},\"insert\":\"th \"},{\"insert\":\"May, 2015 by Ministry of Information and Communications. The journal publishes four Vietnamese issues and two English issues per year.\\nCurrently, there are 35 reputable professors in the editorial board. The main objectives of the journal include: providing an intellectual platform for Vietnamese and international scholars; promoting interdisciplinary studies in social sciences and humanities; becoming the leading journal in social sciences and humanities in Vietnam; being indexed by worldwide databases and having academic recognition internationally in the near future.\\nThe journal is currently indexed by Google Scholar, WorldCat, Open Archives, Cosmos Impact Factor, Advanced Sciences Index, Scientific Indexing Services, CrossRef, EBSCO Information Services and Vietnam National University’s digital archive.\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Journal of Social Sciences and Humanities-Vietnam\"},{\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"ISSN 2354-1172, email: tapchikhxhnv@gmail.com, tckhxhnv@vnu.edu.vn\"},{\"insert\":\"\\n\"}]}","{\"ops\":[{\"insert\":\"Được thành lập ngày 31\u002F8\u002F2015 (giấy phép hoạt động số 155\u002FGP-BVHTT ngày 11 tháng 5 năm 2015 của Bộ Thông tin và Truyền thông, mã số tiêu chuẩn quốc tế ISSN 2354-1172), Tạp chí Khoa học Xã hội và Nhân văn (Journal of Social Sciences and Humanities) là ấn phẩm khoa học chính thức, duy nhất của Trường Đại học Khoa học Xã hội và Nhân văn, ĐHQG Hà Nội, phát triển và kế thừa Chuyên san Khoa học Xã hội và Nhân văn, Tạp chí Khoa học, ĐHQG Hà Nội.\\nTạp chí xuất bản định kỳ (04 số tiếng Việt\u002Fnăm và 02 số tiếng Anh\u002Fnăm), có nhiệm vụ \"},{\"attributes\":{\"italic\":true},\"insert\":\"công bố, giới thiệu các công trình nghiên cứu khoa học khoa học xã hội và nhân văn của các tác giả là các nhà khoa học trong và ngoài nước, phục vụ giảng dạy, học tập và nghiên cứu khoa học\"},{\"insert\":\". Hội đồng biên tập của Tạp chí hiện bao gồm 33 nhà khoa học có uy tín trong nước và quốc tế. Tạp chí tập trung và ưu tiên đăng tải những bài báo theo định hướng của tinh thần cởi mở, sáng tạo, nhanh chóng vươn lên để tiếp cận và sánh ngang với các tạp chí có uy tín hàng đầu của khu vực và trên thế giới. Nội dung chính của Tạp chí bao gồm các Bài nghiên cứu (khoảng 6000 đến 15000 từ), các bài điểm sách, thông tin khoa học (khoảng 300 đến 1500 từ) được trình bày theo đúng cấu trúc và chuẩn mực của một tạp chí khoa học.\\nCác bài viết của Tạp chí hiện đang được trích dẫn bởi Google Scholar, WorldCat, Open Archives, Cosmos Impact Factor, Advanced Sciences Index, Scientific Indexing Services, CrossRef, EBSCO Information Services.\\nMọi thông tin xin liên hệ: \"},{\"attributes\":{\"italic\":true},\"insert\":\"Phòng Tạp chí, 701 - E, Trường Đại học Khoa học Xã hội và Nhân văn, 336 Nguyễn Trãi, Thanh Xuân, Hà Nội. ĐT: 024.35581984; email: tckhxhnv@vnu.edu.vn \"},{\"insert\":\"hoặc \"},{\"attributes\":{\"italic\":true},\"insert\":\"tapchikhxhnv@gmail.com \"},{\"insert\":\"\\n\"}]}",{"EN":494,"VI":495},"VNU Journal of Social Sciences and Humanities","Tạp chí Khoa học Xã hội và Nhân văn",[101,102],[],[499],{"id":500,"createTime":501,"updateTime":502,"relativeEntities":503,"slug":504,"properties":505,"entityType":98,"verifyStatus":25,"verifyTime":509,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":222,"url":26,"parentIds":510,"statistic":511},"8b6e349b-0daf-4895-9c3f-85f30f1bfd42","2023-07-31T12:55:58.430+00:00","2026-06-19T02:30:07.899+00:00",[],"Tr%C6%B0%E1%BB%9Dng-%C4%90%E1%BA%A1i-h%E1%BB%8Dc-Khoa-h%E1%BB%8Dc-X%C3%A3-h%E1%BB%99i-v%C3%A0-Nh%C3%A2n-v%C4%83n-%C4%90%E1%BA%A1i-h%E1%BB%8Dc-Qu%E1%BB%91c-gia-H%C3%A0-N%E1%BB%99i",{"title":506},{"EN":507,"VI":508},"VNU University of Social Sciences and Humanities","Trường Đại học Khoa học Xã hội và Nhân văn, Đại học Quốc gia Hà Nội","2023-08-02T15:28:49.057+00:00",[],{"impactFactor":36,"impactFactorByYear":512,"i10Index":59,"i10IndexLast5Year":115,"totalPublication":514,"totalPublicationByYear":515,"totalCitation":518,"totalCitationByYear":519,"totalCitationPerPublication":520,"totalCitationPerPublicationByYear":521,"hindexLast5Year":162,"hindex":162},{"2016":229,"2017":230,"2018":229,"2021":230,"2022":58,"2023":513,"2024":38},0.15,365,{"2013":115,"2014":158,"2015":125,"2016":252,"2017":44,"2018":516,"2019":286,"2020":396,"2021":259,"2022":517,"2023":396,"2024":115,"2025":59,"2026":115},21,42,169,{"2015":283,"2016":135,"2017":52,"2018":50,"2019":298,"2020":53,"2021":359,"2022":115,"2023":115},0.46,{"2015":266,"2016":57,"2017":57,"2018":522,"2019":523,"2020":524,"2021":368,"2022":229,"2023":39},0.38,0.32,0.37,[],"http:\u002F\u002Fjournal.ussh.vnu.edu.vn\u002Findex.php\u002Fvjossh","\u002Fapi\u002Fpublic\u002Ffile\u002Fpublisher\u002F2b8d7b12-2d20-4777-be98-077f44f03c69\u002F0bd0751202944a4b4165b482e6e623e4.png",{"impactFactor":36,"impactFactorByYear":529,"i10Index":162,"i10IndexLast5Year":115,"totalPublication":530,"totalPublicationByYear":531,"totalCitation":537,"totalCitationByYear":538,"totalCitationPerPublication":343,"totalCitationPerPublicationByYear":540,"hindexLast5Year":135,"hindex":135},{"2016":341,"2017":39,"2018":229,"2019":38,"2020":110,"2021":231,"2022":231,"2023":341,"2024":39},764,{"2015":255,"2016":245,"2017":532,"2018":259,"2019":533,"2020":534,"2021":535,"2022":536,"2023":534,"2024":254,"2025":50},111,106,68,92,89,265,{"2015":539,"2016":241,"2017":168,"2018":51,"2019":349,"2020":260,"2021":244,"2022":298,"2023":114},46,{"2015":541,"2016":523,"2017":524,"2018":290,"2019":542,"2020":522,"2021":523,"2022":57,"2023":39},1.48,0.63,{"id":544,"createTime":545,"updateTime":546,"relativeEntities":547,"slug":548,"properties":549,"entityType":24,"verifyStatus":25,"verifyTime":26,"verifyNote":558,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":50,"subjectFields":559,"manageAffiliations":560,"indexDatabases":561,"url":562,"thumbnailPath":563,"statistic":564,"gsStatistic":26,"type":26,"analyzePriority":26},"6ec01bd0-15c0-469a-86ac-41339076ae0a","2023-08-10T07:08:33.153+00:00","2026-01-31T21:19:06.362+00:00",[],"T%E1%BA%A1p-ch%C3%AD-Da-li%E1%BB%85u-h%E1%BB%8Dc-Vi%E1%BB%87t-Nam",{"country":550,"issn":551,"introduce":553,"title":555},{"VOID":15},{"VOID":552},"18594824",{"VI":554},"{\"ops\":[{\"insert\":\"Tạp chí “Da liễu học Việt Nam” (Tiếng Anh: Vietnamese Journal of Dermatology and Venereology) thuộc Hội Da liễu Việt Nam, xuất bản 4 số mỗi năm bằng tiếng Việt hoặc tiếng Anh.\\nTạp chí Da liễu học Việt Nam hoạt động với mục đích, tôn chỉ là phổ biến, trao đổi thông tin trong lĩnh vực chuyên ngành da liễu; đăng tải các công trình nghiên cứu khoa học; chuyển giao công nghệ - kinh tế và khoa học kỹ thuật liên quan đến lĩnh vực da liễu.\\nPhạm vi của tạp chí là tất cả các bài báo khoa học, bài tổng quan, giới thiệu ca lâm sàng, … có liên quan tới chuyên ngành da liễu trong và ngoài nước. Tạp chí công bố các công trình nghiên cứu liên quan đến mô hình bệnh tật, các phương pháp chẩn đoán, điều trị, dự phòng và phục hồi chức năng các bệnh thuộc chuyên ngành da liễu. Ngoài ra, tạp chí còn đăng tải các bài tổng quan, cập nhật thông tin, kiến thức, hướng dẫn chẩn đoán, điều trị trong chuyên ngành da liễu trong nước và quốc tế; đăng tải các bài ca lâm sàng đặc biệt trong chuyên ngành da liễu.\\nTạp chí Da liễu học Việt Nam được biết tới là một tạp chí chuyên ngành có uy tín trong lĩnh vực da liễu. Các bài báo về nghiên cứu khoa học đăng trong Tạp chí được bình duyệt một cách nghiêm ngặt bởi ít nhất 2 chuyên gia. Hội đồng biên tập tạp chí bao gồm các nhà khoa học có uy tín (Giáo sư, Phó Giáo sư, Tiến sĩ, Bác sĩ…) trong chuyên ngành da liễu nhằm đảm bảo chất lượng và tính khách quan, khoa học cho các bài viết đăng trên Tạp chí.\\n\"}]}",{"EN":556,"VI":557},"Vietnamese Journal of Dermatology and Venereology","Tạp chí Da liễu học Việt Nam","Admin Import",[],[],[],"https:\u002F\u002Fvjdv.vn\u002Findex.php\u002Fvjdv","\u002Fapi\u002Fpublic\u002Ffile\u002Fpublisher\u002F6ec01bd0-15c0-469a-86ac-41339076ae0a\u002F3cbc81720e58429dc7b1c4d7ab1935ca.jpg",{"impactFactor":36,"impactFactorByYear":565,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":566,"totalPublicationByYear":567,"totalCitation":116,"totalCitationByYear":570,"totalCitationPerPublication":109,"totalCitationPerPublicationByYear":571,"hindexLast5Year":115,"hindex":115},{"2023":38,"2024":230},182,{"2022":568,"2023":45,"2024":569},69,56,{"2022":52,"2023":115},{"2022":40,"2023":229},{"id":573,"createTime":574,"updateTime":575,"relativeEntities":576,"slug":577,"properties":578,"entityType":24,"verifyStatus":25,"verifyTime":26,"verifyNote":27,"syncStatus":28,"languages":587,"translateLanguages":26,"viewCount":283,"subjectFields":588,"manageAffiliations":589,"indexDatabases":647,"url":648,"thumbnailPath":649,"statistic":650,"gsStatistic":26,"type":26,"analyzePriority":26},"19221551-7519-47ff-a892-331d1139c64b","2023-09-12T07:03:05.744+00:00","2026-01-24T20:54:40.144+00:00",[],"T%E1%BA%A1p-ch%C3%AD-Khoa-h%E1%BB%8Dc-S%E1%BB%A9c-kho%E1%BA%BB-%C4%90%E1%BA%A1i-h%E1%BB%8Dc-Qu%E1%BB%91c-gia-Th%C3%A0nh-ph%E1%BB%91-H%E1%BB%93-Ch%C3%AD-Minh",{"country":579,"issn":580,"introduce":582,"title":584},{"VOID":15},{"VOID":581},"27349446",{"EN":583},"{\"ops\":[{\"attributes\":{\"bold\":true},\"insert\":\"1. History\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Science and Technology Development Journal\"},{\"insert\":\" (STDJ) (ISSN 2734-9446), Vietnam National University - Ho Chi Minh City (VNU-HCM) was established in 1997. And the first issue was published in January 1998 with ISSN 1859-0128. Since then, STDJ has become the most important scientific forum of scientists from VNU-HCM as well as other universities. The magazine has undergone 20 years of development and has become a bridge for scientific exchanges, as well as enriching reference materials for the faculty, doctoral students, students of VNU-HCM in particular and other universities, institutes...\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Science and Technology Development Journal - Health Sciences (STDJ-HS) is a subjournal of Science and Technology Development Journal since 2020.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\" \"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"2. Focus and Scope\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Publishing articles with contents on healthcare, research projects in the field of health, advanced directions in health education and management. Therefore, STDJ-HS will accept articles from doctors, administrators, teachers, researchers, graduate students and fellows. The authors will be responsible for the accuracy of the data, opinions, opinions and material cited in the article.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Facilitating the exchange of scientific and technological information and act as a bridge between theory and practice in the community of educators, scientists, managers, policy makers and enterprises in and out of the country.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"\\n\"}]}",{"EN":585,"VI":586},"VNUHCM JOURNAL OF HEALTH SCIENCES","Tạp chí Khoa học Sức khoẻ Đại học Quốc gia Thành phố Hồ Chí Minh",[101,102],[],[590],{"id":591,"createTime":592,"updateTime":593,"relativeEntities":594,"slug":595,"properties":596,"entityType":98,"verifyStatus":25,"verifyTime":606,"verifyNote":26,"syncStatus":28,"languages":607,"translateLanguages":26,"viewCount":608,"url":609,"parentIds":610,"statistic":611},"fc4c2560-868c-4677-acb1-8686bef88727","2023-06-26T04:48:23.774+00:00","2026-06-19T01:46:17.248+00:00",[],"%C4%90%E1%BA%A1i-h%E1%BB%8Dc-Qu%E1%BB%91c-gia-Th%C3%A0nh-ph%E1%BB%91-H%E1%BB%93-Ch%C3%AD-Minh",{"country":597,"title":598,"abbreviation":601,"address":603},{"VOID":15},{"EN":599,"VI":600},"Vietnam National University Ho Chi Minh City","Đại học Quốc gia Thành phố Hồ Chí Minh",{"VOID":602},"VNUHCM",{"VI":604,"EN":605},"khu phố 6, Phường Linh Trung, Thành phố Thủ Đức, Thành phố Hồ Chí Minh, Việt Nam","Quarter 6, Linh Trung Ward, Thu Duc City, Ho Chi Minh City, Vietnam","2023-08-16T14:13:07.134+00:00",[101,102],45,"https:\u002F\u002Fvnuhcm.edu.vn\u002F",[],{"impactFactor":36,"impactFactorByYear":612,"i10Index":285,"i10IndexLast5Year":51,"totalPublication":613,"totalPublicationByYear":614,"totalCitation":624,"totalCitationByYear":625,"totalCitationPerPublication":634,"totalCitationPerPublicationByYear":635,"hindexLast5Year":124,"hindex":124},{"2014":36,"2015":38,"2016":109,"2017":39,"2018":229,"2019":38,"2020":110,"2021":171,"2022":110,"2023":110,"2024":171,"2025":229},3708,{"2005":115,"2006":115,"2007":115,"2008":135,"2009":111,"2010":53,"2011":52,"2012":568,"2013":615,"2014":351,"2015":616,"2016":469,"2017":617,"2018":127,"2019":618,"2020":619,"2021":620,"2022":621,"2023":622,"2024":623,"2025":159,"2026":50},164,266,177,226,603,931,314,246,74,2399,{"2006":115,"2008":50,"2010":162,"2011":242,"2012":222,"2013":43,"2014":626,"2015":627,"2016":628,"2017":629,"2018":258,"2019":630,"2020":631,"2021":632,"2022":633,"2023":353,"2024":115},250,124,157,162,152,385,559,128,0.65,{"2006":115,"2008":636,"2010":637,"2011":638,"2012":639,"2013":522,"2014":640,"2015":641,"2016":642,"2017":643,"2018":644,"2019":642,"2020":645,"2021":292,"2022":646,"2023":522,"2024":38},1.33,0.45,2.22,0.39,1.35,0.47,0.67,0.92,0.73,0.64,0.41,[],"http:\u002F\u002Fstdjhs.scienceandtechnology.com.vn\u002Findex.php\u002Fstdjhs","\u002Fapi\u002Fpublic\u002Ffile\u002Fpublisher\u002F19221551-7519-47ff-a892-331d1139c64b\u002F2e10768b7d1e380c36a25ed0c714dd7e.png",{"impactFactor":36,"impactFactorByYear":651,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":652,"totalPublicationByYear":653,"totalCitation":516,"totalCitationByYear":654,"totalCitationPerPublication":151,"totalCitationPerPublicationByYear":655,"hindexLast5Year":59,"hindex":59},{"2022":57,"2023":108,"2024":39},79,{"2020":116,"2021":240,"2022":239,"2023":52,"2024":162,"2025":162},{"2020":59,"2021":51,"2022":59},{"2020":443,"2021":387,"2022":54},{"code":657,"data":658,"meta":26},"SUCCESS",{"id":659,"createTime":660,"updateTime":660,"relativeEntities":661,"slug":662,"properties":663,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":668,"manageAffiliations":669,"indexDatabases":670,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},"83289c5a-0e1a-4089-90d0-8447ef02c8ba","2023-12-05T06:03:54.978+00:00",[],"EMC-Ginecolog%C3%ADa-Obstetricia",{"issn":664,"title":666},{"VOID":665},"1283081X",{"EN":667},"EMC - Ginecología-Obstetricia",[],[],[],{"meta":672,"data":674},{"total":673},"233",[675,773,996,1035,1131,1228,1286,1419,1479,1525],{"id":676,"createTime":677,"updateTime":678,"relativeEntities":679,"slug":680,"properties":681,"entityType":688,"verifyStatus":25,"verifyTime":689,"verifyNote":690,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"primaryUrl":691,"fullTextUrl":26,"authors":692,"publicationType":747,"publisherRelationship":748,"citationCount":36,"citationInfo":762,"publishDate":764,"publishYear":765,"citationAnalyzeStatus":766,"lastCitationAnalyze":767,"indexDatabases":26,"openAccess":26,"references":768,"isForceReanalyzing":772},"2e0022d8-691d-47c1-805b-2646aae83a4e","2024-01-24T08:55:54.986+00:00","2026-06-10T12:40:31.574+00:00",[],"Tratamiento-de-la-f%C3%ADstula-rectovaginal-y-de-las-secuelas-obst%C3%A9tricas",{"title":682,"doi":684,"gsPaper":686},{"ES":683},"Tratamiento de la fístula rectovaginal y de las secuelas obstétricas",{"VOID":685},"10.1016\u002Fs1283-081x(20)43720-8",{"VOID":687},"[\"8941905162942479020\"]","PUBLICATION","2024-05-03T00:37:56.136+00:00","Auto Verify","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1283081X20437208",[693,709,721,733],{"id":694,"sortIndex":59,"researcher":26,"roles":695,"affiliations":697,"properties":706},"39888c05-cf30-4eaf-ab45-faf3ce88e0b8",[696],"AUTHOR",[698],{"id":26,"sortIndex":36,"affiliation":699,"properties":26},{"id":700,"createTime":701,"updateTime":701,"relativeEntities":702,"slug":26,"properties":703,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"d4d18b5e-933d-4c7a-8252-f956d23d19a2","2024-01-24T08:55:55.012+00:00",[],{"title":704},{"VI":705},"Service de chirurgie gynécologique, Hôpital Jeanne-de-Flandre, CHU de Lille, avenue Eugène-Avinée, 59037 Lille cedex, France",{"title":707},{"VI":708},"S. Delplanque",{"id":710,"sortIndex":114,"researcher":26,"roles":711,"affiliations":712,"properties":718},"a42857fa-931d-4443-b6a7-eeb4d3d287d4",[696],[713],{"id":26,"sortIndex":36,"affiliation":714,"properties":26},{"id":700,"createTime":701,"updateTime":701,"relativeEntities":715,"slug":26,"properties":716,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":717},{"VI":705},{"title":719},{"VI":720},"E. Declas",{"id":722,"sortIndex":115,"researcher":26,"roles":723,"affiliations":724,"properties":730},"cf770415-864d-4750-a611-abe739471221",[696],[725],{"id":26,"sortIndex":36,"affiliation":726,"properties":26},{"id":700,"createTime":701,"updateTime":701,"relativeEntities":727,"slug":26,"properties":728,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":729},{"VI":705},{"title":731},{"VI":732},"G. Giraudet",{"id":734,"sortIndex":36,"researcher":26,"roles":735,"affiliations":736,"properties":742},"08fc2047-379d-421d-a1db-869f3b3936fd",[696],[737],{"id":26,"sortIndex":36,"affiliation":738,"properties":26},{"id":700,"createTime":701,"updateTime":701,"relativeEntities":739,"slug":26,"properties":740,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":741},{"VI":705},{"title":743,"gsAuthor":745},{"VI":744},"M. Cosson",{"VOID":746},"[\"mra9H5MAAAAJ\"]","ARTICLE",{"url":691,"publisher":749,"properties":757},{"id":659,"createTime":660,"updateTime":660,"relativeEntities":750,"slug":662,"properties":751,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":754,"manageAffiliations":755,"indexDatabases":756,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":752,"title":753},{"VOID":665},{"EN":667},[],[],[],{"volume":758,"pages":760},{"VOID":759},"56",{"VOID":761},"1-12",{"total":36,"publishYear":36,"statisticByYear":763},{},"2020-05-01",2020,"ERROR_IN_ANALYZE_CITATION","2026-06-10T12:40:31.573+00:00",[769],{"id":26,"text":770,"url":26,"identifiers":771},"Cosson, 2011",{},false,{"id":774,"createTime":775,"updateTime":775,"relativeEntities":776,"slug":26,"properties":777,"entityType":688,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":114,"primaryUrl":782,"fullTextUrl":26,"authors":783,"publicationType":747,"publisherRelationship":980,"citationCount":26,"citationInfo":26,"publishDate":994,"publishYear":995,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":26,"isForceReanalyzing":772},"0b491581-6643-40ef-ba7a-74cd4b3938d3","2023-12-08T20:50:20.342+00:00",[],{"title":778,"doi":780},{"EN":779},"Tratamiento de las masas anexiales durante el embarazo",{"VOID":781},"10.1016\u002FS1283-081X(13)64076-X","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1283081X1364076X",[784,809,828,847,866,885,904,923,942,961],{"id":785,"sortIndex":158,"researcher":26,"roles":786,"affiliations":787,"properties":806},"39be663a-ace1-4dd3-b272-1b38dce6b648",[696],[788,796],{"id":26,"sortIndex":36,"affiliation":789,"properties":26},{"id":790,"createTime":791,"updateTime":791,"relativeEntities":792,"slug":26,"properties":793,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"d8b7ce5a-b970-4d4c-9cb7-84d12c9f1877","2023-12-08T20:50:20.421+00:00",[],{"title":794},{"VI":795},"CHU Clermont-Ferrand, CHU Estaing, Service de chirurgie gynécologique, 1, place Lucie-Aubrac, 63000 Clermont-Ferrand cedex 1, France",{"id":797,"sortIndex":115,"affiliation":798,"properties":805},"65e531f8-98ad-4068-89b0-67a8235a4680",{"id":799,"createTime":800,"updateTime":800,"relativeEntities":801,"slug":26,"properties":802,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"d4a9166a-b341-4050-8204-fa74c5996872","2023-12-08T20:50:20.398+00:00",[],{"title":803},{"VI":804},"Université Clermont 1, Faculté de médecine, 63003 Clermont-Ferrand cedex, France",{},{"title":807},{"VI":808},"N. Bourdel",{"id":810,"sortIndex":135,"researcher":26,"roles":811,"affiliations":812,"properties":825},"f9cf1f86-5b52-4ee7-9053-8e54146eed9a",[696],[813,818],{"id":26,"sortIndex":36,"affiliation":814,"properties":26},{"id":790,"createTime":791,"updateTime":791,"relativeEntities":815,"slug":26,"properties":816,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":817},{"VI":795},{"id":819,"sortIndex":115,"affiliation":820,"properties":824},"6d39e838-771e-4d2b-8f01-eb0c1a8a825b",{"id":799,"createTime":800,"updateTime":800,"relativeEntities":821,"slug":26,"properties":822,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":823},{"VI":804},{},{"title":826},{"VI":827},"K. Jardon",{"id":829,"sortIndex":162,"researcher":26,"roles":830,"affiliations":831,"properties":844},"7fc9c4ac-11a2-44a5-bce4-aebf95e534f8",[696],[832,839],{"id":833,"sortIndex":115,"affiliation":834,"properties":838},"d9f4f19b-da4b-4584-934f-044909d44677",{"id":799,"createTime":800,"updateTime":800,"relativeEntities":835,"slug":26,"properties":836,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":837},{"VI":804},{},{"id":26,"sortIndex":36,"affiliation":840,"properties":26},{"id":790,"createTime":791,"updateTime":791,"relativeEntities":841,"slug":26,"properties":842,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":843},{"VI":795},{"title":845},{"VI":846},"B. Rabischong",{"id":848,"sortIndex":114,"researcher":26,"roles":849,"affiliations":850,"properties":863},"f97c328e-9d96-4508-93fc-357e29f6ed74",[696],[851,856],{"id":26,"sortIndex":36,"affiliation":852,"properties":26},{"id":790,"createTime":791,"updateTime":791,"relativeEntities":853,"slug":26,"properties":854,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":855},{"VI":795},{"id":857,"sortIndex":115,"affiliation":858,"properties":862},"903098cb-3ab0-4568-b7f5-33914f23d565",{"id":799,"createTime":800,"updateTime":800,"relativeEntities":859,"slug":26,"properties":860,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":861},{"VI":804},{},{"title":864},{"VI":865},"A.-S. Azuar",{"id":867,"sortIndex":111,"researcher":26,"roles":868,"affiliations":869,"properties":882},"13059bef-3029-43af-b0a1-9521753388e3",[696],[870,875],{"id":26,"sortIndex":36,"affiliation":871,"properties":26},{"id":790,"createTime":791,"updateTime":791,"relativeEntities":872,"slug":26,"properties":873,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":874},{"VI":795},{"id":876,"sortIndex":115,"affiliation":877,"properties":881},"1223cf09-7275-4555-b5d2-dca6d6df4c53",{"id":799,"createTime":800,"updateTime":800,"relativeEntities":878,"slug":26,"properties":879,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":880},{"VI":804},{},{"title":883},{"VI":884},"C. Houlle",{"id":886,"sortIndex":36,"researcher":26,"roles":887,"affiliations":888,"properties":901},"acc88cf2-83d8-409f-a6fe-e6e61f4c0fa9",[696],[889,894],{"id":26,"sortIndex":36,"affiliation":890,"properties":26},{"id":790,"createTime":791,"updateTime":791,"relativeEntities":891,"slug":26,"properties":892,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":893},{"VI":795},{"id":895,"sortIndex":115,"affiliation":896,"properties":900},"ac0c8489-cf26-4fb5-abc1-4cfb2231f621",{"id":799,"createTime":800,"updateTime":800,"relativeEntities":897,"slug":26,"properties":898,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":899},{"VI":804},{},{"title":902},{"VI":903},"M. Canis",{"id":905,"sortIndex":59,"researcher":26,"roles":906,"affiliations":907,"properties":920},"d920aa3f-177b-454b-8ae0-9fd2f2f75c4e",[696],[908,913],{"id":26,"sortIndex":36,"affiliation":909,"properties":26},{"id":790,"createTime":791,"updateTime":791,"relativeEntities":910,"slug":26,"properties":911,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":912},{"VI":795},{"id":914,"sortIndex":115,"affiliation":915,"properties":919},"390d485a-3ddd-4eaa-8a38-b1f60629eb4b",{"id":799,"createTime":800,"updateTime":800,"relativeEntities":916,"slug":26,"properties":917,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":918},{"VI":804},{},{"title":921},{"VI":922},"R. Botchorishvili",{"id":924,"sortIndex":50,"researcher":26,"roles":925,"affiliations":926,"properties":939},"9463921d-de03-4e9a-9150-b3a92b3460ff",[696],[927,932],{"id":26,"sortIndex":36,"affiliation":928,"properties":26},{"id":790,"createTime":791,"updateTime":791,"relativeEntities":929,"slug":26,"properties":930,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":931},{"VI":795},{"id":933,"sortIndex":115,"affiliation":934,"properties":938},"f2f380d1-3065-480d-8cb0-726159598b37",{"id":799,"createTime":800,"updateTime":800,"relativeEntities":935,"slug":26,"properties":936,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":937},{"VI":804},{},{"title":940},{"VI":941},"J.-L. Pouly",{"id":943,"sortIndex":115,"researcher":26,"roles":944,"affiliations":945,"properties":958},"9e1cb7b1-6746-415f-9b4b-93173001750a",[696],[946,951],{"id":26,"sortIndex":36,"affiliation":947,"properties":26},{"id":790,"createTime":791,"updateTime":791,"relativeEntities":948,"slug":26,"properties":949,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":950},{"VI":795},{"id":952,"sortIndex":115,"affiliation":953,"properties":957},"cb171f93-ccd8-454b-b071-e35a3233b8c0",{"id":799,"createTime":800,"updateTime":800,"relativeEntities":954,"slug":26,"properties":955,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":956},{"VI":804},{},{"title":959},{"VI":960},"E. Lagrange",{"id":962,"sortIndex":52,"researcher":26,"roles":963,"affiliations":964,"properties":977},"20bbaf3c-87cf-49c8-93fa-6e2f13cbffbc",[696],[965,970],{"id":26,"sortIndex":36,"affiliation":966,"properties":26},{"id":790,"createTime":791,"updateTime":791,"relativeEntities":967,"slug":26,"properties":968,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":969},{"VI":795},{"id":971,"sortIndex":115,"affiliation":972,"properties":976},"b8fe775f-b4d5-41c7-943e-2653382564c2",{"id":799,"createTime":800,"updateTime":800,"relativeEntities":973,"slug":26,"properties":974,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":975},{"VI":804},{},{"title":978},{"VI":979},"G. Mage",{"url":782,"publisher":981,"properties":989},{"id":659,"createTime":660,"updateTime":660,"relativeEntities":982,"slug":662,"properties":983,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":986,"manageAffiliations":987,"indexDatabases":988,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":984,"title":985},{"VOID":665},{"EN":667},[],[],[],{"volume":990,"pages":992},{"VOID":991},"49",{"VOID":993},"1-10","2013-03-01",2013,{"id":997,"createTime":998,"updateTime":999,"relativeEntities":1000,"slug":1001,"properties":1002,"entityType":688,"verifyStatus":28,"verifyTime":999,"verifyNote":1009,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":115,"primaryUrl":1010,"fullTextUrl":26,"authors":1011,"publicationType":747,"publisherRelationship":1019,"citationCount":26,"citationInfo":26,"publishDate":1033,"publishYear":1034,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":26,"isForceReanalyzing":772},"25a8ce35-88bb-458a-8224-17fc83481f8c","2024-02-14T10:36:04.493+00:00","2024-10-01T02:13:09.233+00:00",[],"Problemas-de-detecci%C3%B3n-precoz-de-los-c%C3%A1nceres-del-cuello-uterino",{"references":1003,"title":1005,"doi":1007},{"VOID":1004},"Abulafia, 1999, Automated cervical cytology: meta-analyses of the performance of the PAPNET system, Obst Gynecol Survey, 4, 253, 10.1097\u002F00006254-199904000-00022\nAndersson-Ellström, 2000, The Pap-smear history of women with invasive squamous carcinoma. A case-control study from Sweden, Acta Obstet Gynecol Scand, 79, 221, 10.1080\u002Fj.1600-0412.2000.079003221.x\nAndrae, 1999, Clinical impact of quality assurance in an organized cervical screening program, Acta Obstet Gynecol Scand, 78, 429, 10.1080\u002Fj.1600-0412.1999.780516.x\nBenedet, 1992, Results of conservative management of cervical intraepithelial neoplasia, Obstet Gynecol, 79, 105\nBornstein, 1995, Etiology of cervical cancer: current concepts, Obstet Gynecol Survey, 50, 146, 10.1097\u002F00006254-199502000-00027\nBrown, 1999, Cost-effectiveness of 3 methods to enhance the sensitivity of Papanicolaou testing, J Am Med Assoc, 281, 347, 10.1001\u002Fjama.281.4.347\nCampion, 1986, Progressive potential of mild cervical atypia: prospective cytologicai, colposcopie and virologicai study, Lancet, 2, 237, 10.1016\u002FS0140-6736(86)92067-2\nChamberlain, 1986, Reasons that some screening programmes fail tocontrol cervical cancer. In : Hakarna M, Miller AB, Day NE. Screening for cervical cancer of the uterine cervix, lARC Sci Publ, 76, 161\nColeman, 1993, European guidelines for quality assurance in cervical cancer screening. Europe against cancer programme, Eur j Cancer, 29, 1\nElfgren, 1996, Conization for cervical intraepithelial neoplasia is followed by disappearance of human papillomavirus deoxyribonucleic acid and a decline in serum and cervical mucus antibodies against human papillomavirus antigens, Am J Obstet Gynecol, 174, 937, 10.1016\u002FS0002-9378(96)70330-7\nFerenczy, 1996, Tissue effects and host response. The key to the rational triage of cervical neoplasia, Obstet Gynecol Clin North Am, 23, 759, 10.1016\u002FS0889-8545(05)70276-X\nGibson, 1997, Trends in invasive cervical cancer incidence in East Anglia from 1971 to 1993, J Med Screen, 4, 44, 10.1177\u002F096914139700400113\nGustafsson, 1997, International incidence rates of invasive cervical cancer before cytological screening, Int J Cancer, 71, 159, 10.1002\u002F(SICI)1097-0215(19970410)71:2\u003C159::AID-IJC6>3.0.CO;2-#\nHakarna, 1986\nHutchinson, 1994, Homogeneous sampling account for the increased diagnostic accuracy using the ThinPrep processor, Am J Clin Patho, 101, 215, 10.1093\u002Fajcp\u002F101.2.215\nJones, 1995, Rescreening in gynecologic cytology. Rescreening of 3762 previous cases for current high-grade squamous intraepithelial lesions and carcinoma- a College of American Pathologists Q-Probes study of 312 institutions, Arch Pathol Lab Med, 119, 1097\nKennedy, 1996, Results of the clinical evaluation of atypical glandular cells of undetermined significance (AGCUS) detected on cervical cytology screening, Gynecol Oncol, 63, 14, 10.1006\u002Fgyno.1996.0270\nKoss, 1993, Cervical (Pap) smear. New directions, Cancer, 71, 1406, 10.1002\u002Fcncr.2820710405\nLaw, 1999, The importance of age in screening for cancer, J Med Screen, 6, 16, 10.1136\u002Fjms.6.1.16\nLinder J. Liquid-based cytology: comparison of ThinPrep 2000 with conventionally prepared Pap smears. In : Franco E, Monsenego) ed. New Developments in Cervical Cancer Screening and Prevention. (Franco et Monsenego) 1998:284–293\nMälck, 1985, Pap smear screening and changes in cervical cancer mortality in Sweden, Int J Epidemiol, 14, 521, 10.1093\u002Fije\u002F14.4.521\nMiller, 1992, Cervical Cancer Screening Programmes\n1989, The 1988 Bethesda System for reporting cervical\u002Fvaginal cytological diagnoses, JAMA, 262, 931, 10.1001\u002Fjama.1989.03430070079034\nNicoli, 1991, Cervical screening cancer: women's knowledge, attitudes and preferences, Health Bull (Edinburgh), 49, 184\nNobbenhuis, 1999, Relation of human papillomavirus status to cervical lesions and consequences for cervical-cancer screening: a prospective study, Lancet, 354, 20, 10.1016\u002FS0140-6736(98)12490-X\nÖstör, 1993, Natural history of cervical intraepithelial neoplasia: a critical review, Int J GynecolPathol, 12, 186, 10.1097\u002F00004347-199304000-00018\nPetry, 1994, Cellular immunodeficiency enhances the progression of human papilloma-associated cervical lesions, Int J Cancer, 57, 836, 10.1002\u002Fijc.2910570612\nPettersson, 1986, Diagnosis and management of cervical abnormalities, IARC Sci Pubi, 76, 221\nRichert, 1973, Cervical intraepithelial neoplasia, Pathol Assoc, 8, 301\nSasieni, 1995, Accelerated decline in cervical cancer mortality in England and Wales, Lancet, 346, 1566, 10.1016\u002FS0140-6736(95)92099-4\nSigurdsson, 1999, The Icelandic and Nordic cervical screening programs: trends in incidence and mortality rates through 1995, Acta Obstet Gynecol Scand, 78, 478, 10.1080\u002Fj.1600-0412.1999.780602.x\nSigurdsson, 1999, Trends in cervical intra-epithelial neoplasia in Iceland through 1995: evaluation of targeted agegroups and screening intervals, Acta Obstet Gynecol Scand, 78, 486, 10.1080\u002Fj.1600-0412.1999.780603.x\nSyrjänen, 1996, Spontaneous evolution of intraepithelial lesions according to the grade and type of implicated human papillomavirus (HPV), Eur J Obstetr Reprod Biol, 65, 45, 10.1016\u002F0028-2243(95)02303-A\nVan Oortmarssen, 1991, Epidemiological evidence for age-dependent regression of pre-invasive cervical cancer, Br J Cancer, 64, 559, 10.1038\u002Fbjc.1991.350",{"ES":1006},"Problemas de detección precoz de los cánceres del cuello uterino",{"VOID":1008},"10.1016\u002Fs1283-081x(02)71898-5","Author affiliation is blank","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1283081X02718985",[1012],{"id":1013,"sortIndex":36,"researcher":26,"roles":1014,"affiliations":1015,"properties":1016},"06d65672-31e2-4135-81fc-f995142df4f3",[696],[],{"title":1017},{"VI":1018},"A. Norström",{"url":1010,"publisher":1020,"properties":1028},{"id":659,"createTime":660,"updateTime":660,"relativeEntities":1021,"slug":662,"properties":1022,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":1025,"manageAffiliations":1026,"indexDatabases":1027,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":1023,"title":1024},{"VOID":665},{"EN":667},[],[],[],{"volume":1029,"pages":1031},{"VOID":1030},"38",{"VOID":1032},"1-7","2002-01-01",2002,{"id":1036,"createTime":1037,"updateTime":1038,"relativeEntities":1039,"slug":1040,"properties":1041,"entityType":688,"verifyStatus":25,"verifyTime":1038,"verifyNote":690,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"primaryUrl":1048,"fullTextUrl":26,"authors":1049,"publicationType":747,"publisherRelationship":1117,"citationCount":26,"citationInfo":26,"publishDate":1130,"publishYear":765,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":26,"isForceReanalyzing":772},"4e13ffda-37a5-48c4-9ae0-affd04e9d6d9","2024-01-11T02:40:00.744+00:00","2025-01-13T18:40:28.560+00:00",[],"Psiquiatr%C3%ADa-y-embarazo-la-madre-y-el-hijo",{"references":1042,"title":1044,"doi":1046},{"VOID":1043},"Cox, 1987, Detection of postnatal depression. Development of the 10-item Edinburgh Postnatal Depression Scale, Br J Psychiatry, 150, 782, 10.1192\u002Fbjp.150.6.782\nBydlowski, 1997\nHoekzema, 2017, Pregnancy leads to long-lasting changes in human brain structure, Nat Neurosci, 20, 287, 10.1038\u002Fnn.4458\nSutter-Dallay, 2013\nKendell, 1987, Epidemiology of puerperal psychoses, Br J Psychiatry, 150, 662, 10.1192\u002Fbjp.150.5.662\nWinnicott, 1989\nGuedeney, 1993, Post-partum blues: a critical review of the literature, Psychiatr Enf, 36, 329\nGavin, 2005, Perinatal depression: a systematic review of prevalence and incidence, Obstet Gynecol, 106, 1071, 10.1097\u002F01.AOG.0000183597.31630.db\nBales, 2015, Prenatal psychological distress and access to mental health care in the ELFE cohort, Eur Psychiatry, 30, 322, 10.1016\u002Fj.eurpsy.2014.11.004\nBérard, 2019, The French Pregnancy Cohort: Medication use during pregnancy in the French population, PLoS One, 14, e0219095, 10.1371\u002Fjournal.pone.0219095\nMeltzer-Brody, 2011, New insights into perinatal depression: pathogenesis and treatment during pregnancy and postpartum, Dialogues Clin Neurosci, 13, 89, 10.31887\u002FDCNS.2011.13.1\u002Fsmbrody\nElwood, 2019, A systematic review investigating if genetic or epigenetic markers are associated with postnatal depression, J Affect Disord, 253, 51, 10.1016\u002Fj.jad.2019.04.059\nKelly, 2001, Somatic complaints among pregnant women cared for in obstetrics: normal pregnancy or depressive and anxiety symptom amplification revisited?, Gen Hosp Psychiatry, 23, 107, 10.1016\u002FS0163-8343(01)00129-3\nSutter-Dallay, 2012, Evolution of perinatal depressive symptoms from pregnancy to two years postpartum in a low-risk sample: the MATQUID cohort, J Affect Disord, 139, 23, 10.1016\u002Fj.jad.2011.08.018\nStevens, 2019, Risk of recurrence of mood disorders during pregnancy and the impact of medication: A systematic review, J Affect Disord, 249, 96, 10.1016\u002Fj.jad.2019.02.018\nAzorin, 2012, Identifying features of bipolarity in patients with first-episode postpartum depression: findings from the international BRIDGE study, J Affect Disord, 136, 710, 10.1016\u002Fj.jad.2011.10.003\nSantos, 2017, Heterogeneity in perinatal depression: how far have we come?. A systematic review, Arch Womens Ment Health, 20, 11, 10.1007\u002Fs00737-016-0691-8\nAustin, 2007, Maternal mortality and psychiatric morbidity in the perinatal period: challenges and opportunities for prevention in the Australian setting, Med J Aust, 186, 364, 10.5694\u002Fj.1326-5377.2007.tb00940.x\nGuillard, 2017, Suicidality during perinatal period, Presse Med, 46, 565, 10.1016\u002Fj.lpm.2017.05.018\nGressier, 2017, Risk factors for suicide attempt in pregnancy and the post-partum period in women with serious mental illnesses, J Psychiatr Res, 84, 284, 10.1016\u002Fj.jpsychires.2016.10.009\nAbrams, 1995, Newborns of depressed mothers, Infant Ment Health J, 16, 233, 10.1002\u002F1097-0355(199523)16:3\u003C233::AID-IMHJ2280160309>3.0.CO;2-1\nField, 2004, Prenatal depression effects on the fetus and the newborn, Infant Behav Dev, 27, 216, 10.1016\u002Fj.infbeh.2003.09.010\nLundy, 1999, Prenatal depression effects on neonates, Infant Behav Dev, 22, 121, 10.1016\u002FS0163-6383(99)80009-5\nGressier, 2019, Negative impact of maternal antenatal depressive symptoms on neonate's behavioral characteristics, Eur Child Adolesc Psychiatry\nGentile, 2017, Untreated depression during pregnancy: Short- and long-term effects in offspring. A systematic review, Neuroscience, 342, 154, 10.1016\u002Fj.neuroscience.2015.09.001\nLeis, 2014, Associations between maternal mental health and child emotional and behavioral problems: does prenatal mental health matter?, J Abnorm Child Psychol, 42, 161, 10.1007\u002Fs10802-013-9766-4\nGaléra, 2011, Early risk factors for hyperactivity-impulsivity and inattention trajectories from age 17 months to 8 years, Arch Gen Psychiatry, 68, 1267, 10.1001\u002Farchgenpsychiatry.2011.138\nStein, 2014, Effects of perinatal mental disorders on the fetus and child, Lancet, 384, 1800, 10.1016\u002FS0140-6736(14)61277-0\nViguera, 2007, Risk of recurrence in women with bipolar disorder during pregnancy: prospective study of mood stabilizer discontinuation, Am J Psychiatry, 164, 1817, 10.1176\u002Fappi.ajp.2007.06101639\nDi Florio, 2013, Perinatal episodes across the mood disorder spectrum, JAMA Psychiatry, 70, 168, 10.1001\u002Fjamapsychiatry.2013.279\nPope, 2014, Recognition, diagnosis and treatment of postpartum bipolar depression, Expert Rev Neurother, 14, 19, 10.1586\u002F14737175.2014.846219\nViguera, 2011, Episodes of mood disorders in 2,252 pregnancies and postpartum periods, Am J Psychiatry, 168, 1179, 10.1176\u002Fappi.ajp.2011.11010148\nSolé, 2019, Obstetric complications in bipolar disorder: The role of mental health disorders in the risk of caesarean section, J Affect Disord, 252, 458, 10.1016\u002Fj.jad.2019.04.017\nBodén, 2012, Risks of adverse pregnancy and birth outcomes in women treated or not treated with mood stabilisers for bipolar disorder: population based cohort study, Br Med J, 345, e7085, 10.1136\u002Fbmj.e7085\nGrimm, 1966, The relationship of emotional adjustment and attitudes to the course and outcome of pregnancy, Psychosom Med, 28, 34, 10.1097\u002F00006842-196601000-00004\nUguz, 2019, Prevalence of mood and anxiety disorders during pregnancy: A case-control study with a large sample size, Psychiatry Res, 272, 316, 10.1016\u002Fj.psychres.2018.12.129\nDayan, 2014\nBundy, 2011, A systematic review and meta-analysis of the fertility of patients with schizophrenia and their unaffected relatives, Acta Psychiatr Scand, 23, 98, 10.1111\u002Fj.1600-0447.2010.01623.x\nGlangeaud-Freudenthal, 2013, Predictors of infant foster care in cases of maternal psychiatric disorders, Soc Psychiatry Psychiatr Epidemiol, 48, 553, 10.1007\u002Fs00127-012-0527-4\nGlangeaud-Freudenthal, 2014, Treatment – mother-infant inpatient units, Best Pract Res Clin Obstet Gynaecol, 28, 147, 10.1016\u002Fj.bpobgyn.2013.08.015\nWessel, 2002, Frequency of denial of pregnancy: results and epidemiological significance of a 1-year prospective study in Berlin, Acta Obstet Gynecol Scand, 81, 1021, 10.1034\u002Fj.1600-0412.2002.811105.x\n2013\nBeier, 2006, Denial of pregnancy as a reproductive dysfunction: a proposal for international classification systems, J Psychosom Res, 61, 723, 10.1016\u002Fj.jpsychores.2005.11.002\nHumeau E. Le déni de grossesse : revue de la littérature et étude de son lien potentiel avec le néonaticide. [thèse de médecine], Université de Bordeaux, 2018.\nLondon, 2017, Hyperemesis gravidarum: a review of recent literature, Pharmacology, 100, 161, 10.1159\u002F000477853\nEven, 2019, Mental health of children in foster care: a literature review, Encephale, 45, 340, 10.1016\u002Fj.encep.2019.03.006\nCleary, 2011, Methadone and perinatal outcomes: a retrospective cohort study, Am J Obstet Gynecol, 204, 139, 10.1016\u002Fj.ajog.2010.10.004\nCleary, 2013, Methadone dosing and prescribed medication use in a prospective cohort of opioid-dependent pregnant women, Addiction, 108, 762, 10.1111\u002Fadd.12078\nThibaut, 2019, WFSBP and IAWMH Guidelines for the treatment of alcohol use disorders in pregnant women, World J Biol Psychiatry, 20, 17, 10.1080\u002F15622975.2018.1510185\nGlover, 2015, Prenatal stress and its effects on the fetus and the child: possible underlying biological mechanisms, Adv Neurobiol, 10, 269, 10.1007\u002F978-1-4939-1372-5_13\nBarker, 2013, Prenatal maternal depression symptoms and nutrition, and child cognitive function, Br J Psychiatry, 203, 417, 10.1192\u002Fbjp.bp.113.129486\nAllister, 2001, The effects of maternal depression on fetal heart rate response to vibroacoustic stimulation, Dev Neuropsychol, 20, 639, 10.1207\u002FS15326942DN2003_6\nField, 2001, Depressed withdrawn and intrusive mothers’ effects on their fetuses and neonates, Infant Behav Dev, 24, 27, 10.1016\u002FS0163-6383(01)00066-2\nSutter-Dallay AL, Guedeney N, Guedeney A. Psychiatrie périnatale : histoire, concepts, applications, limites, EMC (Elsevier Masson SAS, Paris), Psychiatrie, 37-200-B-20, 2010.\nMitchell, 2011, National Birth Defects Prevention Study. Medication use during pregnancy, with particular focus on prescription drugs: 1976-2008, Am J Obstet Gynecol, 205, 51, 10.1016\u002Fj.ajog.2011.02.029\nYonkers, 2009, The management of depression during pregnancy: a report from the American Psychiatric Association and the American College of Obstetricians and Gynecologists, Gen Hosp Psychiatry, 31, 403, 10.1016\u002Fj.genhosppsych.2009.04.003\nJarde, 2016, Neonatal outcomes in women with untreated antenatal depression compared with women without depression: a systematic review and meta-analysis, JAMA Psychiatry, 73, 826, 10.1001\u002Fjamapsychiatry.2016.0934\nMan, 2018, Prenatal antidepressant exposure and the risk of attention-deficit hyperactivity disorder in children: A systematic review and meta-analysis, Neurosci Biobehav Rev, 86, 1, 10.1016\u002Fj.neubiorev.2017.12.007\nMezzacappa, 2017, Risk for autism spectrum disorders according to period of prenatal antidepressant exposure: a systematic review and meta-analysis, JAMA Pediatr, 171, 555, 10.1001\u002Fjamapediatrics.2017.0124\nWard, 2018, Recommendations for the use of ECT in pregnancy: literature review and proposed clinical protocol, Arch Womens Ment Health, 21, 715, 10.1007\u002Fs00737-018-0851-0\nNational Institute for Health and Care Excellence, 2014. Antenatal and Postnatal Mental Health: Clinical Management and Service Guidance. https:\u002F\u002Fwww.nice.org.uk\u002Fguidance\u002Fcg45.\nSutter-Dallay, 2014, Le lithium et la grossesse, Ann Med Psychol, 172, 229\nMunk-Olsen, 2018, Maternal and infant outcomes associated with lithium use in pregnancy: an international collaborative meta-analysis of six cohort studies, Lancet Psychiatry, 5, 644, 10.1016\u002FS2215-0366(18)30180-9\nDiav-Citrin, 2014, Pregnancy outcome following in utero exposure to lithium: a prospective, comparative, observational study, Am J Psychiatry, 171, 785, 10.1176\u002Fappi.ajp.2014.12111402\nEpstein, 2014, Treatment of bipolar disorders during pregnancy: maternal and fetal safety and challenges, Drug Health Patient Saf, 7, 7, 10.2147\u002FDHPS.S50556\nForsberg, 2018, Maternal mood disorders and lithium exposure in utero were not associated with poor cognitive development during childhood, Acta Paediatr, 107, 1379, 10.1111\u002Fapa.14152\nSchou, 1973, Lithium and pregnancy. 3. Lithium ingestion by children breast-fed by women on lithium treatment, Br Med J, 2, 138, 10.1136\u002Fbmj.2.5859.138\nVan der Lugt, 2012, Fetal, neonatal and developmental outcomes of lithium-exposed pregnancies, Early Hum Dev, 88, 375, 10.1016\u002Fj.earlhumdev.2011.09.013\nCasassus, 2017, France bans sodium-alproate use in case of pregnancy, Lancet, 390, 217, 10.1016\u002FS0140-6736(17)31866-4\nHernández-Díaz, 2012, Comparative safety of antiepileptic drugs during pregnancy, Neurology, 78, 1692, 10.1212\u002FWNL.0b013e3182574f39\nHaskey, 2017, Mood stabilizers in pregnancy and child developmental outcomes: A systematic review, Aust N Z J Psychiatry, 51, 1087, 10.1177\u002F0004867417726175\nBaker, 2015, IQ at 6 years after in utero exposure to antiepileptic drugs: a controlled cohort study, Neurology, 84, 382, 10.1212\u002FWNL.0000000000001182\nMahli, 2005, Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders, Aust N Z J Psychiatry, 49, 1087\nKong, 2018, The risks associated with the use of lamotrigine during pregnancy, Int J Psychiatry Clin Pract, 22, 2, 10.1080\u002F13651501.2017.1341986\nDiav-Citrin, 2005, Safety of haloperidol and penfluridol in pregnancy: a multicenter, prospective, controlled study, J Clin Psychiatry, 66, 317, 10.4088\u002FJCP.v66n0307\nMcAllister-Williams, 2017, British Association for Psychopharmacology consensus guidance on the use of psychotropic medication preconception, in pregnancy and postpartum 2017, J Psychopharmacol, 31, 519, 10.1177\u002F0269881117699361\nMcKenna, 2005, Pregnancy outcome of women using atypical antipsychotic drugs: a prospective comparative study, J Clin Psychiatry, 66, 444, 10.4088\u002FJCP.v66n0406\nNewham, 2008, Birth weight of infants after maternal exposure to typical and atypical antipsychotics: prospective comparison study, Br J Psychiatry, 192, 333, 10.1192\u002Fbjp.bp.107.041541\nDamkier, 2018, The safety of second-generation antipsychotics during pregnancy: a clinically focused review, CNS Drugs, 32, 351, 10.1007\u002Fs40263-018-0517-5\nPoels, 2018, Long-term neurodevelopmental consequences of intrauterine exposure to lithium and antipsychotics: a systematic review and meta-analysis, Eur Child Adolesc Psychiatry, 27, 1209, 10.1007\u002Fs00787-018-1177-1\nSheehy, 2019, Association between incident exposure to benzodiazepines in early pregnancy and risk of spontaneous abortion, JAMA Psychiatry, 10.1001\u002Fjamapsychiatry.2019.0963\nShyken, 2019, Benzodiazepines in pregnancy, Clin Obstet Gynecol, 62, 156, 10.1097\u002FGRF.0000000000000417\nBoyars, 2018, Treatment of perinatal opioid use disorder, Obstet Gynecol Clin North Am, 45, 511, 10.1016\u002Fj.ogc.2018.05.001\nMolyneaux, 2018, Antidepressants for preventing postnatal depression, Cochrane Database Syst Rev, CD004363\nO’Connor, 2019\nGraham, 2018, Is there consensus across international evidence-based guidelines for the psychotropic drug management of bipolar disorder during the perinatal period?, J Affect Disord, 228, 216, 10.1016\u002Fj.jad.2017.12.022\nHeron, 2005, Postnatal euphoria: are “the highs” an indicator of bipolarity?, Bipolar Disord, 7, 103, 10.1111\u002Fj.1399-5618.2005.00185.x\nSharma, 2010, Screening for bipolar disorder during pregnancy and the postpartum period, J Obstet Gynaecol Can, 32, 278, 10.1016\u002FS1701-2163(16)34456-5\nSharma, 2017, Bipolar postpartum depression: An update and recommendations, J Affect Disord, 219, 105, 10.1016\u002Fj.jad.2017.05.014\nO’Hara, 2014, Perinatal mental illness: definition, description and aetiology, Best Pract Res Clin Obstet Gynaecol, 28, 3, 10.1016\u002Fj.bpobgyn.2013.09.002\nHoward, 2014, Non-psychotic mental disorders in the perinatal period, Lancet, 384, 1775, 10.1016\u002FS0140-6736(14)61276-9\nSharma, 2018, Should all women with postpartum depression be screened for bipolar disorder?, Med Hypotheses, 118, 26, 10.1016\u002Fj.mehy.2018.06.016\nSharma, 2014, A prospective study of diagnostic conversion of major depressive disorder to bipolar disorder in pregnancy and postpartum, Bipolar Disord, 16, 16, 10.1111\u002Fbdi.12140\nMunk-Olsen, 2012, Psychiatric disorders with postpartum onset: possible early manifestations of bipolar affective disorders, Arch Gen Psychiatry, 69, 428, 10.1001\u002Farchgenpsychiatry.2011.157\nKhan, 2015, Post-partum depressive episodes and bipolar disorder, Lancet, 385, 771, 10.1016\u002FS0140-6736(15)60433-0\nGressier, 2015, Post-partum psychosis, Rev Prat, 65, 232\nOlde, 2006, Posttraumatic stress following childbirth: a review, Clin Psychol Rev, 26, 1, 10.1016\u002Fj.cpr.2005.07.002\nAyers, 2016, The aetiology of post-traumatic stress following childbirth: a meta-analysis and theoretical framework, Psychol Med, 46, 1121, 10.1017\u002FS0033291715002706\nCohn, 1990, Face-to-face interactions of postpartum depressed and nondepressed mother-infant pairs at 2 months, Dev Psychol, 26, 15, 10.1037\u002F0012-1649.26.1.15\nMurray, 1996, The role of infant factors in postnatal depression and mother-infant interactions, Dev Med Child Neurol, 38, 109, 10.1111\u002Fj.1469-8749.1996.tb12082.x\nTaka-Eilola Nèe Riekki, 2019, Severe mood disorders and schizophrenia in the adult offspring of antenatally depressed mothers in the Northern Finland 1966 Birth Cohort: Relationship to parental severe mental, disorder, J. Affect Disord, 249, 63, 10.1016\u002Fj.jad.2019.02.011\nJunge, 2017, The impact of perinatal depression on children's social-emotional development: a longitudinal study, Matern Child Health J, 21, 607, 10.1007\u002Fs10995-016-2146-2\nRamsauer, 2018, Mothers with acute and chronic postpartum psychoses and impact on the mother-infant interaction, Schizophr Res, 197, 45, 10.1016\u002Fj.schres.2018.02.032\nWendland, 2017, Impact des troubles maternels borderline et psychotiques sur les relations mère-enfant : une revue de la littérature. Carnet de notes sur les maltraitances, Infant, 6, 5\nApter, 2017, The still-face: a greater challenge for infants of mothers with borderline personality disorder, J Pers Disord, 31, 156, 10.1521\u002Fpedi_2016_30_243\nNewman, 2007, Borderline personality disorder, mother-infant interaction and parenting perceptions: preliminary findings, Z J Psychiatry, 41, 598\nSethna, 2015, Paternal depression in the postnatal period and early father-infant interactions, Parent Sci Pract, 15, 1, 10.1080\u002F15295192.2015.992732\nGressier, 2015, Dépression paternelle du post-partum : revue de la littérature, Presse Med, 44, 418, 10.1016\u002Fj.lpm.2014.09.022",{"ES":1045},"Psiquiatría y embarazo: la madre y el hijo",{"VOID":1047},"10.1016\u002Fs1283-081x(20)44317-6","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1283081X20443176",[1050,1075,1087,1102],{"id":1051,"sortIndex":36,"researcher":26,"roles":1052,"affiliations":1053,"properties":1072},"e8dfbf78-5d2f-4c42-b9a6-c6181aa22a9e",[696],[1054,1064],{"id":1055,"sortIndex":115,"affiliation":1056,"properties":1063},"6a7eead7-fe23-47ec-8748-427916fd3278",{"id":1057,"createTime":1058,"updateTime":1058,"relativeEntities":1059,"slug":26,"properties":1060,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"7026e54f-25e2-4873-80fb-b3cc2b2dd806","2024-01-11T02:40:00.770+00:00",[],{"title":1061},{"VI":1062},"Réseau de psychiatrie périnatale, Pôle universitaire de psychiatrie adulte (UNIVA), CH Charles-Perrens, Bordeaux, France",{},{"id":26,"sortIndex":36,"affiliation":1065,"properties":26},{"id":1066,"createTime":1067,"updateTime":1067,"relativeEntities":1068,"slug":26,"properties":1069,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"206a4422-3db1-4d8d-9c45-59e1040658b4","2024-01-11T02:40:00.758+00:00",[],{"title":1070},{"VI":1071},"Inserm 1219, Bordeaux Population Health Center, Université de Bordeaux, Bordeaux, France",{"title":1073},{"VI":1074},"A.-L. Sutter-Dallay",{"id":1076,"sortIndex":115,"researcher":26,"roles":1077,"affiliations":1078,"properties":1084},"cedb144f-727c-4a79-8678-8995dbb08498",[696],[1079],{"id":26,"sortIndex":36,"affiliation":1080,"properties":26},{"id":1057,"createTime":1058,"updateTime":1058,"relativeEntities":1081,"slug":26,"properties":1082,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1083},{"VI":1062},{"title":1085},{"VI":1086},"G. Scotta",{"id":1088,"sortIndex":59,"researcher":26,"roles":1089,"affiliations":1090,"properties":1099},"cb38a56a-0cf2-4baf-9438-f66c74c1f0a7",[696],[1091],{"id":26,"sortIndex":36,"affiliation":1092,"properties":26},{"id":1093,"createTime":1094,"updateTime":1094,"relativeEntities":1095,"slug":26,"properties":1096,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"73821e33-22b2-4157-9494-f19615304845","2024-01-11T02:40:00.786+00:00",[],{"title":1097},{"VI":1098},"Centre de recherche en épidémiologie et santé des populations, Université de Versailles-Saint-Quentin-en-Yvelines, Inserm U1178, Université Paris-Sud, Service de psychiatrie, Hôpital de Bicêtre, Hôpitaux universitaires Paris-Sud, 78, rue du Général-Leclerc, 94275 Le Kremlin-Bicêtre, France",{"title":1100},{"VI":1101},"F. Gressier",{"id":1103,"sortIndex":114,"researcher":26,"roles":1104,"affiliations":1105,"properties":1114},"3ed8f548-a798-4163-987b-828d9acc7b56",[696],[1106],{"id":26,"sortIndex":36,"affiliation":1107,"properties":26},{"id":1108,"createTime":1109,"updateTime":1109,"relativeEntities":1110,"slug":26,"properties":1111,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"b1e9b97c-1f11-48ce-a2c8-6da78dcd3516","2024-01-11T02:40:00.777+00:00",[],{"title":1112},{"VI":1113},"Pôle universitaire de psychiatrie de l’enfant et de l’adolescent, CH Charles-Perrens, 121, rue de la Béchade, 33000 Bordeaux, France",{"title":1115},{"VI":1116},"S. Lemoigne",{"url":1048,"publisher":1118,"properties":1126},{"id":659,"createTime":660,"updateTime":660,"relativeEntities":1119,"slug":662,"properties":1120,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":1123,"manageAffiliations":1124,"indexDatabases":1125,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":1121,"title":1122},{"VOID":665},{"EN":667},[],[],[],{"volume":1127,"pages":1128},{"VOID":759},{"VOID":1129},"1-13","2020-10-01",{"id":1132,"createTime":1133,"updateTime":1134,"relativeEntities":1135,"slug":1136,"properties":1137,"entityType":688,"verifyStatus":25,"verifyTime":1134,"verifyNote":690,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"primaryUrl":1144,"fullTextUrl":26,"authors":1145,"publicationType":747,"publisherRelationship":1212,"citationCount":26,"citationInfo":26,"publishDate":1226,"publishYear":1227,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":26,"isForceReanalyzing":772},"12760f9e-4506-4961-a309-733af58911ac","2023-12-23T06:11:29.605+00:00","2025-01-27T12:33:59.445+00:00",[],"Contribuci%C3%B3n-de-la-tomograf%C3%ADa-por-emisi%C3%B3n-de-positrones-con-fluorodesoxiglucosa-18F-en-las-pacientes-afectadas-de-c%C3%A1ncer-genital-o-mamario",{"references":1138,"title":1140,"doi":1142},{"VOID":1139},"Bourguet, 2003, Utilisation de la tomographie par émission de positons au [18F]-FDG en cancérologie, Bull. Cancer, 90\nFischman, 1993, FDG-PET in oncology: there's more to it than looking at picture, J. Nucl. Med., 34, 6\nEnomoto, 1991, Can fluorodeoxyglucose-positron emission tomography evaluate the functional differentiation of hepatocellular carcinoma, Kaku Igaku, 28, 1353\nAntoch, 2004, Accuracy of whole-body dual-modality fluorine-18-2-fluoro-2-deoxy-D-glucose positron emission tomography and computed tomography (FDG-PET\u002FCT) for tumor staging in solid tumors: comparison with CT and PET, J. Clin. Oncol., 22, 4357, 10.1200\u002FJCO.2004.08.120\nWarburg, 1924, The metabolism of cancer cells, Biochem. Zschr., 152, 129\nHaberkorn, 1994, FDG uptake, tumor proliferation and expression of glucolysis associated genes in animal models, Nucl. Med. Biol., 21, 827, 10.1016\u002F0969-8051(94)90162-7\nGolshani-Hebroni, 1997, Hexokinase binding to mitochondria: a basis for proliferative energy metabolism, J. Bioenerg. Biomembr., 29, 331, 10.1023\u002FA:1022442629543\nYounes, 1997, Overexpression of Glut1 and Glut3 in stage non-small cell lung carcinoma is associated with poor survival, Cancer, 80, 1046, 10.1002\u002F(SICI)1097-0142(19970915)80:6\u003C1046::AID-CNCR6>3.0.CO;2-7\nFlier, 1987, Elevated levels of glucose transport and transporter messenger RNA are induced by ras or src oncogens, Science, 235, 1492, 10.1126\u002Fscience.3103217\nMochizuki, 2001, FDG uptake and glucose transporter subtype expressions in experimental tumor and inflammation models, J. Nucl. Med., 42, 1551\nVranjesevic, 2003, Relationship between 18F-FDG uptake and breast density in women with normal breast tissue, J. Nucl. Med., 44, 1238\nHicks, 2001, Pattern of uptake and excretion of 18F-FDG in the lactating breast, J. Nucl. Med., 42, 1238\nCrippa, 1998, Association between [18F]fluorodeoxyglucose uptake and prospective histology, hormone receptor status, thymidine labelling index and p53 in primary breast cancer: a preliminary observation, Eur. J. Nucl. Med., 25, 1429, 10.1007\u002Fs002590050319\nAvril, 2001, Glucose metabolism of breast cancer assessed by 18F-FDG PET: histologic and immunohistochemical tissue analysis, J. Nucl. Med., 42, 9\nBos, 2002, Biologic correlates of 18fluorodeoxyglucose uptake in human breast cancer measured by positron emission tomography, J. Clin. Oncol., 20, 379, 10.1200\u002FJCO.20.2.379\nAvril, 2000, Breast imaging with positron emission tomography and fluorine-18 fluorodeoxyglucose: use and limitations, J. Clin. Oncol., 18, 3495, 10.1200\u002FJCO.2000.18.20.3495\nBakheet, 2000, F-18 FDG uptake in breast infection and inflammation, Clin. Nucl. Med., 25, 100, 10.1097\u002F00003072-200002000-00003\nAvril, 1997, Breast imaging fluorine-18-FDG PET: quantitative image analysis, J. Nucl. Med., 38, 1186\nHeinisch, 2003, Comparison of FDG-PET and dynamic contrast-enhanced MRI in the evaluation of suggestive breast lesions, Breast, 12, 17, 10.1016\u002FS0960-9776(02)00262-X\nSchirrmeister, 2001, Fluorine-18 2-deoxy-2-fluoro-D-glucose PET in the preoperative staging of breast cancer: comparison with the standard staging procedures, Eur. J. Nucl. Med., 28, 351, 10.1007\u002Fs002590000448\nRosen, 2005, Detection of primary breast carcinoma with a dedicated, large-field-of view FDG PET mammography device: initial experience, Radiology, 234, 527, 10.1148\u002Fradiol.2342040654\nReznik, 2005, An amorphous selenium based positron emission mammography camera with avalanche gain, Technol. Cancer Res. Treat., 4, 61, 10.1177\u002F153303460500400109\nKim, 2005, Incidental ovarian 18F-FDG accumulation on PET: correlation with the menstruel cycle, Eur. J. Nucl. Med. Mol. Imaging, 32, 757, 10.1007\u002Fs00259-005-1771-6\nLerman, 2004, Normal and abnormal 18F-FDG endometrial and ovarian uptake in pre- and postmenopausal patients: assessment by PET\u002FCT, J. Nucl. Med., 45, 266\nKurokawa, 2004, Expression of Glut-1 glucose transfer, cellular proliferation activity and grade of tumor correlate with [F-18]-fluorodeoxyglucose uptake by positron emission tomography in epithelial tumors of ovary, Int. J. Cancer, 109, 926, 10.1002\u002Fijc.20057\nCantuaria, 2000, Expression of Glut-1 glucose in borderline and malignant epithelial tumors of the ovary, Gynecol. Oncol., 79, 33, 10.1006\u002Fgyno.2000.5910\nKawahara, 2004, Evaluation of positron emission tomography with tracer 18-fluorodeoxyglucose in addition to magnetic resonance imaging in the diagnosis of ovarian cancer in selected women after ultrasonography, J. Comput. Assist. Tomogr., 28, 505, 10.1097\u002F00004728-200407000-00011\nRieber, 2001, Preoperative diagnosis of ovarian tumors with MR imaging: comparison with transvaginal sonography, positron emission tomography, and histologic findings, AJR Am. J. Roentgenol., 177, 123, 10.2214\u002Fajr.177.1.1770123\nKoyama, 2003, Evaluation of 18F-FDG with bladder irrigation in patients with uterine and ovarian tumors, J. Nucl. Med., 44, 353\nNishizawa, 2005, Physiological 18F-FDG uptake in ovaries and uterus of healthy female volunteers, Eur. J. Nucl. Med. Mol. Imaging, 32, 549, 10.1007\u002Fs00259-004-1703-x\nYen, 2004, 18F-FDG uptake in squamous cell carcinoma of the cervix is correled with glucose transporter 1 expression, J. Nucl. Med., 45, 22\nCarter, 1989, Relation of tumor size, lymph node status and survival in 24,740 breast cancer cases, Cancer, 63, 181, 10.1002\u002F1097-0142(19890101)63:1\u003C181::AID-CNCR2820630129>3.0.CO;2-H\nBarranger, 2003, Evaluation of fluorodeoxyglucose positron emission tomography in the detection of axillary lymph node metastases in patients with early-stage breast cancer, Ann. Surg. Oncol., 10, 622, 10.1245\u002FASO.2003.12.019\nFehr, 2004, Axillary staging using positron emission tomography in breast cancer patients qualifying for sentinel lymph node biopsy, Breast J., 10, 89, 10.1111\u002Fj.1075-122X.2004.21455.x\nDanforth, 2002, The role of 18F-FDG in the local\u002Fregional evaluation of women with breast cancer, Breast Cancer Res. Treat., 75, 135, 10.1023\u002FA:1019664126220\nWahl, 2004, Prospective multicenter study of axillary nodal staging by positron emission tomography in breast cancer: a report of the staging breast cancer with PET study group, J. Clin. Oncol., 22, 277, 10.1200\u002FJCO.2004.04.148\nEubank, 2001, 18-Fluorodeoxyglucose positron emission tomography to detect mediastinal or internal mammary metastases in breast cancer, J. Clin. Oncol., 19, 3516, 10.1200\u002FJCO.2001.19.15.3516\nBellon, 2004, Evaluation of internal mammary lymph nodes by FDG-PET in locally breast cancer (LABC), Am. J. Clin. Oncol., 27, 407, 10.1097\u002F01.coc.0000128869.19357.9b\nKinkel, 2002, Detection of metastases from cancers of the gastrointestinal tract by using noninvasive imaging methods (US, CT, MR imaging, PET): a meta-analysis, Radiology, 224, 748, 10.1148\u002Fradiol.2243011362\nKurtaran, 2000, 18F-fluorodeoxyglucose (FDG)-PET features of focal nodular hyperplasia (FNH) of the liver, Liver, 20, 487, 10.1034\u002Fj.1600-0676.2000.020006487.x\nMoon, 1998, Accuracy of whole-body fluorine-18-FDG PET for the detection of recurrent or metastatic breast carcinoma, J. Nucl. Med., 39, 431\nOtha, 2001, Whole body PET for the evaluation of bony metastases in patients with 99mTc-MDP bone scintigraphy, Nucl. Med. Commun., 22, 875, 10.1097\u002F00006231-200108000-00005\nYang, 2002, Comparing whole body (18)F-2-deoxyglucose positron emission tomography and technetium-99m methylene diphosphonate bone scan to detect bone metastases in patients with breast cancer, J. Cancer Res. Clin. Oncol., 128, 325, 10.1007\u002Fs00432-002-0342-5\nCook, 1998, Detection of bone metastases in breast cancer by 18FDG PET: differing metabolic activity in osteoblastic and osteolytic lesions, J. Clin. Oncol., 16, 3375, 10.1200\u002FJCO.1998.16.10.3375\nUematsu, 2005, Comparison of FDG PET and SPECT for detection of bone metastases in breast cancer, AJR Am. J. Roentgenol., 184, 1266, 10.2214\u002Fajr.184.4.01841266\nVan der Hoeven, 2004, 18F-2-fluoro-2-deoxy-D-glucose positron emission tomography in staging of locally advanced breast cancer, J. Clin. Oncol., 22, 1253, 10.1200\u002FJCO.2004.07.058\nYoshida, 2004, Incremental benefits of FDG positron emission tomography over CT alone for the preoperative staging of ovarian cancer, AJR Am. J. Roentgenol., 182, 227, 10.2214\u002Fajr.182.1.1820227\nReinhardt, 2001, Metastatic lymph nodes in patients with cervical cancer: detection with MR imaging and FDG PET, Radiology, 218, 766, 10.1148\u002Fradiology.218.3.r01mr19776\nFollen, 2003, Imaging in cervical cancer, Cancer, 98, 2028, 10.1002\u002Fcncr.11679\nBarranger, 2004, Technique et intérêt potentiel de la détection du ganglion sentinelle dans le cancer utérin, Méd. Nucl., 28, 305\nResbeut, 2003, Standards, options, recommandations : cancers invasifs du col utérin stades non métastatiques (version abrégée), Bull. Cancer, 90, 333\nBrémond, 2002, Standards, options et recommandations 2000 : cancer de l'endomètre, stades non métastatiques (rapport abrégé), Bull. Cancer, 89, 697\nBerman, 1984, Survival and patterns of recurrence in cervical cancer metastatic to periaortic lymph nodes (a Gynecology Oncology Group study), Gynecol. Oncol., 19, 8, 10.1016\u002F0090-8258(84)90151-3\nPark, 2005, The usefulness of IRM and PET imaging for the detection of parametrial involment and lymph node metastasis in patients with cervical cancer, Jpn. J. Clin. Oncol., 35, 260, 10.1093\u002Fjjco\u002Fhyi079\nBelhocine, 2002, Contribution of whole-body 18FDG PET imaging in the management of cervical cancer, Gynecol. Oncol., 87, 90, 10.1006\u002Fgyno.2002.6769\nNarayan, 2001, A comparison of MRI and PET scanning in surgically staged loco-regionally advanced cervical cancer: potential impact on treatment, Int. J. Gynecol. Cancer, 11, 263, 10.1046\u002Fj.1525-1438.2001.011004263.x\nLin, 2003, Usefulness of (18)F-fluorodeoxyglucose positron emission tomography to detect para-aortic lymph nodal metastasis in advanced cervical cancer with negative computed tomography findings, Gynecol. Oncol., 89, 73, 10.1016\u002FS0090-8258(03)00058-1\nGrigsby, 2001, Lymph node staging by positron emission tomography in patients with carcinoma of the cervix, J. Clin. Oncol., 19, 3745, 10.1200\u002FJCO.2001.19.17.3745\nHorowitz, 2004, Prospective evaluation of FDG-PET for detection pelvic and para-aortic lymph node metastasis in uterine corpus cancer, Gynecol. Oncol., 95, 546, 10.1016\u002Fj.ygyno.2004.08.009\nTran, 2003, Occult supraclavicular lymph node metastasis identified by FDG-PET in patient with carcinoma of the uterine cervix, Gynecol. Oncol., 90, 572, 10.1016\u002FS0090-8258(03)00402-5\nEubank, 1998, Imaging of oncologic patients: benefit of combined CT and FDG PET in the diagnosis of malignancy, AJR Am. J. Roentgenol., 171, 1103, 10.2214\u002Fajr.171.4.9763005\nNemoto, 1980, Management and survival of female breast cancer: results of a national survey by the American College of Surgeons, Cancer, 45, 2917, 10.1002\u002F1097-0142(19800615)45:12\u003C2917::AID-CNCR2820451203>3.0.CO;2-M\nGiven, 2000, The predictive of tumor markers CA 15-3, TPS and CEA in breast cancer recurrence, Breast, 9, 277, 10.1054\u002Fbrst.1999.0154\nGrahek, 2004, [18F]FDG in recurrent breast cancer: diagnostic performances, clinical impact and relevance of induced changes in management, Eur. J. Nucl. Med., 31, 179, 10.1007\u002Fs00259-003-1348-1\nSuarez, 2002, Early diagnosis of recurrent breast cancer with FDG-PET in patients with progressive elevation of serum tumor markers, Q. J. Nucl. Med., 46, 113\nLonneux, 2000, The place of whole body PET FDG for the diagnosis of distant recurrence of breast cancer, Clin. Positron Imaging, 3, 45, 10.1016\u002FS1095-0397(00)00042-X\nGoerres, 2003, Follow-up of women with breast cancer: comparison between MRI and FDG PET, Eur. Radiol., 13, 1635, 10.1007\u002Fs00330-002-1720-8\nvan Oost, 2004, Staging in patients with locoregional recurrent breast cancer: current practice and prospects for positron emission tomography, Eur. J. Cancer, 40, 1545, 10.1016\u002Fj.ejca.2004.03.012\nGallowitsch, 2003, F-18 fluorodeoxyglucose positron-emission tomography in the diagnosis of tumor recurrence and metastases in the follow-up of patients with breast carcinoma: a comparison to conventional imaging, Invest. Radiol., 38, 250, 10.1097\u002F01.RLI.0000063983.86229.f2\nZang, 2000, Impact of secondary cytoreduction surgery on survival of patients with advanced epithelial ovarian cancer, Eur. J. Surg. Oncol., 26, 789, 10.1053\u002Fejso.2000.1007\nTorizuka, 2002, Ovarian cancer recurrence: role of whole-body positron emission tomography using 2-[fluorine-18]-fluoro-2-deoxy-D-glucose, Eur. J. Nucl. Med., 29, 797, 10.1007\u002Fs00259-001-0750-9\nChang, 2002, Usefulness of whole body positron emission tomography (PET) with 18F-fluoro-2-deoxyglucose (FDG) to detect recurrent ovarian cancer based on asymptomatically elevated serum levels of tumor marker, Neoplasma, 49, 329\nBristow, 2003, Clinically occult recurrent ovarian cancer: patient selection for secondary cytoreductive surgery using combined PET\u002FCT, Gynecol. Oncol., 90, 519, 10.1016\u002FS0090-8258(03)00336-6\nNanni, 2005, 18F-FDG PET\u002FCT in the evaluation of recurrent ovarian cancer: a prospective study on forty-one patients, Eur. J. Surg. Oncol., 31, 792, 10.1016\u002Fj.ejso.2005.02.029\nMenzel, 2004, The influence of CA125 and CEA levels on the results of (18)F-deoxyglucose positron emission tomography in suspected recurrence of epithelial ovarian cancer, Strahlenther. Onkol., 180, 497, 10.1007\u002Fs00066-004-1208-3\nPannu, 2004, PET-CT detection of abdominal recurrence of ovarian cancer: radiologic-surgical correlation, Abdom. Imaging, 39, 398\nBristow, 2005, Combined PET\u002FCT for detecting recurrent ovarian cancer limited to retroperitoneal lymph nodes, Gynecol. Oncol., 99, 294, 10.1016\u002Fj.ygyno.2005.06.019\nRiuz-Hernandez, 2005, Impact of positron emission tomography with FDG-PET in treatment of patients with suspected recurrent ovarian cancer, Rev. Esp. Med. Nucl., 24, 113\nNakamoto, 2002, Pronostic value of positron emission tomography using F-18-fluorodeoxyglucose in patients with cervical cancer undergoing radiotherapy, Gynecol. Oncol., 84, 289, 10.1006\u002Fgyno.2001.6504\nUnger, 2004, Detection of recurrent cervical cancer by whole-body FDG PET scan in asymptomatic and symptomatic women, Gynecol. Oncol., 94, 212, 10.1016\u002Fj.ygyno.2004.04.021\nRyu, 2003, Detection of early recurrence with 18F-FDG PET in patients with cervical cancer, J. Nucl. Med., 44, 347\nMaiman, 1993, Squamous cell carcinoma antigen in serum for monitoring of head and neck and uterine cervical squamous cell carcinoma after radiotherapy, Acta Oncol., 32, 663, 10.3109\u002F02841869309092449\nChang, 2004, Positron emission tomography for unexplained elevation of serum squamous cell carcinoma antigen levels during follow-up for patients with cervical malignancies, Cancer, 101, 164, 10.1002\u002Fcncr.20349\nPark, 2000, Diagnosis of recurrent uterine cervical cancer: computed tomography versus positron emission tomography, Korean J. Radiol., 1, 51, 10.3348\u002Fkjr.2000.1.1.51\nYen, 2003, Value of dual-phase 2-fluoro-2-deoxy-D-glucose positron emission tomography in cervical cancer, J. Clin. Oncol., 21, 3651, 10.1200\u002FJCO.2003.01.102\nYen, 2004, Defining the priority of using 18F-FDG PET for recurrent cervical cancer, J. Nucl. Med., 45, 1632\nBelhocine, 2002, Usefulness of 18F-FDG PET in the post-therapy surveillance of endometrial carcinoma, Eur. J. Nucl. Med., 29, 1132, 10.1007\u002Fs00259-002-0878-2\nOshida, 1998, Predicting the prognoses of breast carcinoma patients with positron emission tomography using 2-deoxy-2-fluoror[18F]-D-glucose, Cancer, 82, 2227, 10.1002\u002F(SICI)1097-0142(19980601)82:11\u003C2227::AID-CNCR18>3.0.CO;2-W\nInoue, 2004, Preoperative evaluation of prognosis in breast cancer patients by [18F]2-deoxy-2-fluoro-D-glucose-positron emission tomography, J. Cancer Res. Clin. Oncol., 130, 273, 10.1007\u002Fs00432-003-0536-5\nMankoff, 2002, Blood flow and metabolism in locally advanced breast cancer: relationship to response to therapy, J. Nucl. Med., 43, 500\nDose Schwarz, 2005, Early prediction of response to chemotherapy in metastatic breast cancer using sequential 18F-FDG PET, J. Nucl. Med., 46, 1144\nSchelling, 2000, Positron emission tomography using [(18)F]Fluorodeoxyglucose for monitoring primary chemotherapy in breast cancer, J. Clin. Oncol., 18, 1689, 10.1200\u002FJCO.2000.18.8.1689\nSmith, 2000, Positron emission tomography using [(18)F]-fluorodeoxy-D-glucose to predict the pathologic response of breast cancer to primary chemotherapy, J. Clin. Oncol., 18, 1676, 10.1200\u002FJCO.2000.18.8.1676\nChen, 2004, Combined use MRI and PET to monitoring response and assess residual disease for locally advanced breast cancer treated with neoadjuvant chemotherapy, Acad. Radiol., 11, 1115, 10.1016\u002Fj.acra.2004.07.007\nVranjesevic, 2002, Whole-body 18F-FDG PET and conventional imaging for predicting outcome in previously treated breast cancer patients, J. Nucl. Med., 43, 325\nMortimer, 2001, Metabolic flare: indicator of hormone responsiveness in advanced breast cancer, J. Clin. Oncol., 19, 2797, 10.1200\u002FJCO.2001.19.11.2797\nMorris, 1992, What are the benefits of routine breast cancer follow-up?, Postgrad. Med., 68, 904, 10.1136\u002Fpgmj.68.805.904\nVogel, 1995, Worsening bone scan in the evaluation of antitumor response during hormonal therapy of breast cancer, J. Clin. Oncol., 13, 1123, 10.1200\u002FJCO.1995.13.5.1123\nSchneider, 1994, Flare on bone scintigraphy following Taxol chemotherapy for metastastic breast cancer, J. Nucl. Med., 35, 1748\nStafford, 2002, Use of serial FDG PET to mesure the response of bone-dominant breast cancer to therapy, Acad. Radiol., 9, 913, 10.1016\u002FS1076-6332(03)80461-0\nSijmons, 2000, Second-look and second surgery: second chance or second best?, Semin. Surg. Oncol., 19, 54, 10.1002\u002F1098-2388(200007\u002F08)19:1\u003C54::AID-SSU9>3.0.CO;2-9\nSironi, 2004, Integrated FDG PET\u002FCT in patients with persistent ovarian cancer: correlation with histologic findings, Radiology, 233, 433, 10.1148\u002Fradiol.2332031800\nRose, 2001, Positive emission tomography for evaluating a complete clinical response in patients with ovarian or peritoneal carcinoma: correlation with second-look laparotomy, Gynecol. Oncol., 82, 17, 10.1006\u002Fgyno.2001.6246\nKim, 2004, [18F]FDG PET as a substitute for second look laparotomy in patients with advanced ovarian carcinoma, Eur. J. Nucl. Med. Mol. Imaging, 31, 196, 10.1007\u002Fs00259-003-1367-y\nZimny, 2001, 2-[fluorine-18]-fluoro-2-deoxy-d-glucose positron emission tomography in the diagnosis of recurrent ovarian cancer, Gynecol. Oncol., 83, 310, 10.1006\u002Fgyno.2001.6386\nYoshida, 2004, Metabolic monitoring of advanced uterine cervical cancer neoadjuvant chemotherapy by using [F-18]-fluorodeoxyglucose positron emission tomography: preliminary results in three patients, Gynecol. Oncol., 95, 597, 10.1016\u002Fj.ygyno.2004.08.037\nTsai, 2004, Preliminary report of using FDG-PET to detect extrapelvic lesions in cervical cancer patients with enlarged pelvic lymph nodes on MRI\u002FCT, Int. J. Radiat. Oncol. Biol. Phys., 58, 1506, 10.1016\u002Fj.ijrobp.2003.09.013\nGrigsby, 2005, Lack of benefit of concurrent chemotherapy in patients with cervical cancer and negative lymph nodes by FDG-PET, Int. J. Radiat. Oncol. Biol. Phys., 61, 444, 10.1016\u002Fj.ijrobp.2004.05.046\nGrigsby, 2004, Lymph node control in cervical cancer, Int. J. Radiat. Oncol. Biol. Phys., 59, 706, 10.1016\u002Fj.ijrobp.2003.12.038\nGrigsby, 2004, Posttherapy [18F] fluorodeoxyglucose positron emission tomography in carcinoma of the cervix: response and outcome, J. Clin. Oncol., 22, 2167, 10.1200\u002FJCO.2004.09.035",{"ES":1141},"Contribución de la tomografía por emisión de positrones con fluorodesoxiglucosa (18F) en las pacientes afectadas de cáncer genital o mamario",{"VOID":1143},"10.1016\u002Fs1283-081x(06)47735-3","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1283081X06477353",[1146,1161,1176,1188,1200],{"id":1147,"sortIndex":114,"researcher":26,"roles":1148,"affiliations":1149,"properties":1158},"3ba7b276-82fc-41fa-a9dc-5354cd83adf0",[696],[1150],{"id":26,"sortIndex":36,"affiliation":1151,"properties":26},{"id":1152,"createTime":1153,"updateTime":1153,"relativeEntities":1154,"slug":26,"properties":1155,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"c80a299c-8c5b-4e3a-a5c1-417c02048ad6","2023-12-23T06:11:29.649+00:00",[],{"title":1156},{"VI":1157},"Service de gynécologie obstétrique, Hôpital Tenon, 4, rue de la Chine, 75020 Paris France",{"title":1159},{"VI":1160},"E. Daraï",{"id":1162,"sortIndex":36,"researcher":26,"roles":1163,"affiliations":1164,"properties":1173},"e4842113-801c-45fc-b06d-028cd515fc24",[696],[1165],{"id":26,"sortIndex":36,"affiliation":1166,"properties":26},{"id":1167,"createTime":1168,"updateTime":1168,"relativeEntities":1169,"slug":26,"properties":1170,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"5f77f196-0b94-4eff-8210-6c09adfe8e54","2024-01-08T10:49:26.208+00:00",[],{"title":1171},{"VI":1172},"Centre TEP et service de médecine nucléaire, hôpital Tenon, 4, rue de la Chine, 75020 Paris, France",{"title":1174},{"VI":1175},"D. Grahek",{"id":1177,"sortIndex":111,"researcher":26,"roles":1178,"affiliations":1179,"properties":1185},"5a1d9758-0ec3-41d5-991e-4bfa5e183f76",[696],[1180],{"id":26,"sortIndex":36,"affiliation":1181,"properties":26},{"id":1167,"createTime":1168,"updateTime":1168,"relativeEntities":1182,"slug":26,"properties":1183,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1184},{"VI":1172},{"title":1186},{"VI":1187},"J.-N. Talbot",{"id":1189,"sortIndex":115,"researcher":26,"roles":1190,"affiliations":1191,"properties":1197},"29ab6308-ea8c-4855-9eba-1f3478549f46",[696],[1192],{"id":26,"sortIndex":36,"affiliation":1193,"properties":26},{"id":1152,"createTime":1153,"updateTime":1153,"relativeEntities":1194,"slug":26,"properties":1195,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1196},{"VI":1157},{"title":1198},{"VI":1199},"E. Barranger",{"id":1201,"sortIndex":59,"researcher":26,"roles":1202,"affiliations":1203,"properties":1209},"05154dc5-2a8b-446c-bba4-c71599268d3d",[696],[1204],{"id":26,"sortIndex":36,"affiliation":1205,"properties":26},{"id":1152,"createTime":1153,"updateTime":1153,"relativeEntities":1206,"slug":26,"properties":1207,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1208},{"VI":1157},{"title":1210},{"VI":1211},"S. Uzan",{"url":1144,"publisher":1213,"properties":1221},{"id":659,"createTime":660,"updateTime":660,"relativeEntities":1214,"slug":662,"properties":1215,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":1218,"manageAffiliations":1219,"indexDatabases":1220,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":1216,"title":1217},{"VOID":665},{"EN":667},[],[],[],{"volume":1222,"pages":1224},{"VOID":1223},"42",{"VOID":1225},"1-15","2006-01-01",2006,{"id":1229,"createTime":1230,"updateTime":1231,"relativeEntities":1232,"slug":1233,"properties":1234,"entityType":688,"verifyStatus":25,"verifyTime":1231,"verifyNote":690,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"primaryUrl":1241,"fullTextUrl":26,"authors":1242,"publicationType":747,"publisherRelationship":1270,"citationCount":26,"citationInfo":26,"publishDate":1284,"publishYear":1285,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":26,"isForceReanalyzing":772},"daa358ca-9bd9-40b2-a389-53468e94ae58","2024-02-09T01:40:49.026+00:00","2025-01-28T12:07:31.028+00:00",[],"Ventosa-obst%C3%A9trica",{"references":1235,"title":1237,"doi":1239},{"VOID":1236},"Bergsjo, 1983, Differences in the reported frequencies of some obstetrical interventions in Europe, Br J Obstet Gynaecol, 90, 628, 10.1111\u002Fj.1471-0528.1983.tb09279.x\nHillier, 1994, Worldwide survey of assisted vaginal delivery, Int J Gynaecol Obstet, 47, 109, 10.1016\u002F0020-7292(94)90349-2\nChalmers, 1989, The obstetric vacuum extractor is the instrument of first choice for operative vaginal delivery, Br J Obstet Gynaecol, 96, 505, 10.1111\u002Fj.1471-0528.1989.tb03246.x\nLearman, 1998, Regional differences in operative obstetrics: a look to the South, Obstet Gynecol, 92 4Pt1, 514, 10.1016\u002FS0029-7844(98)00260-9\nVentura, 1998, Report of final natality statistics, 1996, Mon Vital Stat Rep, 46 suppl11, 1\nCurtin, 1999, Recent changes in birth attendant, place of birth, and the use of obstetric interventions, United States, 1989-1997, J Nurse Midwifery, 44, 349, 10.1016\u002FS0091-2182(99)00059-2\nMacfarlane, 1998, At last--maternity statistics for England, Br Med J, 316, 566, 10.1136\u002Fbmj.316.7131.566\nRoberts, 2002, Operative delivery during labour: trends and predictive factors, Paediatr Perinat Epidemiol, 16, 115, 10.1046\u002Fj.1365-3016.2002.00409.x\nRoberts, 2002, Trends in labour and birth interventions among low-risk women in New South Wales, Aust N Z J Obstet Gynaecol, 42, 176, 10.1111\u002Fj.0004-8666.2002.00176.x\nBofill, 1996, Forceps and vacuum delivery: a survey of North American residency programs, Obstet Gynecol, 88 4Pt1, 622, 10.1016\u002F0029-7844(96)00208-6\nBofill, 1996, Operative vaginal delivery: a survey of fellows of ACOG, Obstet Gynecol, 88, 1007, 10.1016\u002FS0029-7844(96)00328-6\nHankins, 1999, Forceps and vacuum delivery: expectations of residency and fellowship training program directors, Am J Perinatol, 16, 23, 10.1055\u002Fs-2007-993831\nSchaal, 1993, Extractions instrumentales et césariennes dans les CHU français en 1993\nVacca, 2001, Operative vaginal delivery: clinical appraisal of a new vacuum extraction device, Aust N Z J Obstet Gynaecol, 41, 156, 10.1111\u002Fj.1479-828X.2001.tb01200.x\nHayman, 2002, Clinical evaluation of a “hand pump” vacuum delivery device, Obstet Gynecol, 100, 1190, 10.1016\u002FS0029-7844(02)02384-0\nMuise, 1993, The effect of artificial caput on performance of vacuum extractors, Obstet Gynecol, 81, 170\nLim, 1997, Stepwise compared with rapid application of vacuum in ventouse extraction procedures, Br J Obstet Gynaecol, 104, 33, 10.1111\u002Fj.1471-0528.1997.tb10645.x\nBofill, 1996, A randomized prospective trial of the obstetric forceps versus the M- cup vacuum extractor, Am J Obstet Gynecol, 175, 1325, 10.1016\u002FS0002-9378(96)70049-2\nBofill, 1997, A randomized trial of two vacuum extraction techniques, Obstet Gynecol, 89 5Pt1, 758, 10.1016\u002FS0029-7844(97)00080-X\n1992, Int J Gynaecol Obstet, 38, 55, 10.1016\u002F0020-7292(92)90733-Y\n1994, Int J Gynaecol Obstet, 47, 179, 10.1016\u002F0020-7292(94)90365-4\n1999, American College of Obstetricians and Gynecologists, Int J Gynaecol Obstet, 64, 96, 10.1016\u002FS0020-7292(98)99993-3\n2001, Int J Gynaecol Obstet, 74, 69, 10.1016\u002FS0020-7292(01)00434-9\nHenrion, 1992, Les extractions instrumentales: forceps, spatules, ventouses, 262\nPusey, 1991, Maternal impressions of forceps or the Silc-cup, Br J Obstet Gynaecol, 98, 487, 10.1111\u002Fj.1471-0528.1991.tb10347.x\nRiethmuller, 1998, Conduite à tenir avant extraction instrumentale devant des difficultés de diagnostic de variété d'une présentation du sommet : intérêt de l'échographie, J Gynécol Obstét Biol Reprod, 27, 455\nBerthet J, Racinet C. Extractions instrumentales du fœtus. Encycl Méd Chir, (Elsevier SAS, Paris), Obstétrique, 5-095 A-10. 1993:20\nLee, 1996, Vacuum delivery at The Maternity Hospital Kuala Lumpur: a comparison of metal and silicone cups, Singapore Med J, 37, 55\nSoutoul, 1990\nFDA Public Health Advisory: need for caution when using vacuum assisted delivery devices. U.S. Food an Drug Administration: Center for Devices and Radiologic Health Web site\nBenedetti, 1999, Birth injury and method of delivery [editorial; comment], N Engl J Med, 341, 1758, 10.1056\u002FNEJM199912023412308\nPutta, 2000, Assisted vaginal delivery using the vacuum extractor, Am Fam Physician, 62, 1316\nRoss, 2000, Impact of FDA advisory on reported vacuum-assisted delivery and morbidity, J Matern Fetal Med, 9, 321, 10.1002\u002F1520-6661(200011\u002F12)9:6\u003C321::AID-MFM1000>3.0.CO;2-W\nHankins, 1996, Operative vaginal delivery--year 2000 [see comments], Am J Obstet Gynecol, 175, 275, 10.1016\u002FS0002-9378(96)70135-7\nJain, 1993, Mode of delivery in deep transverse arrest, Int J Gynaecol Obstet, 43, 129, 10.1016\u002F0020-7292(93)90319-R\nVintzileos, 1996, Effect of vacuum extraction on umbilical cord blood acid-base measurements, J Matern Fetal Med, 5, 11, 10.1002\u002F(SICI)1520-6661(199601\u002F02)5:1\u003C11::AID-MFM3>3.0.CO;2-W\nHofmeyr, 1990, New design rigid and soft vacuum extractor cups: a preliminary comparison of traction forces, Br J Obstet Gynaecol, 97, 681, 10.1111\u002Fj.1471-0528.1990.tb16238.x\nWilliams, 1991, A randomized comparison of assisted vaginal delivery by obstetric forceps and polyethylene vacuum cup, Obstet Gynecol, 78 5Pt1, 789\nChenoy, 1992, A randomized prospective study comparing delivery with metal and silicone rubber vacuum extractor cups, Br J Obstet Gynaecol, 99, 360, 10.1111\u002Fj.1471-0528.1992.tb13748.x\nLoghis, 1992, Comparison between metal cup and silicone rubber cup vacuum extractor, Eur J Obstet Gynecol Reprod Biol, 45, 173, 10.1016\u002F0028-2243(92)90079-E\nJohanson, 1993, A randomised prospective study comparing the new vacuum extractor policy with forceps delivery, Br J Obstet Gynaecol, 100, 524, 10.1111\u002Fj.1471-0528.1993.tb15301.x\nKuit, 1993, A randomized comparison of vacuum extraction delivery with a rigid and a pliable cup, Obstet Gynecol, 82, 280\nSrisomboon, 1998, Comparison of vacuum extraction delivery between the conventional metal cup and the new soft rubber cup, J Med Assoc Thai, 81, 480\nYeomans, 1992, Operative vaginal delivery in the 1990s, Clin Obstet Gynecol, 35, 487, 10.1097\u002F00003081-199209000-00008\nVacca, 1999, The trouble with vacuum extraction, Curr Obstet Gynaecol, 9, 41, 10.1016\u002FS0957-5847(99)90072-0\nSchaal, 1993\nMeniru, 1996, An analysis of recent trends in vacuum extraction and forceps delivery in the United Kingdom, Br J Obstet Gynaecol, 103, 168, 10.1111\u002Fj.1471-0528.1996.tb09670.x\nJohanson RB. Instrumental vaginal delivery. Guidelines and Audit Committee of the Royal College of Obstetricians and Gynaecologists.\nRaynal, 2002, La ventouse d'engagement d'essai. Série de 50 cas en Guyane française, Gynecol Obstet Fertil, 30, 765, 10.1016\u002FS1297-9589(02)00448-4\nZaloudek, 1966, Use of the vacuum extractor in breech deliveries, Cesk Gynekol, 31, 425\nRiethmuller, 1996, La grande extraction du siège sur deuxième jumeau. À propos d'une série continue de 56 cas et revue de la littérature, J Gynécol Obstét Biol Reprod, 25, 94\nSchaal, 1998\nLandy, 1994, Abdominal rescue using the vacuum extractor after entrapment of the aftercoming head, Obstet Gynecol, 84 4Pt2, 644\nPelosi, 1993, Vaginal foreign body extraction by obstetric soft vacuum cup: an alternative to forceps, Am J Obstet Gynecol, 168 6Pt1, 1891, 10.1016\u002F0002-9378(93)90708-Q\nJohnson, 1996, Nonsurgical removal of a rectal foreign body using a vacuum extractor. Report of a case, Dis Colon Rectum, 39, 935, 10.1007\u002FBF02053994\nPollak, 1999, Revival of non-surgical management of neonatal depressed skull fractures, J Paediatr Child Health, 35, 96, 10.1046\u002Fj.1440-1754.1999.00327.x\nTannirandorn, 1993, Elevation of depressed skull fracture in the neonate by obstetrical vacuum extractor, J Med Assoc Thai, 76, 698\nLucas, 1994, The role of vacuum extraction in modern obstetrics, Clin Obstet Gynecol, 37, 794, 10.1097\u002F00003081-199412000-00004\nWilliams, 1995, Vacuum-assisted delivery, Clin Perinatol, 22, 933, 10.1016\u002FS0095-5108(18)30263-X\nJohanson, 1997, Choice of instrument for vaginal delivery, Curr Opin Obstet Gynecol, 9, 361, 10.1097\u002F00001703-199712000-00005\nMorales, 1995, Vacuum extraction of preterm infants with birth weights of 1 500-2 499 grams, J Reprod Med, 40, 127\nThomas, 1997, The risk of periventricular-intraventricular hemorrhage with vacuum extraction of neonates weighing 2 000 grams or less, J Perinatol, 17, 37\nAldridge, 1999, Is vacuum extraction a safe alternative to obstetric forceps in pre-term delivery?, Am J Obstet Gynecol, 180 1supplII, 111s\nVacca, 1992\nO'Grady, 1995\nBofill, 1997, Neonatal cephalohematoma from vacuum extraction, J Reprod Med, 42, 565\nTeng, 1997, Vacuum extraction: does duration predict scalp injury?, Obstet Gynecol, 89, 281, 10.1016\u002FS0029-7844(96)00495-4\nNeri, 1995, The management of persistent occipito-posterior position, Clin Exp Obstet Gynecol, 22, 126\nEscamilla, 1997, The vacuum extraction to forceps in posterior presentation comparison, Am J Obstet Gynecol, 176, 1398, 10.1016\u002FS0002-9378(97)70374-0\nOkunwobi-Smith, 2000, Decision to delivery intervals for assisted vaginal vertex delivery, Br J Obstet Gynaecol, 107, 467, 10.1111\u002Fj.1471-0528.2000.tb13263.x\nMola, 2002, Factors associated with success or failure in trials of vacuum extraction, Aust N Z J Obstet Gynaecol, 42, 35, 10.1111\u002Fj.0004-8666.2002.00041.x\nTowner, 1999, Effect of mode of delivery in nulliparous women on neonatal intracranial injury, N Engl J Med, 341, 1709, 10.1056\u002FNEJM199912023412301\nGardella, 2001, The effect of sequential use of vacuum and forceps for assisted vaginal delivery on neonatal and maternal outcomes, Am J Obstet Gynecol, 185, 896, 10.1067\u002Fmob.2001.117309\nVacca, 2002, Vacuum-assisted delivery, Best Pract Res Clin Obstet Gynaecol, 16, 17, 10.1053\u002Fbeog.2001.0252\nRevah, 1997, Failed trial of vacuum or forceps - maternal and fetal outcome, Am J Obstet Gynecol, 176 1Pt1, 200, 10.1016\u002FS0002-9378(97)80036-1\nFritel, 1997, La controverse sur l'épisiotomie, ou faut-il continuer à prévenir les déchirures périnéales? In: Société française de médecine perinatale, 27e journées nationales, 211\nJacquetin, 1997, Épisiotomie : contre une utilisation de routine, 215\nWoolley, 1995, Benefits and risks of episiotomy: a review of the English-language literature since 1980. Part II, Obstet Gynecol Surv, 50, 821, 10.1097\u002F00006254-199511000-00021\nWoolley, 1995, Benefits and risks of episiotomy: a review of the English-language literature since 1980. Part I, Obstet Gynecol Surv, 50, 806, 10.1097\u002F00006254-199511000-00020\nLede, 1996, Is routine use of episiotomy justified?, Am J Obstet Gynecol, 174, 1399, 10.1016\u002FS0002-9378(96)70579-3\nEcker, 1996, Is there a benefit to episiotomy at operative vaginal delivery? Observations over ten years in a stable population, Am J Obstet Gynecol, 176, 411, 10.1016\u002FS0002-9378(97)70507-6\nJander, 2001, Third and fourth degree perineal tears. Predictor factors in a referral hospital, Acta Obstet Gynecol Scand, 80, 229, 10.1034\u002Fj.1600-0412.2001.080003229.x\nCombs, 1990, Risk factors for third-degree and fourth-degree perineal lacerations in forceps and vacuum deliveries, Am J Obstet Gynecol, 163 1Pt1, 100, 10.1016\u002FS0002-9378(11)90678-4\nSultan, 1994, Third degree obstetric anal sphincter tears: risk factors and outcome of primary repair, Br Med J, 308, 887, 10.1136\u002Fbmj.308.6933.887\nMoller Bek, 1992, Intervention during labor: risk factors associated with complete tear of the anal sphincter, Acta Obstet Gynecol Scand, 71, 520, 10.3109\u002F00016349209041443\nPoen, 1997, Third degree obstetric perineal tears: risk factors and the preventive role of mediolateral episiotomy, Br J Obstet Gynaecol, 104, 563, 10.1111\u002Fj.1471-0528.1997.tb11533.x\nde Leeuw, 2001, Risk factors for third degree perineal ruptures during delivery, Br J Obstet Gynaecol, 108, 383, 10.1016\u002FS0306-5456(00)00090-5\nRiskin-Mashiah, 2002, Risk factors for severe perineal tear: can we do better?, Am J Perinatol, 19, 225, 10.1055\u002Fs-2002-33088\nYip, 1997, Vesico-uterine fistula: a rare complication of vacuum extraction in a patient with previous caesarean section, Br J Urol, 80, 502, 10.1046\u002Fj.1464-410X.1997.00385.x\nGil, 2001, Vesicouterine fistula after vacuum delivery and two previous cesarean sections. A case report, J Reprod Med, 46, 853\nTetzschner, 1995, Pudendal nerve damage increases the risk of fecal incontinence in women with anal sphincter rupture after childbirth, Acta Obstet Gynecol Scand, 74, 434, 10.3109\u002F00016349509024405\nTetzschner, 1996, Anal and urinary incontinence in women with obstetric anal sphincter rupture, Br J Obstet Gynaecol, 103, 1034, 10.1111\u002Fj.1471-0528.1996.tb09557.x\nTetzschner, 1997, Delivery and pudendal nerve function, Acta Obstet Gynecol Scand, 76, 324, 10.1111\u002Fj.1600-0412.1997.tb07986.x\nMacArthur, 1997, Faecal incontinence after childbirth, Br J Obstet Gynaecol, 104, 46, 10.1111\u002Fj.1471-0528.1997.tb10648.x\nKamm, 1994, Obstetric damage and faecal incontinence, Lancet, 344, 730, 10.1016\u002FS0140-6736(94)92213-6\nRichter, 2002, Risk factors associated with anal sphincter tear: a comparison of primiparous patients, vaginal births after cesarean deliveries, and patients with previous vaginal delivery, Am J Obstet Gynecol, 187, 1194, 10.1067\u002Fmob.2002.126977\nSultan, 1998, Occult anal sphincter trauma following randomized forceps and vacuum delivery, Int J Gynaecol Obstet, 61, 113, 10.1016\u002FS0020-7292(98)00017-4\nNotzon, 1990, International differences in the use of obstetric interventions, JAMA, 263, 3286, 10.1001\u002Fjama.1990.03440240076019\nSvigos, 1990, Silastic cup vacuum extractor or forceps: a comparative study, Asia Oceania J Obstet Gynaecol, 16, 323, 10.1111\u002Fj.1447-0756.1990.tb00356.x\nAnate, 1991, Instrumental (operative) vaginal deliveries: vacuum extraction compared with forceps delivery at Ilorin University Teaching Hospital, Nigeria, West Afr J Med, 10, 127\nJohanson, 1991, Ventouse or forceps?, Br J Hosp Med, 46, 13\nAchanna, 1994, Outcome of forceps delivery versus vacuum extraction--a review of 200 cases, Singapore Med J, 35, 605\nLilford, 1996, Choice and instrumental delivery, Br J Obstet Gynaecol, 103, 1270, 10.1111\u002Fj.1471-0528.1996.tb09647.x\nKovavisarach, 1999, Neonatal and maternal complications among pregnant women delivered by vacuum extraction or forceps extraction, J Med Assoc Thai, 82, 319\nAngioli, 2000, Severe perineal lacerations during vaginal delivery: the University of Miami experience, Am J Obstet Gynecol, 182, 1083, 10.1067\u002Fmob.2000.105403\nEason, 2000, Preventing perineal trauma during childbirth: a systematic review, Obstet Gynecol, 95, 464, 10.1016\u002FS0029-7844(99)00560-8\nArya, 2001, Risk of new-onset urinary incontinence after forceps and vacuum delivery in primiparous women, Am J Obstet Gynecol, 185, 1318, 10.1067\u002Fmob.2001.120365\nKabiru, 2001, Trends in operative vaginal delivery rates and associated maternal complication rates in an inner-city hospital, Am J Obstet Gynecol, 184, 1112, 10.1067\u002Fmob.2001.115178\nWen, 2001, Comparison of maternal and infant outcomes between vacuum extraction and forceps deliveries, Am J Epidemiol, 153, 103, 10.1093\u002Faje\u002F153.2.103\nJohanson, 2000, Vacuum extraction versus forceps for assisted vaginal delivery, Cochrane Database Syst Rev, 2, CD000224\nLydon-Rochelle, 2000, Association between method of delivery and maternal rehospitalization, JAMA, 283, 2411, 10.1001\u002Fjama.283.18.2411\nWebb, 2003, Mode of delivery and risk of postpartum rehospitalization, JAMA, 289, 46, 10.1001\u002Fjama.289.1.46-b\nJohanson, 1999, Maternal and child health after assisted vaginal delivery: five-year follow-up of a randomised controlled study comparing forceps and ventouse, Br J Obstet Gynaecol, 106, 544, 10.1111\u002Fj.1471-0528.1999.tb08322.x\nHagadorn, 1996, Vesicular neonatal rash at the site of vacuum application, Obstet Gynecol, 87 5Pt2, 879\nBenaron, 1993, Subgaleal hematoma causing hypovolemic shock during delivery after failed vacuum extraction: a case report, J Perinatol, 13, 228\nGovaert, 1992, Vacuum extraction, bone injury and neonatal subgaleal bleeding, Eur J Pediatr, 151, 532, 10.1007\u002FBF01957762\nFlorentino-Pineda, 1994, Subgaleal hemorrhage in the newborn infant associated with silicone elastomer vacuum extractor, J Perinatol, 14, 95\nChadwick, 1996, Neonatal subgaleal haematoma: associated risk factors, complications and outcome, J Paediatr Child Health, 32, 228, 10.1111\u002Fj.1440-1754.1996.tb01559.x\nHanigan, 1990, Tentorial hemorrhage associated with vacuum extraction, Pediatrics, 85, 534, 10.1542\u002Fpeds.85.4.534\nHall, 1992, Simultaneous occurrence of intracranial and subgaleal hemorrhages complicating vacuum extraction delivery, J Perinatol, 12, 185\nAvrahami, 1993, CT demonstration of intracranial haemorrhage in term newborn following vacuum extractor delivery, Neuroradiology, 35, 107, 10.1007\u002FBF00593964\nHuang, 1995, Tentorial hemorrhage associated with vacuum extraction in a newborn, Pediatr Radiol, 25 suppl1, S230, 10.1007\u002FBF03545639\nOdita, 1996, CT and MRI characteristics of intracranial hemorrhage complicating breech and vacuum delivery, Pediatr Radiol, 26, 782, 10.1007\u002FBF01396201\nLiu, 1998, Vacuum extraction delivery complicated with acute subdural hematoma and cerebral infarction: report of one case, Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi, 39, 119\nKent, 2001, Posterior fossa haemorrhage in a preterm infant following vacuum assisted delivery, Br J Obstet Gynecol, 108, 1008\nJensen, 1992, Risk of cerebral hemorrhage in premature and mature newborn infants, Geburtshilfe Frauenheilkd, 52, 6, 10.1055\u002Fs-2007-1022943\nWilliams, 1993, Obstetric correlates of neonatal retinal hemorrhage, Obstet Gynecol, 81 5Pt1, 688\nHickey, 1996, Skull fracture caused by vacuum extraction [see comments], Obstet Gynecol, 88 4Pt2, 671, 10.1016\u002F0029-7844(96)00227-X\nPapaefthymiou, 1996, Craniocerebral birth trauma caused by vacuum extraction: a case of growing skull fracture as a perinatal complication, Childs Nerv Syst, 12, 117, 10.1007\u002FBF00819511\nRoss, 1997, Skull fracture caused by vacuum extraction, Obstet Gynecol, 89, 319, 10.1016\u002FS0029-7844(97)81072-1\nKaapa, 1993, Maternal and neonatal C-reactive protein after interventions during delivery, Acta Obstet Gynecol Scand, 72, 543, 10.3109\u002F00016349309058160\nGalbraith, 1994, Incidence of neonatal sixth nerve palsy in relation to mode of delivery, Am J Obstet Gynecol, 170, 1158, 10.1016\u002FS0002-9378(94)70113-X\nWesley, 1993, The effect of forceps delivery on cognitive development, Am J Obstet Gynecol, 169, 1091, 10.1016\u002F0002-9378(93)90261-G\nSeidman, 1991, Long-term effects of vacuum and forceps deliveries, Lancet, 337, 1583, 10.1016\u002F0140-6736(91)93273-C\nNgan, 1990, Long-term neurological sequelae following vacuum extractor delivery, Aust N Z J Obstet Gynaecol, 30, 111, 10.1111\u002Fj.1479-828X.1990.tb03237.x\nChan, 1999, Is the vacuum extractor really the instrument of first choice?, Aust N Z J Obstet Gynaecol, 39, 305, 10.1111\u002Fj.1479-828X.1999.tb03402.x\nRobinson, 1994, Forceps and vacuum extraction, Curr Opin Obstet Gynecol, 6, 414, 10.1097\u002F00001703-199410000-00004\nNikolov, 1995, The place of vacuum extraction in modern obstetrics, Akush Ginekol, 34, 3\nPaluska, 1997, Vacuum-assisted vaginal delivery, Am Fam Physician, 55, 2197",{"ES":1238},"Ventosa obstétrica",{"VOID":1240},"10.1016\u002Fs1283-081x(05)70238-1","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1283081X05702381",[1243,1258],{"id":1244,"sortIndex":36,"researcher":26,"roles":1245,"affiliations":1246,"properties":1255},"7617c4ba-d1c5-4115-8b49-7a1e31000c02",[696],[1247],{"id":26,"sortIndex":36,"affiliation":1248,"properties":26},{"id":1249,"createTime":1250,"updateTime":1250,"relativeEntities":1251,"slug":26,"properties":1252,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"4711d323-37fa-4c89-9314-81796ba119e0","2024-02-09T01:40:49.045+00:00",[],{"title":1253},{"VI":1254},"Service de gynécologie-obstétrique CHU de Besançon, hôpital Saint-Jacques, 2, place Saint-Jacques, 25030 Besançon cedex, France",{"title":1256},{"VI":1257},"J.-P. Schaal",{"id":1259,"sortIndex":115,"researcher":26,"roles":1260,"affiliations":1261,"properties":1267},"2236ef69-78de-4899-87e0-6d57941779df",[696],[1262],{"id":26,"sortIndex":36,"affiliation":1263,"properties":26},{"id":1249,"createTime":1250,"updateTime":1250,"relativeEntities":1264,"slug":26,"properties":1265,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1266},{"VI":1254},{"title":1268},{"VI":1269},"D. Riethmuller",{"url":1241,"publisher":1271,"properties":1279},{"id":659,"createTime":660,"updateTime":660,"relativeEntities":1272,"slug":662,"properties":1273,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":1276,"manageAffiliations":1277,"indexDatabases":1278,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":1274,"title":1275},{"VOID":665},{"EN":667},[],[],[],{"volume":1280,"pages":1282},{"VOID":1281},"41",{"VOID":1283},"1-17","2005-01-01",2005,{"id":1287,"createTime":1288,"updateTime":1289,"relativeEntities":1290,"slug":1291,"properties":1292,"entityType":688,"verifyStatus":25,"verifyTime":1289,"verifyNote":690,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"primaryUrl":1299,"fullTextUrl":26,"authors":1300,"publicationType":747,"publisherRelationship":1403,"citationCount":26,"citationInfo":26,"publishDate":1417,"publishYear":1418,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":26,"isForceReanalyzing":772},"4100459d-6ddb-4709-837d-a0ce7de0f9ee","2024-01-20T11:51:32.052+00:00","2024-12-06T07:26:45.401+00:00",[],"Epidemiolog%C3%ADa-y-prevenci%C3%B3n-primaria-y-secundaria-del-c%C3%A1ncer-de-c%C3%A9rvix",{"references":1293,"title":1295,"doi":1297},{"VOID":1294},"Defossez, 2019\nRonco, 2014, Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials, Lancet, 383, 524, 10.1016\u002FS0140-6736(13)62218-7\nMcNall, 2004, Adenocarcinoma of the cervix and vagina in pediatric patients, Pediatr Blood Cancer, 43, 289, 10.1002\u002Fpbc.20113\nBurd, 2003, Human papillomavirus and cervical cancer, Clin Microbiol Rev, 16, 1, 10.1128\u002FCMR.16.1.1-17.2003\nLorincz, 1992, Human papillomavirus infection of the cervix: relative risk associations of 15 common anogenital types, Obstet Gynecol, 79, 328, 10.1097\u002F00006250-199203000-00002\nEgawa, 2017, The low-risk papillomaviruses, Virus Res, 231, 119, 10.1016\u002Fj.virusres.2016.12.017\nHandsfield, 1997, Clinical presentation and natural course of anogenital warts, Am J Med, 102, 16, 10.1016\u002FS0002-9343(97)00179-4\nMunoz, 2004, Against which human papillomavirus types shall we vaccinate and screen? The international perspective, Int J Cancer, 111, 278, 10.1002\u002Fijc.20244\nde Villiers, 2004, Classification of papillomaviruses, Virology, 324, 17, 10.1016\u002Fj.virol.2004.03.033\nDalstein, 2003, Persistence and load of high-risk HPV are predictors for development of high-grade cervical lesions: a longitudinal French cohort study, Int J Cancer, 106, 396, 10.1002\u002Fijc.11222\nDunne, 2007, Prevalence of HPV infection among females in the United States, JAMA, 297, 813, 10.1001\u002Fjama.297.8.813\nDaling, 2002, A population-based study of squamous cell vaginal cancer: HPV and cofactors, Gynecol Oncol, 84, 263, 10.1006\u002Fgyno.2001.6502\nChan, 2003, HPV infection and number of lifetime sexual partners are strong predictors for ‘natural’ regression of CIN2 and 3, Br J Cancer, 89, 1062, 10.1038\u002Fsj.bjc.6601196\nMcIntyre-Seltman, 2005, Smoking is a risk factor for cervical intraepithelial neoplasia grade 3 among oncogenic human papillomavirus DNA-positive women with equivocal or mildly abnormal cytology, Cancer Epidemiol Biomarkers Prev, 14, 1165, 10.1158\u002F1055-9965.EPI-04-0918\nTrimble, 2005, Spontaneous regression of high-grade cervical dysplasia: effects of human papillomavirus type and HLA phenotype, Clin Cancer Res, 11, 4717, 10.1158\u002F1078-0432.CCR-04-2599\nBrown, 2019, Genetic susceptibility to cervical neoplasia, Papillomavirus Res, 7, 132, 10.1016\u002Fj.pvr.2019.04.002\nInternational Collaboration of Epidemiological Studies of Cervical Cancer, 2006, Cervical carcinoma and reproductive factors: collaborative reanalysis of individual data on 16,563 women with cervical carcinoma and 33,542 women without cervical carcinoma from 25 epidemiological studies, Int J Cancer, 119, 1108, 10.1002\u002Fijc.21953\nInternational Collaboration of Epidemiological Studies of Cervical Cancer, 2007, Cervical cancer and hormonal contraceptives: collaborative reanalysis of individual data for 16,573 women with cervical cancer and 35,509 women without cervical cancer from 24 epidemiological studies, Lancet, 370, 1609, 10.1016\u002FS0140-6736(07)61684-5\nCuzick, 2006, Overview of the European and North American studies on HPV testing in primary cervical cancer screening, Int J Cancer, 119, 1095, 10.1002\u002Fijc.21955\nCollins, 2002, High incidence of cervical human papillomavirus infection in women during their first sexual relationship, Bjog, 109, 96, 10.1111\u002Fj.1471-0528.2002.01053.x\nEdgren, 2007, Risk of anogenital cancer after diagnosis of cervical intraepithelial neoplasia: a prospective population-based study, Lancet Oncol, 8, 311, 10.1016\u002FS1470-2045(07)70043-8\nBertoli, 2020, Risk of vulvar, vaginal and anal high-grade intraepithelial neoplasia and cancer according to cervical human papillomavirus (HPV) status: a population- based prospective cohort study, Gynecol Oncol, 157, 456, 10.1016\u002Fj.ygyno.2020.01.030\nJudson, 2006, Trends in the incidence of invasive and in situ vulvar carcinoma, Obstet Gynecol, 107, 1018, 10.1097\u002F01.AOG.0000210268.57527.a1\nLukasiewicz, 2002, Incidence and management of condylomata acuminata by French general physicians, Ann Dermatol Venereol, 129, 991\nMonsonego, 2007, Anogenital warts incidence, medical management and costs in women consulting gynaecologists in France, Gynecol Obstet Fertil, 35, 107\nFrisch, 1999, Variants of squamous cell carcinoma of the anal canal and perianal skin and their relation to human papillomaviruses, Cancer Res, 59, 753\nHeim, 2005, Specific serologic response to genital human papillomavirus types in patients with vulvar precancerous and cancerous lesions, Am J Obstet Gynecol, 192, 1073, 10.1016\u002Fj.ajog.2004.09.130\nDarragh, 2013, The Lower Anogenital Squamous Terminology Standardization project for HPV-associated lesions: background and consensus recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology, Int J Gynecol Pathol, 32A, 76, 10.1097\u002FPGP.0b013e31826916c7\nEgawa, 2015, Human papillomaviruses; epithelial tropisms, and the development of neoplasia, Viruses, 7, 3863, 10.3390\u002Fv7072802\nHerrero, 2005, Epidemiologic profile of type-specific human papillomavirus infection and cervical neoplasia in Guanacaste, Costa Rica, J Infect Dis, 191, 1796, 10.1086\u002F428850\nKero, 2019, HPV infections in heterosexual couples: mechanisms and covariates of virus transmission, Acta Cytol, 63, 143, 10.1159\u002F000494710\nWiner, 2006, Condom use and the risk of genital human papillomavirus infection in young women, N Engl J Med, 354, 2645, 10.1056\u002FNEJMoa053284\nBurchell, 2010, Human papillomavirus infections among couples in new sexual relationships, Epidemiology, 21, 31, 10.1097\u002FEDE.0b013e3181c1e70b\nKum-Nji, 2019, Tobacco smoke exposure as a risk factor for human papillomavirus infections in women 18-26 years old in the United States, PLoS One, 14, e0223532, 10.1371\u002Fjournal.pone.0223532\nZhu, 2016, Chlamydia trachomatis infection-associated risk of cervical cancer: a meta-analysis, Medicine, 95, e3077, 10.1097\u002FMD.0000000000003077\nGuidry, 2017, The interaction between human papillomavirus and other viruses, Virus Res, 231, 139, 10.1016\u002Fj.virusres.2016.11.002\nCastellsague, 2006, Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention, J Natl Cancer Inst, 98, 303, 10.1093\u002Fjnci\u002Fdjj067\nRoura, 2016, The influence of hormonal factors on the risk of developing cervical cancer and pre-cancer: results from the EPIC cohort, PLoS One, ll, e0147029, 10.1371\u002Fjournal.pone.0147029\nGormley, 2012, Human papillomavirus-related genital disease in the immunocompromised host: part II, J Am Acad Dermatol, 66, 883e1, 10.1016\u002Fj.jaad.2010.12.050\nGormley, 2012, Human papillomavirus-related genital disease in the immunocompromised host: part I, J Am Acad Dermatol, 66, 867e1, 10.1016\u002Fj.jaad.2010.12.050\nBrotman rM, 2014, Interplay between the temporal dynamics of the vaginal microbiota and human papillomavirus detection, J Infect Dis, 210, 1723, 10.1093\u002Finfdis\u002Fjiu330\nKjaer, 2001, High-risk human papillomavirus is sexually transmitted: evidence from a follow-up study of virgins starting sexual activity (intercourse), Cancer Epidemiol Biomarkers Prev, 10, 101\nGiuliano, 2011, Incidence and clearance of genital human papillomavirus infection in men (HIM): a cohort study, Lancet, 377, 932, 10.1016\u002FS0140-6736(10)62342-2\nWiner, 2011, Early natural history of incident, type-specific human papillomavirus infections in newly sexually active young women, Cancer Epidemiol Biomarkers Prev, 20, 699, 10.1158\u002F1055-9965.EPI-10-1108\nRodriguez, 2010, Longitudinal study of human papillomavirus persistence and cervical intraepithelial neoplasia grade 2\u002F3: critical role of duration of infection, J Natl Cancer Inst, 102, 315, 10.1093\u002Fjnci\u002Fdjq001\nCastle, 2009, Evidence for frequent regression of cervical intraepithelial neoplasia-grade 2, Obstet Gynecol, 113, 18, 10.1097\u002FAOG.0b013e31818f5008\nMoscicki, 2010, Rate of and risks for regression of cervical intraepithelial neoplasia 2 in adolescents and young women, Obstet Gynecol, 116, 1373, 10.1097\u002FAOG.0b013e3181fe777f\nBekos, 2018, Influence of age on histologic outcome of cervical intraepithelial neoplasia during observational management: results from large cohort, systematic review, meta-analysis, Sci Rep, 8, 6383, 10.1038\u002Fs41598-018-24882-2\nPlummer, 2007, A 2-year prospective study of human papillomavirus persistence among women with a cytological diagnosis of atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesion, J Infect Dis, 195, 1582, 10.1086\u002F516784\nMoscicki Ab, 2010, The role of sexual behavior and human papillomavirus persistence in predicting repeated infections with new human papillomavirus types, Cancer Epidemiol Biomarkers Prev, 19, 2055, 10.1158\u002F1055-9965.EPI-10-0394\nSchiffman, 2005, The carcinogenicity of human papillomavirus types reflects viral evolution, Virology, 337, 76, 10.1016\u002Fj.virol.2005.04.002\nBulkmans, 2007, High-risk HPV type-specific clearance rates in cervical screening, Br J Cancer, 96, 1419, 10.1038\u002Fsj.bjc.6603653\nSchiffman, 2007, Human papillomavirus and cervical cancer, Lancet, 370, 890, 10.1016\u002FS0140-6736(07)61416-0\nGravitt, 2011, The known unknowns of HPV natural history, J Clin Invest, 121, 4593, 10.1172\u002FJCI57149\nRositch, 2012, Contributions of recent and past sexual partnerships on incident human papillomavirus detection: acquisition and reactivation in older women, Cancer Res, 72, 6183, 10.1158\u002F0008-5472.CAN-12-2635\nZielinski, 2001, HPV presence precedes abnormal cytology in women developing cervical cancer and signals false negative smears, Br J Cancer, 85, 398, 10.1054\u002Fbjoc.2001.1926\nRen, 2019, Prognostic and diagnostic validity of p16\u002FKi-67, HPV E6\u002FE7 mRNA, and HPV DNA in women with ASCUS: a follow-up study, Virol J, 16, 143, 10.1186\u002Fs12985-019-1251-4\nBalasubramaniam, 2019, Key molecular events in cervical cancer development, Medicina, 55\nWiner, 2005, Development and duration of human papillomavirus lesions, after initial infection, J Infect Dis, 191, 731, 10.1086\u002F427557\nJoura, 2014, Attribution of 12 high-risk human papillomavirus genotypes to infection and cervical disease, Cancer Epidemiol Biomarkers Prev, 23, 1997, 10.1158\u002F1055-9965.EPI-14-0410\nTjalma, 2013, Differences in human papillomavirus type distribution in high-grade cervical intraepithelial neoplasia and invasive cervical cancer in Europe, Int J Cancer, 132, 854, 10.1002\u002Fijc.27713\nKukimoto, 2015, Genetic variations of human papillomavirus type 16: implications for cervical carcinogenesis, Jpn J Infect Dis, 68, 169, 10.7883\u002Fyoken.JJID.2014.584\nSun, 2001, The significance of human papillomavirus viral load in prediction of histologic severity and size of squamous intraepithelial lesions of uterine cervix, Gynecol Oncol, 83, 95, 10.1006\u002Fgyno.2001.6336\nInsinga, 2007, Incidence and duration of cervical human papillomavirus 6, 11, 16, and 18 infections in young women: an evaluation from multiple analytic perspectives, Cancer Epidemiol Biomarkers Prev, 16, 709, 10.1158\u002F1055-9965.EPI-06-0846\nCervical cancer statistics. https:\u002F\u002Fwww.cancerresearchuk.org\u002Fhealth-professional\u002Fcancer-statistics\u002Fstatistics-by-cancer-type\u002Fcervical- cancer#heading-One\nINCa, 2019\nOrumaa, 2019, Recent increase in incidence of cervical precancerous lesions in Norway: nationwide study from 1992 to 2016, Int J Cancer, 145, 2629, 10.1002\u002Fijc.32195\nFrance SP, 2020\nBarré, 2017, Caractérisation des femmes ne réalisant pas de dépistage du cancer du col de l’utérus par frottis cervico-utérin en France, Bull Epidemiol Hebd, 39\nBrisson, 2013, Inequalities in Human Papillomavirus (HPV)-associated cancers: implications for the success of HPV vaccination, J Natl Cancer Inst, 105, 158, 10.1093\u002Fjnci\u002Fdjs638\nNayar, 2015, The Pap Test and Bethesda 2014. “The reports of my demise have been greatly exaggerated” (after a quotation from Mark Twain), Acta Cytol, 59, 121, 10.1159\u002F000381842\nMartin-Hirsch, 2013, Surgery for cervical intraepithelial neoplasia, Cochrane Database Syst Rev, CD001318\nMaura, 2017, Dépistage du cancer du col de l’utérus et actes associés chez les femmes de moins de 25 ans entre 2007 et 2013 en France : une étude sur les bases de données médico-administratives françaises, Bull Epidemiol Hebd, 32\nMaura, 2018, Cervical cancer screening and subsequent procedures in women under the age of 25 years between 2007 and 2013 in France: a nationwide French healthcare database study, Eur J Cancer Prev, 27, 479, 10.1097\u002FCEJ.0000000000000360\nLiebrich, 2009, Primary cervical cancer truly negative for high-risk human papillomavirus is a rare but distinct entity that can affect virgins and young adolescents, Eur J Gynaecol Oncol, 30, 45\nCastanon, 2013, Characteristics and screening history of women diagnosed with cervical cancer aged 20-29 years, Br J Cancer, 109, 35, 10.1038\u002Fbjc.2013.322\nBoulanger, 2007, Histoire cytologique des cancers du col utérin diagnostiqués en France en 2006, Gynecol Obstet Fertil, 35, 764, 10.1016\u002Fj.gyobfe.2007.07.019\nSasieni, 2003, Benefit of cervical screening at different ages: evidence from the UK audit of screening histories, Br J Cancer, 89, 88, 10.1038\u002Fsj.bjc.6600974\nLavoue, 2009, Histoire cytologique de 191 patientes atteintes d’un cancer invasif du col de l’utérus en région Bretagne, J Gynecol Obstet Biol Reprod, 38, 396, 10.1016\u002Fj.jgyn.2009.04.009\nArbyn, 2012, Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer, Vaccine, 30, F88, 10.1016\u002Fj.vaccine.2012.06.095\nAndrae, 2008, Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden, J Natl Cancer Inst, 100, 622, 10.1093\u002Fjnci\u002Fdjn099\nMeijer, 2009, Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older, Int J Cancer, 124, 516, 10.1002\u002Fijc.24010\nEide, 2012, HPV detection methods and genotyping techniques in screening for cervical cancer, Ann Pathol, 32, 401, 10.1016\u002Fj.annpat.2012.09.200\nArbyn, 2018, Collaboration on Self-Sampling and HPV Testing. Detecting cervical precancer and reaching underscreened women by using HPV testing on self-samples: updated meta-analyses, BMJ, 363, k4823, 10.1136\u002Fbmj.k4823\nMunoz, 2004, Incidence, duration, and determinants of cervical human papillomavirus infection in a cohort of Colombian women with normal cytological results, J Infect Dis, 190, 2077, 10.1086\u002F425907\nKorostil, 2014, The potential impact of HPV-16 reactivation on prevalence in older Australians, BMC Infect Dis, 14, 312, 10.1186\u002F1471-2334-14-312\nStroope, 2015, Marital characteristics and the sexual relationships of U.S. older adults: an analysis of national social life, health, and aging project data, Arch Sex Behav, 44, 233, 10.1007\u002Fs10508-014-0379-y\nBergengren, 2020, Prevalence of HPV and pathological changes among women 70 years of age, 10 years after exclusion from the Swedish cervical cancer screening program, Cancer Causes Control, 31, 377, 10.1007\u002Fs10552-020-01278-0\nBaldauf, 2019, Cervical morbidity in Alsace, France: results from a regional organized cervical cancer screening program, Eur J Cancer Prev, 28, 33, 10.1097\u002FCEJ.0000000000000415\nHammer, 2018, Cervical cancer screening history prior to diagnosis of cervical cancer in Danish women aged 60 years old and older - A national cohort study, Cancer Med, 8, 418, 10.1002\u002Fcam4.1926\nCastanon, 2014, Cervical screening at age 50-64 years and the risk of cervical cancer at age 65 years and older: population-based case control study, PLoS Med, 11, e1001585, 10.1371\u002Fjournal.pmed.1001585\nMeyer, 2012, Existe-t-il un intérêt à poursuivre les frottis de dépistage du cancer du col utérin après 65 ans ? Étude rétrospective sur 53 644 femmes, Bull Cancer, 99, 409, 10.1684\u002Fbdc.2012.1556\nHermansson, 2018, HPV prevalence and HPV-related dysplasia in elderly women, PLoS One, 13, e0189300, 10.1371\u002Fjournal.pone.0189300\nStokes-Lampard, 2006, Vaginal vault smears after hysterectomy for reasons other than malignancy: a systematic review of the literature, BJOG, 113, 1354, 10.1111\u002Fj.1471-0528.2006.01099.x\nNicolas, 2013, Faut-il pratiquer des frottis vaginaux après hystérectomie totale pour CIN3 ?, Gynecol Obstet Fertil, 41, 196, 10.1016\u002Fj.gyobfe.2013.01.009\nHAS, 2019\nANRSC, 2017\nCenters for Disease Control and Prevention, tNIoH, HIV Medicine Association of the Infectious Diseases Society of America. Guidelines for the prevention and treatment of opportunistic infections in adults and adolescents with HIV. http:\u002F\u002Faidsinfonihgov 2019.\nMoscicki, 2019, Guidelines for cervical cancer screening in immunosuppressed women without HIV infection, J Low Genit Tract Dis, 23, 87, 10.1097\u002FLGT.0000000000000468\nSchiller, 2004, Delivering on the promise: HPV vaccines and cervical cancer, Nat Rev Microbiol, 2, 343, 10.1038\u002Fnrmicro867\nArbyn, 2018, Efficacy and safety of prophylactic HPV vaccines. A Cochrane review of randomized trials, Expert Rev Vaccines, 17, 1085, 10.1080\u002F14760584.2018.1548282\nArbyn, 2018, Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors, Cochrane Database Syst Rev, CD009069\nLopalco, 2017, Spotlight on the 9-valent HPV vaccine, Drug Des Devel Ther, 11, 35, 10.2147\u002FDDDT.S91018\nHuh, 2017, Final efficacy, immunogenicity, and safety analyses of a ninevalent human papillomavirus vaccine in women aged 16-26 years: a randomised, double-blind trial, Lancet, 390, 2143, 10.1016\u002FS0140-6736(17)31821-4\nDehlendorff, 2020, Real-world effectiveness of Human Papillomavirus vaccination against vulvovaginal high-grade pre-cancerous lesions and cancers, J Natl Cancer Inst\nLei, 2020, HPV vaccination and the risk of invasive cervical cancer, N Engl J Med, 383, 1340, 10.1056\u002FNEJMoa1917338\nEbisch, 2017, Long-lasting increased risk of human papillomavirus-related carcinomas and premalignancies after cervical intraepithelial neoplasia grade 3: a population-based cohort study, J Clin Oncol, 35, 2542, 10.1200\u002FJCO.2016.71.4543\nKalliala, 2020, Incidence and mortality from cervical cancer and other malignancies after treatment of cervical intraepithelial neoplasia: a systematic review and meta-analysis of the literature, Ann Oncol, 31, 213, 10.1016\u002Fj.annonc.2019.11.004\nLin, 2019, Cervical determinants of anal HPV infection and high-grade anal lesions in women: a collaborative pooled analysis, Lancet Infect Dis, 19, 880, 10.1016\u002FS1473-3099(19)30164-1\nJentschke, 2020, Prophylactic HPV vaccination after conization: a systematic review and meta-analysis, Vaccine, 38, 6402, 10.1016\u002Fj.vaccine.2020.07.055\nDrolet, 2019, Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis, Lancet, 394, 497, 10.1016\u002FS0140-6736(19)30298-3",{"ES":1296},"Epidemiología y prevención primaria y secundaria del cáncer de cérvix",{"VOID":1298},"10.1016\u002Fs1283-081x(22)47071-8","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1283081X22470718",[1301,1316,1328,1340,1355,1367,1379],{"id":1302,"sortIndex":111,"researcher":26,"roles":1303,"affiliations":1304,"properties":1313},"44f08123-bfda-4d68-99d4-2bfd31d31b2a",[696],[1305],{"id":26,"sortIndex":36,"affiliation":1306,"properties":26},{"id":1307,"createTime":1308,"updateTime":1308,"relativeEntities":1309,"slug":26,"properties":1310,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"6770ebdb-1f05-48f0-a9d9-285d52ff63fa","2024-01-20T11:51:32.216+00:00",[],{"title":1311},{"VI":1312},"Département de gynécologie obstétrique et reproduction humaine, CHU Anne-de-Bretagne, 16, boulevard de Bulgarie, 35203 Rennes cedex 2, France",{"title":1314},{"VI":1315},"K. Nyangoh-Timoh",{"id":1317,"sortIndex":36,"researcher":26,"roles":1318,"affiliations":1319,"properties":1325},"863d8c00-3f74-4770-b721-afcf5c9785a6",[696],[1320],{"id":26,"sortIndex":36,"affiliation":1321,"properties":26},{"id":1307,"createTime":1308,"updateTime":1308,"relativeEntities":1322,"slug":26,"properties":1323,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1324},{"VI":1312},{"title":1326},{"VI":1327},"L. Dion",{"id":1329,"sortIndex":115,"researcher":26,"roles":1330,"affiliations":1331,"properties":1337},"0fee9bca-2c7e-4b83-be19-84eb036dd5e7",[696],[1332],{"id":26,"sortIndex":36,"affiliation":1333,"properties":26},{"id":1307,"createTime":1308,"updateTime":1308,"relativeEntities":1334,"slug":26,"properties":1335,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1336},{"VI":1312},{"title":1338},{"VI":1339},"M. Mairé",{"id":1341,"sortIndex":59,"researcher":26,"roles":1342,"affiliations":1343,"properties":1352},"bb88777c-f89b-439e-b51c-c7ea126a3a83",[696],[1344],{"id":26,"sortIndex":36,"affiliation":1345,"properties":26},{"id":1346,"createTime":1347,"updateTime":1347,"relativeEntities":1348,"slug":26,"properties":1349,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"48806fb3-c4d2-4c81-8d98-d27ff67712ad","2023-12-06T10:49:32.907+00:00",[],{"title":1350},{"VI":1351},"Service de gynécologie obstétrique, Hôpital de Hautepierre, 1, avenue Molière, 67098 Strasbourg, France",{"title":1353},{"VI":1354},"J.-J. Baldauf",{"id":1356,"sortIndex":114,"researcher":26,"roles":1357,"affiliations":1358,"properties":1364},"455308a8-e84f-4cda-a550-5c7ed003cf55",[696],[1359],{"id":26,"sortIndex":36,"affiliation":1360,"properties":26},{"id":1346,"createTime":1347,"updateTime":1347,"relativeEntities":1361,"slug":26,"properties":1362,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1363},{"VI":1351},{"title":1365},{"VI":1366},"L. Lecointre",{"id":1368,"sortIndex":162,"researcher":26,"roles":1369,"affiliations":1370,"properties":1376},"04b09e20-9dd9-43ac-8b16-d480b767d683",[696],[1371],{"id":26,"sortIndex":36,"affiliation":1372,"properties":26},{"id":1307,"createTime":1308,"updateTime":1308,"relativeEntities":1373,"slug":26,"properties":1374,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1375},{"VI":1312},{"title":1377},{"VI":1378},"V. Lavoué",{"id":1380,"sortIndex":135,"researcher":26,"roles":1381,"affiliations":1382,"properties":1400},"ad230467-08fe-4629-b973-e70698d0c4be",[696],[1383,1395],{"id":1384,"sortIndex":115,"affiliation":1385,"properties":1394},"9e0c12fa-eae9-49fb-b2cb-909692c621fc",{"id":1386,"createTime":1387,"updateTime":1388,"relativeEntities":1389,"slug":1390,"properties":1391,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"06ce1d5c-8eeb-4d9f-a588-f9af43b6a252","2024-01-20T11:51:32.267+00:00","2025-06-11T19:51:51.306+00:00",[],"Soci%C3%A9t%C3%A9-fran%C3%A7aise-de-colposcopie-et-pathologie-cervico-vaginale-64-rue-de-Rennes-75006-Paris-France",{"title":1392},{"VI":1393},"Société française de colposcopie et pathologie cervico-vaginale, 64, rue de Rennes, 75006 Paris, France",{},{"id":26,"sortIndex":36,"affiliation":1396,"properties":26},{"id":1307,"createTime":1308,"updateTime":1308,"relativeEntities":1397,"slug":26,"properties":1398,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1399},{"VI":1312},{"title":1401},{"VI":1402},"J. Levêque",{"url":1299,"publisher":1404,"properties":1412},{"id":659,"createTime":660,"updateTime":660,"relativeEntities":1405,"slug":662,"properties":1406,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":1409,"manageAffiliations":1410,"indexDatabases":1411,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":1407,"title":1408},{"VOID":665},{"EN":667},[],[],[],{"volume":1413,"pages":1415},{"VOID":1414},"58",{"VOID":1416},"1-16","2022-12-01",2022,{"id":1420,"createTime":1421,"updateTime":1422,"relativeEntities":1423,"slug":1424,"properties":1425,"entityType":688,"verifyStatus":25,"verifyTime":1422,"verifyNote":690,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"primaryUrl":1432,"fullTextUrl":26,"authors":1433,"publicationType":747,"publisherRelationship":1463,"citationCount":26,"citationInfo":26,"publishDate":1477,"publishYear":1478,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":26,"isForceReanalyzing":772},"43acb280-1c0c-4866-91c0-8788dadce0ac","2024-01-17T13:36:24.521+00:00","2024-12-29T17:06:57.149+00:00",[],"Infecciones-de-transmisi%C3%B3n-sexual",{"references":1426,"title":1428,"doi":1430},{"VOID":1427},"Newman, 2015, Global estimates of the prevalence and incidence of four curable sexually transmitted infections in 2012 based on systematic review and global reporting, PLoS One, 10, 10.1371\u002Fjournal.pone.0143304\nLa Ruche, 2014, Évolution des résistances du gonocoque aux antibiotiques en France de 2001 à 2012, Bull Epidemiol Hebd, 5, 93\nBulletin des réseaux de surveillance des IST : données au 31 décembre 2013. INVS; novembre 2014.\nBulletin des réseaux de surveillance des infections sexuellement transmissibles (IST) - Rénago, Rénachla et RésIST : données au 31 décembre 2012. Saint-Maurice : InVS, 2015, consultation en ligne : http:\u002F\u002Fwww.invs.sante.fr\u002FDossiers-thematiques\u002FMaladies-infectieuses\u002FVIH-sida-IST\u002FInfections-sexuellement-transmissibles-IST\u002FBulletins-des-reseaux-de-surveillance-des-IST.\nBowen, 2015, Increase in incidence of congenital syphilis—United States, 2012-2014, MMWR Morb Mortal Wkly Rep, 64, 1241, 10.15585\u002Fmmwr.mm6444a3\nBerwald, 2009, Self-administered vaginal swabs are a feasible alternative to physician-assisted cervical swabs for sexually transmitted infection screening in the emergency department, Acad Emerg Med, 16, 360, 10.1111\u002Fj.1553-2712.2009.00359.x\nMiettinen, 1993, Test performance of erythrocyte sedimentation rate and C-reactive protein in assessing the severity of acute pelvic inflammatory disease, Am J Obstet Gynecol, 169, 1143, 10.1016\u002F0002-9378(93)90271-J\nAlthaus, 2012, Towards more robust estimates of the transmissibility of Chlamydia trachomatis, Sex Transm Dis, 39, 402, 10.1097\u002FOLQ.0b013e318248a550\nDavies, 2013, Risk of pelvic inflammatory disease after Chlamydia infection in a prospective cohort of sex workers, Sex Transm Dis, 40, 230, 10.1097\u002FOLQ.0b013e31827b9d75\nDavies, 2014, Heterogeneity in risk of pelvic inflammatory diseases after Chlamydia infection: a population-based study in Manitoba, Canada, J Infect Dis, 210, S549, 10.1093\u002Finfdis\u002Fjiu483\nHammerschlag, 1989, Chlamydial infections, J Pediatr, 114, 727, 10.1016\u002FS0022-3476(89)80128-3\nLanjouw, 2016, 2015 European guideline on the management of Chlamydia trachomatis infections, Int J STD AIDS, 27, 333, 10.1177\u002F0956462415618837\nLand, 2006, Chlamydia antibody testing in subfertile women, Drugs Today, 42, 35\nRenault, 2011, Time to clearance of Chlamydia trachomatis ribosomal RNA in women treated for chlamydial infection, Sex Health, 8, 69, 10.1071\u002FSH10030\nChan, 2016, Extragenital infections caused by Chlamydia trachomatis and Neisseria gonorrhoeae: a review of the literature, Infect Dis Obstet Gynecol, 2016, 5758387, 10.1155\u002F2016\u002F5758387\nTrebach, 2015, Neisseria gonorrhoeae and Chlamydia trachomatis among women reporting extragenital exposures, Sex Transm Dis, 42, 233, 10.1097\u002FOLQ.0000000000000248\nTully, 1981, A newly discovered mycoplasma in the human urogenital tract, Lancet, 1, 1288, 10.1016\u002FS0140-6736(81)92461-2\nTaylor-Robinson, 2011, Mycoplasma genitalium: from chrysalis to multicolored butterfly, Clin Microbiol Rev, 24, 498, 10.1128\u002FCMR.00006-11\nHaggerty, 2011, Mycoplasma genitalium: an emerging cause of pelvic inflammatory disease, Infect Dis Obstet Gynecol, 2006\nOliphant, 2016, Pelvic inflammatory disease associated with Chlamydia trachomatis but not Mycoplasma genitalium in New Zealand, Sex Health, 13, 43, 10.1071\u002FSH14238\nLillis, 2011, Utility of urine, vaginal, cervical, and rectal specimens for detection of Mycoplasma genitalium in women, J Clin Microbiol, 49, 1990, 10.1128\u002FJCM.00129-11\nJernberg, 2008, Azithromycin and moxifloxacin for microbiological cure of Mycoplasma genitalium infection: an open study, Int J STD AIDS, 19, 676, 10.1258\u002Fijsa.2008.008038\nJensen, 2016, 2016 European guideline on Mycoplasma genitalium infections, J Eur Acad Dermatol Venereol, 30, 1650, 10.1111\u002Fjdv.13849\nKokkayil, 2015, Ureaplasma: current perspectives, Indian J Med Microbiol, 33, 205, 10.4103\u002F0255-0857.154850\nZdrodowska-Stefanow, 2006, Ureaplasma urealyticum and Mycoplasma hominis infection in women with urogenital diseases, Adv Med Sci, 51, 250\nKataoka, 2006, Association between preterm birth and vaginal colonization by mycoplasmas in early pregnancy, J Clin Microbiol, 44, 51, 10.1128\u002FJCM.44.1.51-55.2006\nSilver, 2014, Trichomonas vaginalis as a cause of perinatal morbidity: a systematic review and meta-analysis, Sex Transm Dis, 41, 369, 10.1097\u002FOLQ.0000000000000134\nWorld Health Organisation. Sexually transmitted infections management guidelines 1999. http:\u002F\u002Fwww.who.int\u002FHIV_AIDS.\nMark, 2008, Rapidly cleared episodes of herpes simplex virus reactivation in immunocompetent adults, MJ Infect Dis, 198, 1141, 10.1086\u002F591913\nTronstein, 2011, Genital shedding of herpes simplex virus among symptomatic and asymptomatic persons with HSV-2 infection, JAMA, 305, 1441, 10.1001\u002Fjama.2011.420\nBrown, 2003, Effect of serologic status and cesarean delivery on transmission rates of herpes simplex virus from mother to infant, JAMA, 289, 203, 10.1001\u002Fjama.289.2.203\nCorey, 2004, Once-daily valacyclovir to reduce the risk of transmission of genital herpes, N Engl J Med, 350, 11, 10.1056\u002FNEJMoa035144\nCentre national de référence des Papillomavirus humains (CNR HPV), Institut Pasteur, 2016.\nDuport, 2004, Le cancer du col de l’utérus : état des connaissances en 2014, Bull Epidemiol Hebd\nMonsonego, 2006\nAlain, 2010, Papillomavirus : les virus et la physiopathologie de l’infection, Med Ther Pediatr, 13, 5\nGavillon, 2010, How did I contract human Papillomavirus (HPV)?, Gynecol Obstet Fertil, 38, 199, 10.1016\u002Fj.gyobfe.2010.01.003\nWiner, 2006, Condom use and the risk of genital human papillomavirus infection in young women, N Engl J Med, 354, 2645, 10.1056\u002FNEJMoa053284\nHuman Papillomaviruses, IARC Monographs on the Evaluation of Carcinogenic Risks to Humans (vol. 90), 2007.\nSyrjänen, 2000\nKoutsky, 1997, Epidemiology of genital human papillomavirus infection, Am J Med, 102, 3, 10.1016\u002FS0002-9343(97)00177-0\nD'Souza, 2007, Case-control study of human papillomavirus and oropharyngeal cancer, N Engl J Med, 356, 1944, 10.1056\u002FNEJMoa065497\nFerenczy, 1995, Epidemiology and clinical pathophysiology of condylomata acuminate, Am J Obstet Gynecol, 172, 1331, 10.1016\u002F0002-9378(95)90399-2\nCox, 2006, The development of cervical cancer and its precursors: what is the role of human papillomavirus infection?, Curr Opin Obstet Gynecol, 18\nWang, 2003, Viral and host factors in human papillomavirus persistence and progression, J Natl Cancer Inst Monogr, 31, 35, 10.1093\u002Foxfordjournals.jncimonographs.a003480\nIversen, 1998, Intraepithelial and invasive squamous cell neoplasia of the vulva: trends in incidence, recurrence, and survival rate in Norway, Obstet Gynecol, 91, 969\nCarter, 1993, Invasive vulvar tumors in young women- a disease of the immunosuppressed?, Gynecol Oncol, 51, 307, 10.1006\u002Fgyno.1993.1295\nANAES. Évaluation de l’intérêt de la recherche des papillomavirus humains (HPV) dans le dépistage des lésions précancéreuses et cancéreuses du col de l’utérus. Mai 2004.\nTamalet, 2016, Genotyping and follow-up of HR-HPV types detected by self-sampling in women from low socioeconomic groups not participating in regular cervical cancer screening in France, J Clin Virol, 78, 102, 10.1016\u002Fj.jcv.2016.02.027\nHaut Conseil de la Santé Publique : Avis sur les infections à HPV des jeunes filles : révision de l’âge de vaccination. Janvier 2013.\nChemlal, 2013\nJoura, 2015, A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women, N Engl J Med, 372, 711, 10.1056\u002FNEJMoa1405044\nHaute Autorité de santé. État des lieux et recommandations pour le dépistage du cancer du col de l’utérus en France. 2010.",{"ES":1429},"Infecciones de transmisión sexual",{"VOID":1431},"10.1016\u002Fs1283-081x(18)89322-5","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1283081X18893225",[1434,1451],{"id":1435,"sortIndex":36,"researcher":26,"roles":1436,"affiliations":1437,"properties":1448},"b7870109-cf54-4554-9ca5-b93c5f621fa4",[696],[1438],{"id":26,"sortIndex":36,"affiliation":1439,"properties":26},{"id":1440,"createTime":1441,"updateTime":1442,"relativeEntities":1443,"slug":1444,"properties":1445,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"06538763-c522-4171-81a3-5c78cfc57486","2024-01-10T16:43:12.676+00:00","2025-06-11T19:24:55.428+00:00",[],"Institut-Fournier-25-boulevard-Saint-Jacques-75014-Paris-France",{"title":1446},{"VI":1447},"Institut Fournier, 25, boulevard Saint-Jacques, 75014 Paris, France",{"title":1449},{"VI":1450},"J.-M. Bohbot",{"id":1452,"sortIndex":115,"researcher":26,"roles":1453,"affiliations":1454,"properties":1460},"c4367592-9996-4f01-972b-815ca8971b61",[696],[1455],{"id":26,"sortIndex":36,"affiliation":1456,"properties":26},{"id":1440,"createTime":1441,"updateTime":1442,"relativeEntities":1457,"slug":1444,"properties":1458,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1459},{"VI":1447},{"title":1461},{"VI":1462},"A. Marchal",{"url":1432,"publisher":1464,"properties":1472},{"id":659,"createTime":660,"updateTime":660,"relativeEntities":1465,"slug":662,"properties":1466,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":1469,"manageAffiliations":1470,"indexDatabases":1471,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":1467,"title":1468},{"VOID":665},{"EN":667},[],[],[],{"volume":1473,"pages":1475},{"VOID":1474},"54",{"VOID":1476},"1-9","2018-06-01",2018,{"id":1480,"createTime":1481,"updateTime":1482,"relativeEntities":1483,"slug":1484,"properties":1485,"entityType":688,"verifyStatus":25,"verifyTime":1482,"verifyNote":690,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"primaryUrl":1492,"fullTextUrl":26,"authors":1493,"publicationType":747,"publisherRelationship":1509,"citationCount":26,"citationInfo":26,"publishDate":1523,"publishYear":1524,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":26,"isForceReanalyzing":772},"9ae06f7b-84e9-4ba1-9226-45afccb334ee","2024-01-03T17:55:54.391+00:00","2024-12-30T05:23:19.179+00:00",[],"Embarazo-y-parto-a-partir-de-los-40-a%C3%B1os-de-edad",{"references":1486,"title":1488,"doi":1490},{"VOID":1487},"Khoshnood, 2008, Impact de l’âge maternel élevé sur la fertilité, la santé de la mère et la santé de l’enfant, J Gynecol Obstet Biol Reprod, 37, 733, 10.1016\u002Fj.jgyn.2008.08.007\nJoseph, 2009, Recent changes in maternal characteristics by socioeconomic status, J Obstet Gynaecol Can, 31, 422, 10.1016\u002FS1701-2163(16)34173-1\nDufour, 1997, La grossesse chez les femmes de plus de 40 ans, Contracept Fertil Sex, 25, 415\nBerkowitz, 1990, Delayed childbearing and the outcome of pregnancy, N Engl J Med, 322, 659, 10.1056\u002FNEJM199003083221004\nGilbert, 1999, Childbearing beyond age 40 pregnancy outcome in 24,032 cases, Obstet Gynecol, 93, 9\nLuke, 2007, Elevated risks of pregnancy complications and adverse outcome with increasing maternal age, Hum Reprod, 22, 1264, 10.1093\u002Fhumrep\u002Fdel522\nWarbuton, 2000, Cytogenetic abnormalities in spontaneous abortions of recognised conceptions\nFIVNAT, 1997, Âge et PMA, Contracept Fertil Sex, 25, 503\nBoue, 1975, Retrospective and prospective epidemiological studies of 1500 kariotypes spontaneous human abortions, Teratology, 12, 11, 10.1002\u002Ftera.1420120103\nSifroi, 1991, Le point sur le diagnostic prénatal des anomalies chromosomiques, Reprod Hum Horm, 4, 185\nHecht, 1994, The imprecision in rates of Down syndrome by 1-year maternal age intervals: a critical analysis of rates used in biochemical screening, Prenat Diagn, 14, 729, 10.1002\u002Fpd.1970140814\nThorburn, 1986, Background factors of ectopic pregnancy. II. Risk estimation by means of a logistic model, Eur J Obstet Gynecol Reprod Biol, 23, 333, 10.1016\u002F0028-2243(86)90168-1\nBouyer, 2003, Risk factors for ectopic pregnancy: a comprehensive analysis based on a large case-control, population-based study in France, Am J Epidemiol, 157, 185, 10.1093\u002Faje\u002Fkwf190\nHasan, 1991, Uterine leimyomata in pregnancy, Int J Gynaecol Obstet, 34, 45, 10.1016\u002F0020-7292(91)90537-F\nBelaisch-Allart, 1991, Les grossesses après 40 ans, Reprod Hum Horm, 4, 176\nBianco, 1996, Pregnancy outcome at age 40 and older, Obstet Gynecol, 87, 917, 10.1016\u002F0029-7844(96)00045-2\nHansen, 1986, Older maternal age and pregnancy outcome: a review of the litterature, Obstet Gynecol Surv, 41, 726, 10.1097\u002F00006254-198611000-00024\nGrimes, 1981, Pregnancy outcomes in black women aged 35 and older, Obstet Gynecol, 58, 614\nUsta, 2008, Advanced maternal age. Part I: obstetric complications, Am J Perinatol, 25, 521, 10.1055\u002Fs-0028-1085620\nBlum, 1979, Is the elderly primipara really at high risk, J Perinat Med, 7, 108, 10.1515\u002Fjpme.1979.7.2.108\nBooth, 1964, Elderly primipravidae, J Obstet Gynaecol Br Common W, 71, 249, 10.1111\u002Fj.1471-0528.1964.tb04274.x\nCleary-Goldman, 2005, FASTER: Consortium impact of maternal age on obstetric outcome, Obstet Gynecol, 10, 983, 10.1097\u002F01.AOG.0000158118.75532.51\nKirz, 1985, Advanced maternal age: the mature gravida, Am J Obstet Gynecol, 152, 7, 10.1016\u002FS0002-9378(85)80166-6\nAbu-Heija, 2000, Maternal and perinatal outcome of pregnancies after the age 45, J Obstet Gynaecol, 26, 27, 10.1111\u002Fj.1447-0756.2000.tb01196.x\nAbenhaim, 2008, Incidence and risk factors of amniotic fluid embolism: a population-based study on 3 million births in the United State, Am J Obstet Gynecol, 199, 10.1016\u002Fj.ajog.2007.11.061\nKnight, 2012, Amniotic fluid embolism incidence, risk factors and recommendations, BMC Pregnancy Childbirth, 12, 7, 10.1186\u002F1471-2393-12-7\nRoman, 2004, Grossesses chez 382 femmes de plus de 40 ans : étude rétrospective dans la population de l’île de la Réunion, J Gynecol Obstet Biol Reprod, 33, 615, 10.1016\u002FS0368-2315(04)96602-1\nZiadeh, 2001, Pregnancy outcome at age 40 and older, Arch Gynecol Obstet, 65, 30, 10.1007\u002Fs004040000122\nTreacy, 2006, Dystocia increases with advancing maternal age, Am J Obstet Gynecol, 195, 760, 10.1016\u002Fj.ajog.2006.05.052\nDarbois, 1990, Les grossesses survenant après 40 ans sont-elles à haut risque ?, Rev Fr Gynecol Obstet, 85, 158\nYasin, 1988, Pregnancy outcome at 20 weeks gestation in women in their 40. Case control study, J Reprod Med, 33, 209\nKessier, 1980, The problems of the older primipara, Obstet Gynecol, 56, 165\nChan, 1999, Influence of parity on the obstetric performance of mothers aged 40 years and above, Hum Reprod, 14, 833, 10.1093\u002Fhumrep\u002F14.3.833\nTuck, 1988, Pregnancy outcome in elderly primigravidae with and without a history of infertility, Br J Obstet Gynaecol, 95, 230, 10.1111\u002Fj.1471-0528.1988.tb06862.x\nFliehr, 1956, Management of the elderly primigravida, Obstet Gynecol, 8, 494\nEzra, 1995, High delivery interventions in nulliparous women over age 35, Eur J Obstet Gynecol Reprod Biol, 62, 203, 10.1016\u002F0301-2115(95)02201-H\nYogev, 2010, Pregnancy at extremely advanced maternal age, Am J Obstet Gynecol, 203, 10.1016\u002Fj.ajog.2010.07.039\nJolly, 2000, The risks associated with pregnancy in women aged 35 years or older, Hum Reprod, 15, 2433, 10.1093\u002Fhumrep\u002F15.11.2433\nSaucedo, 2013, Épidémiologie de la mortalité maternelle en France, 2007-2009, J Gynecol Obstet Biol Reprod, 42, 613, 10.1016\u002Fj.jgyn.2013.06.011\nIsraël, 1964, Relation of the mother's age to obstetric performance, Obstet Gynecol, 24, 411, 10.1097\u002F00006250-196409000-00014\nMorrison, 1975, The elderly primigravida, Am J Obstet Gynecol, 121, 465, 10.1016\u002F0002-9378(75)90076-9\nLee, 1988, Maternal age and incidence of low birth weight at term: a population study, Am J Obstet Gynecol, 158, 84, 10.1016\u002F0002-9378(88)90783-1\nSimchen, 2006, Pregnancy outcome after age 50, Obstet Gynecol, 108, 1084, 10.1097\u002F01.AOG.0000240139.46018.bd\nSheiner, 2001, Infertility treatment is an independent risk factor for cesarian section among nulliparous women aged 40 and above, Am J Obstet Gynecol, 185, 888, 10.1067\u002Fmob.2001.117308\nJacobson, 2004, Advanced maternal age and adverse perinatal outcomes, Obstet Gynecol, 104, 727, 10.1097\u002F01.AOG.0000140682.63746.be\nVincent-Rohfritsch, 2012, Grossesse à 43 ans et plus : risques maternels et périnataux, J Gynecol Obstet Biol Reprod, 41, 468, 10.1016\u002Fj.jgyn.2012.04.013\nGhazi, 1991, Delivery outcome after infertility. A registry study, Fertil Steril, 55, 726, 10.1016\u002FS0015-0282(16)54238-1\nHollier, 2000, Maternal age and malformation in singleton births, Obstet Gynecol, 96, 701\nReefhuis, 2004, Maternal age and non chromosomal birth defects. Atlanta-1968-2000: teenager or thirty-something, who is at risk?, Birth Defects Res A Clin Mol Teratol, 70, 572, 10.1002\u002Fbdra.20065\nFretts, 1995, Increased maternal age and the risk of fetal death, N Engl J Med, 333, 953, 10.1056\u002FNEJM199510123331501\nKiely, 1986, An assessment of the effects of maternal age and parity in different components of perinatal mortality, Am J Epidemiol, 123, 444, 10.1093\u002Foxfordjournals.aje.a114259\nReddy, 2006, Maternal age and the risk of stillbirth throughout pregnancy in the United States, Obstet Gynecol, 195, 764\nLeridon, 1996, Des naissances de plus en plus tardives, Lettre Gynecol, 210, 5\nDildy, 1994, Very advanced maternal age: pregnancy after age 45, Am J Obstet Gynecol, 175, 668, 10.1053\u002Fob.1996.v175.a74402\nDulitzki, 1998, Effect of very advanced maternal age on pregnancy outcome and rate of cesarian delivery, Obstet Gynecol, 92, 935\nSunol Sala, 2007, Evolution of clinical pregnancies obtained from patients > 45 years old receiving oocyte donation. O256 Abstracts of the 23rd Annual Meeting of the ESHRE, Lyon, France, 1-4 july 2007, Hum Reprod, 22, i102\nSchoen, 2009, Maternal and perinatal risks for women over 44: a review, Maturitas, 64, 109, 10.1016\u002Fj.maturitas.2009.08.012\nJackson, 2015, Pregnancy outcome in very advanced maternal age pregnancies: the impact of assisted reproductive technology, Fertil Steril, 103, 76, 10.1016\u002Fj.fertnstert.2014.09.037\nINED 1991 et 1992. Rapport sur la situation démographique en France.\nINSEE. Résultats. La situation démographique en 1989. 1991. p. 75–110.\nSauer, 1993, Pregnancy after age 50: applying oocyte donation to women following natural menopause, Lancet, 341, 321, 10.1016\u002F0140-6736(93)90132-Z\nSauer, 1995, Pregnancy in women 50 or more years of age: outcomes of 22 consecutively established pregnancies from oocyte donation, Fertil Steril, 64, 111, 10.1016\u002FS0015-0282(16)57665-1\nSalihu, 2003, Childbearing beyond maternal age 50 and fetal outcomes in the United States, Obstet Gynecol, 102, 1006\nSauer, 2015, Reproduction at an advanced maternal age and maternal health, Fertil Steril, 103, 1136, 10.1016\u002Fj.fertnstert.2015.03.004\nAuroux, 1991, Évolution de la fertilité masculine en fonction de l’âge et risque pour la progéniture, Contracept Fertil Sex, 19, 945\nEthics Committee of the American Society for Reproductive Medecine, 2013, Oocyte or embryo donation to women of advanced age: a committee opinion, Fertil Steril, 100, 337, 10.1016\u002Fj.fertnstert.2013.02.030\nVan Der Hoorn, 2010, Clinical and immunologic aspects of egg donation pregnancies: a systematic review, Hum Reprod Update, 16, 704, 10.1093\u002Fhumupd\u002Fdmq017\nSerhal, 1987, Immune basis for pre-eclampsia evidence from oocyte recipients, Lancet, 2, 744, 10.1016\u002FS0140-6736(87)91104-4\nLeray, 2012, Association between oocyte donation and maternal and perinatal outcomes in women aged 43 or older, Hum Reprod, 27, 896, 10.1093\u002Fhumrep\u002Fder469\nHenne, 2007, Comparison of obstetric outcomes in recipient of donor oocyte vs women of advanced age with autologous oocytes, J Reprod Med, 52, 585\nMills, 2014, Advanced maternal age, Obstet Gynaecol Reprod Med, 24, 85, 10.1016\u002Fj.ogrm.2014.01.004\nTearne, 2015, Older maternal age and child behavioral and cognitive outcomes: a review of the literature, Fertil Steril, 103, 1381, 10.1016\u002Fj.fertnstert.2015.04.027\nSutclife, 2012, The health and development of children born to older mothers in the United Kingdom: observational study using longitudinal cohort data, Br Med J, 345, e5116, 10.1136\u002Fbmj.e5116",{"ES":1489},"Embarazo y parto a partir de los 40 años de edad",{"VOID":1491},"10.1016\u002Fs1283-081x(17)86886-7","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1283081X17868867",[1494],{"id":1495,"sortIndex":36,"researcher":26,"roles":1496,"affiliations":1497,"properties":1506},"b6ba86c5-9d2e-46a2-a55e-e5e6d3ea43e2",[696],[1498],{"id":26,"sortIndex":36,"affiliation":1499,"properties":26},{"id":1500,"createTime":1501,"updateTime":1501,"relativeEntities":1502,"slug":26,"properties":1503,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"d07e2865-2fcf-401f-9e15-06d6ecea22a3","2024-01-03T17:55:54.400+00:00",[],{"title":1504},{"VI":1505},"Centre hospitalier des Quatre Villes, rue Charles-Lauer, 92210 Saint-Cloud, France",{"title":1507},{"VI":1508},"J. Belaisch-Allart",{"url":1492,"publisher":1510,"properties":1518},{"id":659,"createTime":660,"updateTime":660,"relativeEntities":1511,"slug":662,"properties":1512,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":1515,"manageAffiliations":1516,"indexDatabases":1517,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":1513,"title":1514},{"VOID":665},{"EN":667},[],[],[],{"volume":1519,"pages":1521},{"VOID":1520},"53",{"VOID":1522},"1-11","2017-12-01",2017,{"id":1526,"createTime":1527,"updateTime":1528,"relativeEntities":1529,"slug":1530,"properties":1531,"entityType":688,"verifyStatus":25,"verifyTime":1528,"verifyNote":690,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":115,"primaryUrl":1538,"fullTextUrl":26,"authors":1539,"publicationType":747,"publisherRelationship":1615,"citationCount":26,"citationInfo":26,"publishDate":1628,"publishYear":1629,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":26,"isForceReanalyzing":772},"8ce5b912-190e-4de7-9264-4fc6361c5b93","2024-01-05T17:45:26.099+00:00","2024-12-30T17:48:33.353+00:00",[],"Incontinencia-urinaria-de-la-mujer",{"references":1532,"title":1534,"doi":1536},{"VOID":1533},"Fritel, 2010, Diagnosis and management of adult female stress urinary incontinence: guidelines for clinical practice from the French College of Gynaecologists and Obstetricians, Eur J Obstet Gynecol Reprod Biol, 151, 14, 10.1016\u002Fj.ejogrb.2010.02.041\nHaylen, 2010, An International Urogynecological Association (IUGA)\u002FInternational Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction, Neurourol Urodyn, 29, 4, 10.1002\u002Fnau.20798\nHaab, 2004, Terminology of lower urinary tract dysfunction: French adaptation of the terminology of the International Continence Society, Prog Urol, 14, 1103\nSubak, 2009, Weight loss to treat urinary incontinence in overweight and obese women, N Engl J Med, 360, 481, 10.1056\u002FNEJMoa0806375\nBoyle, 2012, Pelvic floor muscle training for prevention and treatment of urinary and faecal incontinence in antenatal and postnatal women, Cochrane Database Syst Rev, 10.1002\u002F14651858.CD007471.pub2\nRai, 2012, Anticholinergic drugs versus non-drug active therapies for non-neurogenic overactive bladder syndrome in adults, Cochrane Database Syst Rev, 10.1002\u002F14651858.CD003193.pub4\nRegusci S. Neurostimulation sacrée : technique d’implantation. EMC (Elsevier Masson SAS, Paris), Techniques chirurgicales - Urologie, 41-260, 2009.\nKhodari M, Yiou R. Toxine botulique dans le traitement de l’hyperactivité vésicale neurogène. EMC (Elsevier Masson SAS, Paris), Techniques chirurgicales – Urologie, 41-261, 2011.\nHermieu JF. Traitement de l’incontinence urinaire d’effort de la femme par bandelette sous-urétrale. EMC (Elsevier Masson SAS, Paris), Techniques chirurgicales – Urologie, 41-361-C, 2011.\nDeffieux, 2011, Urinary incontinence in pregnant women, Rev Prat, 61, 966\nMichel-Laaengh, 2009, Urinary incontinence in aged women, J Gynecol Obstet Biol Reprod, 38, S232, 10.1016\u002FS0368-2315(09)73581-1",{"ES":1535},"Incontinencia urinaria de la mujer",{"VOID":1537},"10.1016\u002Fs1283-081x(15)76283-1","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1283081X15762831",[1540,1555,1567,1579,1591,1603],{"id":1541,"sortIndex":59,"researcher":26,"roles":1542,"affiliations":1543,"properties":1552},"9d79f265-4e45-479d-a60e-3c46134179ca",[696],[1544],{"id":26,"sortIndex":36,"affiliation":1545,"properties":26},{"id":1546,"createTime":1547,"updateTime":1547,"relativeEntities":1548,"slug":26,"properties":1549,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"b50f481a-5c7d-4fd5-9828-d603ca93dcb1","2024-01-05T17:45:26.139+00:00",[],{"title":1550},{"VI":1551},"Service de gynécologie obstétrique et médecine de la reproduction, Hôpital Antoine-Béclère, Hôpitaux universitaires Paris Sud, AP–HP, 157, rue de la Porte-de-Trivaux, 92140 Clamart, France",{"title":1553},{"VI":1554},"A.-L. Rivain",{"id":1556,"sortIndex":162,"researcher":26,"roles":1557,"affiliations":1558,"properties":1564},"68c70681-cb30-4d88-a24a-dc2edd794709",[696],[1559],{"id":26,"sortIndex":36,"affiliation":1560,"properties":26},{"id":1546,"createTime":1547,"updateTime":1547,"relativeEntities":1561,"slug":26,"properties":1562,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1563},{"VI":1551},{"title":1565},{"VI":1566},"C. Trichot",{"id":1568,"sortIndex":111,"researcher":26,"roles":1569,"affiliations":1570,"properties":1576},"912e68af-f22e-4406-b9e9-f9b804411b4b",[696],[1571],{"id":26,"sortIndex":36,"affiliation":1572,"properties":26},{"id":1546,"createTime":1547,"updateTime":1547,"relativeEntities":1573,"slug":26,"properties":1574,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1575},{"VI":1551},{"title":1577},{"VI":1578},"E. Faivre",{"id":1580,"sortIndex":36,"researcher":26,"roles":1581,"affiliations":1582,"properties":1588},"9d7d5c8c-b8a4-4e67-a6ba-baaa49309fc7",[696],[1583],{"id":26,"sortIndex":36,"affiliation":1584,"properties":26},{"id":1546,"createTime":1547,"updateTime":1547,"relativeEntities":1585,"slug":26,"properties":1586,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1587},{"VI":1551},{"title":1589},{"VI":1590},"X. Deffieux",{"id":1592,"sortIndex":114,"researcher":26,"roles":1593,"affiliations":1594,"properties":1600},"68f3a491-a237-47e5-89a0-05f63eee772e",[696],[1595],{"id":26,"sortIndex":36,"affiliation":1596,"properties":26},{"id":1546,"createTime":1547,"updateTime":1547,"relativeEntities":1597,"slug":26,"properties":1598,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1599},{"VI":1551},{"title":1601},{"VI":1602},"G. Demoulin",{"id":1604,"sortIndex":115,"researcher":26,"roles":1605,"affiliations":1606,"properties":1612},"b980607c-fb31-4520-a6a0-b2a032f47eab",[696],[1607],{"id":26,"sortIndex":36,"affiliation":1608,"properties":26},{"id":1546,"createTime":1547,"updateTime":1547,"relativeEntities":1609,"slug":26,"properties":1610,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1611},{"VI":1551},{"title":1613},{"VI":1614},"T. Thubert",{"url":1538,"publisher":1616,"properties":1624},{"id":659,"createTime":660,"updateTime":660,"relativeEntities":1617,"slug":662,"properties":1618,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":1621,"manageAffiliations":1622,"indexDatabases":1623,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":1619,"title":1620},{"VOID":665},{"EN":667},[],[],[],{"volume":1625,"pages":1627},{"VOID":1626},"52",{"VOID":1416},"2016-03-01",2016]